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Anion exchanger proteins facilitate chloride-bicarbonate movement across the plasma 
membrane and play an important role in maintaining acid-base homeostasis in the human body. 
Kidney anion exchanger 1 (kAE1) is one of the major bicarbonate transporters among this group 
and helps to reabsorb bicarbonate for chloride in distal nephrons. Defects of this protein result 
in functional impairment of the anion exchange process that eventually leads to the 
development of a clinical condition known as distal renal tubular acidosis (dRTA). Although 
the genetic basis of kAE1 mutants leading to disease is largely known, the precise molecular 
processes of dRTA pathophysiology are still inadequately understood. Here, the potential of 
baker’s yeast was evaluated to address various cellular aspects of kAE1 physiology. For the 
first time, unmodified and tagged full-length versions of kAE1 were successfully expressed in 
yeast. Moreover, partial localization of the anion exchanger at the plasma membrane was 
validated by accomplishing several light and confocal microscopy techniques and biochemical 
assays. Subsequently, biological activity of the protein was demonstrated by performing 
intracellular pH measurements and chloride uptake assays. Additionally, a set of novel dRTA 
mutants was characterized in mIMCD3 cells, resembling the closest cellular model to 
α-intercalated cells. In sum, this study highlights novel possibilities to investigate kAE1-related 
physiology and pathology in more detail. 
Anionenaustauscherproteine erleichtern die Bewegung von Chlorid-Bicarbonat durch die 
Plasmamembran und spielen eine wichtige Rolle bei der Aufrechterhaltung der 
Säure-Base-Homöostase im menschlichen Körper. Der Anionenaustauscher 1 (kAE1) der Niere 
ist einer der wichtigsten Bicarbonat-Transporter, der die Resorption von Bicarbonat für Chlorid 
im distalen Nephron unterstützt. Defekte dieses Proteins führen zu einer Beeinträchtigung des 
Anionen-Austauschprozesses und zur Entwicklung der distalen renalen tubulären Azidose 
(dRTA). Obwohl der genetische Hintergrund der krankmachenden kAE1-Mutanten weitgehend 
bekannt ist, sind die molekularen Prozesse der dRTA-Pathophysiologie nur unzureichend 
verstanden. In dieser Studie wurde die Bäckerhefe zur Untersuchung zellulärer Aspekte der 
kAE1-Physiologie eingesetzt. Erstmalig wurden eine unmodifizierte und getaggte 
kAE1-Volllängenversion erfolgreich in Hefe exprimiert. Darüber hinaus wurde die partielle 
Lokalisierung des Anionenaustauschers in der Plasmamembran durch Mikroskopietechniken 
und biochemische Assays validiert. Anschließend wurde die biologische Proteinaktivität durch 
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intrazelluläre pH-Messungen und Chlorid-Aufnahmestudien nachgewiesen. Zusätzlich wurde 
eine Reihe von neuen dRTA-Mutanten in mIMCD3-Zellen charakterisiert, die als zelluläres 
Modell den α-interkalierten Zellen am nächsten kommen. Damit eröffnet die vorliegende 













 Nephron: the functional unit of the kidney 
Every day various metabolic waste products from consumed food and the surrounding 
environment are generated in the human body which need to be excreted. In this respect, the 
human body depends on two main organs for detoxification and secretion of unwanted 
metabolites, toxins and chemicals: the liver and the kidney. The latter, naturally found pairwise 
in vertebrates, represents the central organ of the urinary system and plays a fundamental role 
in filtering blood plasma to remove waste products. Hence, they excrete the metabolic waste 
along with toxins through the urine and reabsorb solutes, essential molecules such as glucose, 
amino acids, and water eventually returning them into the bloodstream. Moreover, kidneys also 
participate in controlling the blood volume, pH, osmolarity and ionic composition by regulating 
the water-electrolyte and acid-base balance (Kriz & Kaissling, 2013). 
The kidney possesses a complex structure consisting of its functional unit known as nephron. 
A single kidney of a healthy adult is composed of about one million nephrons, which contribute 
to the urine formation through a series of sophisticated processes involved in filtering, 
reabsorption, secretion and excretion of molecules to and from the blood. Each nephron 
comprises a renal corpuscle and a renal tubule (Figure 1.1). The renal corpuscle is formed of a 
tuft of capillaries known as glomerulus and the surrounding double-walled epithelial cup, the 
so-called glomerular capsule or Bowman’s capsule. Blood from the afferent arteriole enters into 
the renal corpuscle, and the blood plasma is then filtered by traversing through the fenestrated 
glomerular endothelial cells (GEnC). Thereafter, the filtered fluid passes through the renal 
tubule which contains three different sections: the proximal convoluted tubule, the nephron 
loop (also known as the loop of Henle) and the distal convoluted tubule. Next, the collecting 
duct, linked to the distal convoluted tubule by the connecting tubule, is accumulating luminal 
fluid from the distal convoluted tubule of several nephrons and releases into the minor calyx 
(Kriz et al., 1988). Each section of the nephron is composed of diverse groups of cells and, 
thereby, the functions of each segment is determined by its cell types, tight junction properties 
and expressed ion-channels or solute carriers. Interestingly, the conversion from one section to 
the next takes place gradually because the expression of several essential proteins is overlapping 
between one-another. For example, the sodium-chloride cotransporter and the epithelium 
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sodium channel (ENaC) can be found in the transitional section of the distal convoluted tubule 
as well as in the collecting duct (Lashhab et al., 2019; Tortora & Derrickson, 2014). 
 
 
Figure 1.1: Schematic outline of nephron anatomy. 
The diagram is showing a nephron (blue) associated with a blood vessel (red). Blood from the 
afferent arteriole flows into the glomerulus for filtration. The filterable blood components pass 
through the capillary network of the glomerulus and move into the Bowman’s capsule. Then, 
the filtrate travels across the renal tubule consisting of the proximal convoluted tubule, loop of 
Henle, and distal convoluted tubule, where most of the electrolytes, macromolecules, and water 
reabsorption happens. Eventually, the tubular fluid arrives into the collecting duct system in 
which the final reabsorption of ions occurs, and the urine is formed (adopted from Tortora & 
Derrickson, 2014). 
 
The filtered fluid in the proximal tubule has a similar composition as the blood plasma, except 
that it contains a lower amount of proteins. While passing through the nephron, the filtrate 
composition is constantly modified by reabsorption and excretion of its substances. In the 
proximal tubule, a significant portion of ions, solutes and water is reabsorbed, whereas the 
reabsorption of calcium, magnesium, sodium and chloride occurs in both, the nephron loop and 
distal convoluted tubule. Furthermore, the collecting duct controls the final absorption of 
protons, sodium, bicarbonate, chloride, potassium and water, thereby fine-tuning the urine 
composition and acidification. This absorption of water and electrolytes in the collecting duct 
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is mediated through both transcellular and paracellular pathways by the participation of at least 
three types of cells: the principal cells, α-, and β-intercalated cells (Koeppen et al., 2013). 
 The intercalated cells 
Kloth and colleagues reported that the electron microscopy of the embryonic collecting duct 
epithelium reveals a heterogeneous structure composed of different cell types where the light 
cells refer to the principal cells and the dark cells refer to the intercalated cells (Kloth et al., 
1993). In mouse, rat, and rabbit, one-third of the cortical collecting duct’s cells were found to 
be intercalated cells (Kim et al., 1999; LeFurgey & Tisher, 1979). These cells are characterized 
by their high enrichment of mitochondria, a dark cytoplasm and apically located 
microprojections (Schuster, 1993). Depending on the cell morphology and localization of the 
key surface proteins, three types of intercalated cells have been identified, α-/type-A 
intercalated cells, β-/type-B intercalated cells and non-α/non-β (or non-A/non-B) intercalated 
cells (Roy et al., 2015).  
The α-intercalated cells (also known as acid-secreting cells) have a columnar shape with the 
micro-projections at the apical pole and tubulovesicular structure beneath the apical surface. 
These cells express V-H+-ATPase and H+/K+-ATPase, two major proton pumps, at their apical 
membrane, while the kidney anion exchanger 1 (kAE1), a spliced variant of erythroid anion 
exchanger 1 (eAE1), is expressed at the basolateral membrane (Figure 1.2, left). The 
α-intercalated cells contribute to the acid-base homeostasis and urine acidification in distal 
nephrons by extruding protons (H+) through the two proton pumps and absorbing bicarbonate 





Figure 1.2: Model illustrating transepithelial transport of bicarbonate and protons in α- 
and β-intercalated cells. 
In the collecting duct of the kidney, α-intercalated cells (left) excrete H+ through apically 
located V-H+-ATPase and H+/K+-ATPase, and exchange HCO3− for Cl− across the basolateral 
membrane through kAE1 to the interstitium in an electroneutral manner. This leads to the 
acidification of urine and distribution of HCO3− into the blood. Conversely, β-intercalated cells 
(right) secrete HCO3− into the tubular fluid using pendrin and reabsorb H+ into the blood via 
the basolaterally expressed V-H+-ATPase. This results in the maintenance of the blood pH 
during alkalemia. Both cells also express a chloride channel at the basolateral membrane that 
regulates Cl− homeostasis in the distal nephron (modified from Koeppen, 2009).  
 
In contrast, β-intercalated cells are not only displaying a squamous-like structure but also have 
a smooth apical side and an organelle-free zone under the apical membrane. Moreover, they 
possess an opposite polarity compared to α-intercalated cells manifesting in a basolateral 
location of the V-H+-ATPase and expression of a different bicarbonate exchanger named 
pendrin (SLC26A4) at the apical membrane (Figure 1.2, right). In case of alkalosis, 
β-intercalated cells contribute to the excretion of excess HCO3− and reabsorption of H+ 
maintaining the acid-base balance. In addition, these cells are involved in chloride (Cl−) 
reabsorption leading to ion homeostasis. Finally, non-α-/non-β-intercalated cells are identified 
by the expression of both, pendrin and V-H+-ATPase, at the apical membrane with a large 
number of cytoplasmic vesicles. The function of this type of intercalated cells is still not well 
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understood. However, the location of pendrin and V-H+-ATPase at the same pole suggests that 
these cells might participate in ion homeostasis rather than in acid-base balance, or they 
represent an intermediate cell-type that underwent interconversion (Almomani et al., 2014; 
Lashhab et al., 2019; Teng-umnuay et al., 1996a). It has been reported that immortalized 
β-intercalated cells can convert into α-intercalated cells by basolateral deposition of the 
extracellular matrix protein hensin. In support of these findings, hensin knock-out mice exhibit 
a significantly higher number of β-intercalated cells with a simultaneously reduced number of 
α-intercalated cells in the collecting duct and a progression of metabolic acidosis (Gao et al., 
2010). 
 The SLC4A1 bicarbonate transporter 
1.3.1 Bicarbonate transport mechanisms in human 
Carbon dioxide (CO2) represents a conjugate acid that is continuously generated as a metabolic 
byproduct in the human body. To maintain acid-base equilibrium, it needs to be eliminated from 
the body. CO2 is released through the lungs and kidneys as part of a CO2/HCO3− buffer system 
by the following reaction: CO2 + H2O ↔ H2CO3 ↔ H+ + HCO3−. Unlike gaseous CO2 that can 
permeate across the plasma membrane (PM), HCO3− is negatively charged and cannot penetrate 
membranes freely. However, HCO3− transport is facilitated by bicarbonate transporters which 
are integral membrane proteins ubiquitously expressed in various cell-types (Cordat & Casey, 
2009). Fourteen gene products have been identified facilitating bicarbonate transport in the 
human body (Figure 1.3). According to the Human Genome Organization, these bicarbonate 
transport proteins are classified as solute carriers or “SLC” and belong to two evolutionarily 
distinct superfamilies, SLC4 and SLC26 (Wain, 2004).  
The SLC4 gene family contains ten members, where the majority of them (nine proteins) are 
bicarbonate transporters. This gene family is further categorized into three subfamilies: 
(1) electroneutral Na+-independent Cl−/HCO3− exchangers SLC4A1–3 (AE1–3), 
(2) electrogenic Na+-coupled HCO3− cotransporters SLC4A4 and 5 (NBCe1 and NBCe2), and 
(3) electroneutral Na+-coupled HCO3− cotransporters SLC4A7, 8, 10 (NBCn1, NDCBE and 
NBCn2) and SLC4A9. SLC4A11 clusters separately within the SLC4 superfamily as it is 
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known to transport borate ions (Park et al., 2005) and water (Vilas et al., 2013) or exchange 
Na+/H+ (Jalimarada et al., 2013). 
 
 
Figure 1.3: Bicarbonate transporters in mammals. 
Bicarbonate transporters cluster into the two superfamilies SLC4 and SLC26 comprising 
fourteen gene products in total. SLC4 can be further subdivided into three sub-families, the 
electroneutral Na+-independent transporters, the electrogenic Na+-coupled cotransporters and 
the electroneutral Na+-coupled cotransporters. In the SLC26 superfamily, SLC26A3, 4, 6, 7, 
and 9 are involved in transporting HCO3− (modified from Alka & Casey, 2014). 
 
In contrast, the SLC26 family members act as Na+-independent anion exchangers or anion 
channels that transport a wide range of substrates including Cl−, I−, HCO3−, SO42−, formate, 
glycolate and oxalate. The SLC26 family consists of eleven members, where SLC26A10 is 
considered to be a pseudogene (Alper & Sharma, 2013). Among these eleven members, only 




























6, 7, 9  
 18 
1.3.2 SLC4A1 isoforms: eAE1 and kAE1 
The SLC4A1 gene encodes two anion exchanger 1 (AE1) isoforms in humans, one of them is 
the erythroid anion exchanger 1 (eAE1, also named as Band 3), which is also the most studied 
bicarbonate transport protein of the SLC4 superfamily (Cordat & Reithmeier, 2014). The gene 
is located on chromosome 17 (17q21–q22) with a length of approximately 20 kb and composes 
of 20 exons split by 19 introns (Tanner et al., 1988). In 1971, Fairbanks and colleagues 
identified eAE1 by analyzing red blood cell (RBC) ghost membrane proteins by gel 
electrophoresis; the third major band within the top of the gel corresponded to eAE1 resulting 
in the initial name “Band 3” (Fairbanks et al., 1971). The glycoprotein eAE1 consists of 911 
amino acids and is highly abundant in the plasma membrane of RBCs. Initial findings suggested 
that eAE1 is expressed with a copy number of approximately 1 x 106 per cell, where it 
comprehends approximately 50% of all membrane proteins in RBCs (Yenchitsomanus et al., 
2005). 
eAE1 mediates chloride/bicarbonate (Cl−/HCO3−) anion exchange across the plasma membrane 
of RBCs. This activity is essential for efficient respiration, which requires the adequate delivery 
of oxygen (O2) to tissues coupled with the removal of CO2. In tissues, the metabolic product 
CO2 diffuses into RBCs, interacts with water, and is then converted into HCO3− and H+ by the 
carbonic anhydrase II (CA II). This allows the Bohr effect to take place: an increase in the 
proton concentration results in a pH drop, leading to a conformational change of hemoglobin 
from its “relaxed form” to the so-called “taut form” which has a low-affinity for O2 (Benner et 
al., 2018). Thus, O2 is released from hemoglobin and diffuses into tissues. This system does not 
only allow for the unloading of oxygen, but also results in the conversion of CO2 to the more 
soluble HCO3− ions. HCO3− is the form in which ~90% of CO2 is transported to the lung. The 
eAE1 protein is responsible for the efflux of HCO3− into the plasma in exchange for Cl−, thereby 
inhibiting HCO3− accumulation in RBCs. In the lungs, however, the exchange activity of eAE1 
reverses. Plasma HCO3− which moves into the RBCs through eAE1 is converted to CO2 by the 
catalytic activity of CA II. Then, the produced CO2 diffuses out of the RBCs and is breathed 
out by the lung. The high quantity of eAE1 protein in RBCs demonstrates the importance of 
this transport system, allowing the mediation of respiration (Cordat & Reithmeier, 2014; 
Reithmeier, 2001).  
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The kidney anion exchanger 1 (kAE1) represents the second isoform encoded by SLC4A1 and 
is highly enriched at the basolateral membrane of the α-intercalated cells in the connecting 
tubule and the collecting duct. The kAE1 protein was initially described by Drenckhahn and 
colleagues in 1985 (Drenckhahn et al., 1985). It resembles a truncated version of eAE1 lacking 
the first 65 N-terminal amino acids (aa), and plays a central role in the maintenance of renal 
acid-base balance. In the process of urine acidification, kAE1 mediates a Na+-independent 
electroneutral exchange of HCO3− for Cl−, which permits the exit of HCO3− from the 
α-intercalated cells. The α-intercalated cells are involved in active H+ secretion into the tubular 
lumen through the activity of apically located V-H+-ATPase. When CO2 diffuses into 
α-intercalated cells, it is hydrolyzed by the catalytic activity of cytosolic CA II into carbonic 
acid (H2CO3) which subsequently dissociates into H+ and HCO3−. H+ is pumped out by the 
V-H+-ATPase into the tubular lumen, and HCO3− is absorbed into the interstitial fluid by the 
basolateral kAE1 protein. Thus, the function of kAE1 causes a net H+ secretion into urine by 
absorbing HCO3− to the body (Alper et al., 1989; Alper et al., 2002). 
1.3.3 Structure of eAE1 and kAE1 
Apart from kAE1 lacking the first 65 N-terminal aa compared to eAE1, both AE1 variants share 
the same structural features. AE1 is divided into two distinct domains, the N-terminal cytosolic 
domain (1–360 aa) and the integral membrane domain (361–911 aa). Moreover, the protein 
consists of 14 transmembrane segments (TMs), six helical segments, and an N-glycosylation 
site at Asn642 in the long disordered fourth extracellular loop that connects TM7 and TM8 
(Figure 1.4). An important feature of AE1 is the division into separate structural and functional 




Figure 1.4: Membrane topology of monomeric AE1. 
The topology model illustrates the membrane domain of AE1 (mdAE1) encompassing 14 
transmembrane segments (TMs). The long cytosolic N-terminus is not depicted in this scheme, 
α helices are colored as blue to red from N-terminus to the C-terminal end and shown in 
proportion to their length. TMs are noted by numbers (1–14), and amphipathic helices on the 
protein surface are labeled as H1–6. mdAE1 comprises two domains: a core domain (left) 
consisting of TM1–4 and TM8–11, and a gate domain (right) containing TM5–7 and TM12–
14. The anion binding site of AE1 is located in the core domain indicated by a “purple sphere” 
between TM3 and TM10. The protein is incorporated with a single N-glycosylation site located 
at Asn642, in the fourth long exofacial loop connecting TM7 and 8. The binding site of the 
irreversible anion inhibitor H2DIDS is shown that crosslinks between TM5 and 13 (adopted 
from Abbas et al., 2018). 
 
Many attempts have been made to determine the 3D structure of the membrane domain of AE1 
(mdAE1) by using techniques such as cysteine scanning mutagenesis and N-glycan insertion. 
In 2015, Arakawa and colleagues were able to identify the crystal structure of the open 4,4-
diisothiocyanatodihydro-stilbene2,2-disulfonic acid (H2DIDS) bound conformation of mdAE1 
(Arakawa et al., 2015). C-terminal mdAE1 is responsible for mediating the transport of anions 
across the lipid bilayer and is fully functional in the absence of the cytosolic N-terminus 
domain. mdAE1 can be further divided into the core (TM1–4 and 8–11) and gate (TM5–7 and 
12–14) domains. The relative rocking movement of these two domains is responsible for the 
anion transport by changing the accessibility of the substrate-binding site of AE1 to either side 
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of the membrane. This permits translocation of substrates across the membrane, as well as the 
efficient transport mechanism allowing the transport of 1 x 105 anions per second per protein 
(Arakawa et al., 2015; Reithmeier et al., 2016). 
Under physiological conditions, AE1 tends to dimerize at the plasma membrane, although 
dimerization is not required for its in vivo function. In addition, eAE1 can form tetramers via 
its N-terminal interactions with the cytoskeletal proteins ankyrin and EPB42. However, kAE1 
does not tetramerize due to its lack of interaction with ankyrin in α-intercalated cells (Ding et 
al., 1994). The crystal structure of mdAE1 reveals that the transmembrane domains 5, 6, and 7 
of the gate domains are located at the dimer interface (1092Å2) and are involved in the 
dimerization through an interaction of TM5 and the Leu572 residue at the end of TM6. So far, 
nothing is known about the interface during substrate transport, but it is likely that the dimer 
interface stays unchanged while the core domain shifts. However, a conformational transition 
during anion translocation can not be fully excluded (Arakawa et al., 2015; Reithmeier et al., 
2016). 
1.3.4 Intracellular trafficking of eAE1 and kAE1 
Both eAE1 and kAE1 are imported into the endoplasmic reticulum (ER) and transported to the 
plasma membrane or the basolateral membrane, respectively. In the case of eAE1, the 
interaction with glycophorin A, a red blood cell membrane protein that acts as a chaperone, has 
facilitated its targeting to the red blood cell surface (Young & Tanner, 2003). It has been 
suggested that both proteins interact within the ER and are transported to the surface of the 
erythrocytes together. Previous studies in SLC4A1 knock-out mice (Slc4a1−/−) indicated that 
there is a complete depletion of glycophorin A in red blood cells of the mice (Hassoun et al., 
1998). Consequently, impaired activity of eAE1 could be detected at the erythrocyte surface in 
glycophorin A-deficient patients (Bruce et al., 2004). Glycophorin A most likely stabilizes the 
structural feature of eAE1 because its absence results in a flexible conformation of eAE1 with 
reduced transport activity. Moreover, it might be involved in blocking the movement of the core 
and gate domains of eAE1 within the ER and Golgi. eAE1 was identified as being inactive until 
it dissociates from glycophorin A and is inserted into the plasma membrane. Thus, the coupling 
of eAE1 with glycophorin A prevents fast HCO3− transport across the ER and Golgi membrane, 
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which is likely to stop eAE1 from interfering with the internal pH control of these organelles 
(Reithmeier et al., 2016). 
Interestingly, glycophorin A is not expressed in α-intercalated cells (Tanphaichitr et al., 1998). 
It has been reported that in α-intercalated cells, kAE1 directly interacts with the mu1A subunit 
of the adaptor protein complex 1 (AP-1 mu1A) via its C-terminus (Sawasdee et al., 2010). The 
C-terminus of kAE1 contains the tyrosine-based sorting motif Y904DEV907, and a 
class-II PDZ-binding domain A908MPV911, which are known to be responsible for its targeting 
to basolateral membranes (Devonald et al., 2003; Toye et al., 2004). kAE1 binds to AP-1 mu1A 
through its tyrosine sorting motif identified by a yeast two-hybrid screen (Sawasdee et al., 
2010). In human embryonic kidney 293 cells (HEK293), the knock-down of AP-1 mu1A using 
short interfering RNA (siRNA) resulted in impaired kAE1 targeting to the basolateral 
membrane (Junking et al., 2014). Furthermore, other interacting partners of kAE1 have been 
identified that are involved in its cell surface trafficking, such as glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), transmembrane protein 139 (TMEM139) and peroxiredoxin 6 
(PRDX6). GAPDH protein was suggested to be involved in kAE1 trafficking to the basolateral 
membrane through interaction with the C-terminal D902EYDE906 motif of kAE1. In 
madin-darby canine kidney cells (MDCK), the knock-down of GAPDH results in intracellular 
retention of kAE1, postulating a role in the cell surface targeting of kAE1 (Su et al., 2011). In 
case of TMEM139 protein, Nuiplot and colleagues found that TMEM139 overexpression in 
HEK293 cells results in an increased kAE1 protein level at the basolateral membrane. In 
addition, they also detected a kAE1-TMEM139 complex in the membrane fraction. It was thus 
proposed that TMEM139 acts as a chaperone that facilitates intracellular kAE1 trafficking 
(Nuiplot et al., 2015). In addition, PRDX6, a protein with peroxidase and antioxidant activity, 
has been found to colocalize with kAE1 at the plasma membrane. This interaction is supposed 
to mediate kAE1 expression during cellular stress. Specifically, it was found that under 
conditions of metabolic acidosis PRDX6-deficient mice showed acutely reduced kAE1 
expression level, suggesting PRDX6 stabilizes kAE1 at the basolateral membrane (Sorrell et 
al., 2016). 
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 Distal renal tubular acidosis (dRTA) 
Mutations in the SLC4A1 gene cause an impairment in trafficking or activity of kAE1 that 
ultimately leads to a renal disorder named distal renal tubular acidosis (dRTA). Primary dRTA, 
also known as type 1 RTA or complete dRTA, is characterized as a defect of urine acidification. 
Under such pathophysiological conditions, the α-intercalated cells are incapable of discharging 
the excessive amounts of H+ produced in metabolic reactions. This general reduction in net acid 
excretion by the kidney results in the production of more alkaline urine with a pH that can not 
drop below 5.5 and does, eventually, manifest in systemic acidemia (Alper, 2002; Batlle et al., 
2001). Moreover, dRTA patients typically display a low plasma potassium concentration 
(hypokalemia), as well as a high plasma chloride (hyperchloremia) and CO2 concentration 
which is often accompanied by a high amount of calcium in the urine (hypercalciuria). 
Prolonged disease conditions lead to calcium deposition in the kidney (nephrocalcinosis), 
kidney stone formation (nephrolithiasis) and eventually result in kidney failure (Buckalew, 
1989; Yenchitsomanus et al., 2005). Children suffering from dRTA show impairment of growth 
along with vomiting and dehydration (Sharma et al., 2007). In a few patients, incomplete dRTA 
has been observed, which can be defined as the inability to acidify urine after an acute acid load 
(typically with ammonium chloride). Consequently, following a low acid diet, the bicarbonate 
concentration in the blood of these patients can be at normal levels without the display of 
metabolic acidosis. Thus, the risk for dRTA symptoms such as nephrocalcinosis and 
nephrolithiasis only increases in the case of severely high intakes of acid-containing food 
(Batlle & Haque, 2012; Soriano, 2002). 
In addition to the variants related to kAE1, dRTA can also be developed due to the mutations 
in the genes coding for the V-H+-ATPase and CA II. V-H+-ATPase is a multi-subunit protein 
complex consisting of two functional domains: the cytoplasmic V1 domain and the membrane-
spanning V0 domain. The V1 domain encompasses a hexamer of three A subunits and three B 
subunits together with six other subunits (C-H), and catalyzes for ATP hydrolysis. The V0 
domain is composed of six different subunits (a, c, c', c'', d, and e) and responsible for proton 
translocation. In mammals, the a subunit is found in four isoforms (a1, a2, a3, and a4) and the 
B subunit exists in two isoforms (B1 and B2) (Stevens & Forgac, 1997; Toei et al., 2010). 
Hereditary dRTA associated with defects in the V-H+-ATPase is caused by either mutation of 
the a4 or B1 isoform. Mutations of the a4 isoform often result in sensorineural deafness together 
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with other dRTA symptoms. In a4 knock-out mice, a severe dRTA phenotype develops, 
including nephrocalcinosis, hypocitraturia, deafness and defects in the olfactory sensation 
(Hennings et al., 2012; Norgett et al., 2012). In contrast, mutant variants of the B1 isoform do 
not result in such phenotypes, and it has been postulated that the B2 isoform of the 
V-H+-ATPase may compensate for a defective B1 isoform (Finberg et al., 2005). Patients with 
mutant CA II variants develop dRTA, which is associated with the recessive mutations in the 
encoding gene Car-2, and display increased bone density (osteopetrosis), hearing defects, 
mental retardation along with a growth deficiency (Vainsel et al., 1972). A previous study with 
a null mutation in the Car-2b allele shows that these mice develop dRTA along with the down-
regulation of multiple proteins in intercalated cells such as kAE1, pendrin and SLC26A7 which 
are involved in acid-base homeostasis (Lewis et al., 1988; Sun et al., 2008). 
1.4.1 dRTA associated with kAE1 mutants 
Mutant variants of kAE1 cause an impairment of HCO3− reabsorption across the basolateral 
membrane of α-intercalated cells, resulting in the intracellular accumulation of HCO3− ions. To 
maintain the intracellular acid-base and electrochemical balance, cells retain H+ or acid 
intracellularly albeit discharging it across the apical membrane into the tubular lumen. The 
accumulation of H+ and HCO3− ions subsequently reduces the intracellular dissociation of 
H2CO3. The impairment in H+ secretion into the urine due to the kAE1 defect will eventually 
lead to dRTA. Clinically, two types of mutations have been identified in the kAE1 encoding 
gene, triggering either autosomal dominant or autosomal recessive dRTA (Bruce et al., 2000; 
Bruce et al., 1997; Jarolim et al., 1998; Tanphaichitr et al., 1998). Dominant dRTA has only 
been found in a heterozygous background, suggesting that homozygous mutations might be 
lethal in an embryonic or postnatal stage. Moreover, dominant dRTA mutations in AE1 neither 
show any abnormal RBCs phenotype nor lead to hemolytic anemia. Conversely, patients with 
recessive dRTA have been reported to carry a homozygous or a compound heterozygous form 
involving two different mutations in the SLC4A1 gene. Typically, recessive dRTA is often 
associated with hemolytic anemia, and patients additionally exhibit a different morphology of 
RBCs compared to a healthy person (Khositseth et al., 2012; Yenchitsomanus et al., 2005). 
To characterize both dominant and recessive dRTA mutants, many studies have been performed 
in kidney cells such as MDCK cells and HEK293 cells. Dominant dRTA mutants expressed in 
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MDCK cells result in either intracellular retention (R589H, S613F) or mistargeting of kAE1 to 
the apical membrane (R901X, G609R). Besides, none of these dominant mutants displays an 
impaired anion exchange activity. On the contrary, recessive mutants expressed in MDCK cells 
exhibit different kAE1 trafficking defects such as a retention of the protein in the Golgi 
(G701D), or its proteasome-dependent degradation as misfolded protein (S773P) (Cordat et al., 
2006; Toye, 2005; Toye et al., 2004). It has been reported that both dominant and recessive 
dRTA mutants can form heterodimers with wild-type kAE1 (Kittanakom et al., 2004; Quilty et 
al., 2002). Based on the different trafficking behavior of mutant kAE1 heterodimers in MDCK 
cells, phenotypic explanations of dominant and recessive dRTA have been proposed. In case of 
dominant dRTA conditions, when the mutants are co-expressed with wild-type protein, thereby 
mimicking the situation in dRTA patients, the heterodimers are retained in the ER (R589H) or 
mistargeted to the apical membrane (R901X) of polarized MDCK cells. Thus, dominant dRTA 
heterodimers exhibit a “dominant-negative effect” on kAE1 trafficking. Alternatively, 
homodimers of recessive mutants (G701D) could not exit from the secretory pathway and were 
retained in Golgi compartments. However, when wild-type kAE1 was co-expressed with 
recessive dRTA mutants (G701D or S773P), the heterodimers were able to reach the basolateral 
membrane. Here, the wild-type kAE1 shows a “dominant-positive effect” with respect to the 
recessive kAE1 mutant (Cordat et al., 2006; Yenchitsomanus et al., 2005). The before 
mentioned kAE1 G701D mutation (also called as “Band 3 Bangkok I”) is located in the 
hydrophilic loop that connects TM8 and 9 on the cytosolic side of the protein and results in a 
missense substitution of glycine by the aspartic acid in the AE1 peptide sequence (Reithmeier 
et al., 2016). It was the first identified SLC4A1 mutation associated with autosomal recessive 
dRTA (Tanphaichitr et al., 1998). In Xenopus oocytes, the kAE1 G701D variant displayed a 
lack of cell surface expression and anion ion exchange activity, however, co-expression with 
glycophorin A could rescue its plasma membrane localization and chloride influx activity. This 
explains the normal cell surface expression and anion exchange activity of the kAE1 mutant in 
patients’ RBCs, which naturally contain glycophorin A. In recent years, nephrologist Dr. Rosa 
Verga-Poussou (Georges Pompidou Hospital in Paris) identified three new kAE1 mutants from 
patients with complete dRTA (Figure 1.5). Among them, one patient was carrying the 
homozygous kAE1 R295H mutation, and the other two patients were carrying heterozygous 
kAE1 Y413H and S525F mutations. The recessive kAE1 R295H mutation was the first 
dRTA-causing mutation detected in the cytosolic N-terminus of the protein, caused by a 
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missense mutation. On the contrary, the two dominant dRTA mutations were located within the 
transmembrane domains TM1 (Y413H) and TM5 (S525F) (Reithmeier et al., 2016). 
 
 
Figure 1.5: Topology model of kAE1 showing the location of mutations. 
Linear topology model of kAE1 is illustrating the positions of the kAE1 mutations. The TMs 
are numbered from N-terminus (1) to C-terminus (14). The cytosolic side is at the bottom. 
Dominant dRTA mutations are indicated as black circles and recessive mutants are labeled as 
gray circles. The solid circles (black and gray) represent dRTA mutants investigated in this 
study (R295H, Y413H, S525F, and G701D). The hatched circles (black and gray) indicate 
dRTA mutants previously studied in mammalian cells and animal models. The gray triangle 
shows the location of the induced mutation E681Q. The N-glycosylation site at position N642 
residue is indicated (modified from Almomani et al., 2011). 
 
In the kAE1 E681Q mutant, glutamine replaces the glutamate at position 681 in the AE1 peptide 
sequence, resulting in significant inhibition of monovalent anion exchange activity. Glutamate 
681 (Glu681) is located in TM8 and known as the binding site for H+ (Jennings & Smith, 1992). 
When the Glu681 residue becomes protonated, AE1/kAE1 can transport divalent anions such as 
SO42− instead of monovalent anions. Moreover, the AE1 E699Q knock-in mouse (equivalent to 
human E681Q) exhibited a proton independent Cl−/SO42− exchange activity, indicating that this 
mutation converts the protein from an electroneutral to an electrogenic transporter which is 
much less sensitive to pH changes than the native protein. In HEK293 cells, kAE1 E689Q 
displays a cell surface localization and an impaired Cl−/HCO3− exchange activity, suggesting 
that Glu681 is required as an active site for the Cl−/HCO3− exchange. However, the kAE1 E681Q 
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mutant is not clinically found and typically has been used as a transport-negative control 
(Chernova et al., 2008; Jennings, 2005; Shnitsar et al., 2013). 
1.4.2 Controversy on the intracellular localization of kAE1 in dominant dRTA 
Previously, in vitro studies using the kAE1 R589H mutant showed that it is retained in the ER 
as a homodimer and it can also lead to the retention of wild-type kAE1 into the ER by forming 
heterodimer (Reithmeier et al., 2016). In HEK293 cells, kAE1 R589H mutant was 
predominantly retained in the ER despite being similarly folded as the wild-type protein (Quilty 
et al., 2002). Further studies in MDCK cells also demonstrated the ER-retention of the mutant 
protein. However, the addition of the ER chaperon inhibitor castanospermine could rescue the 
kAE1 R589H mutant to the cell surface of MDCK cells, suggesting that inhibition of 
ER chaperones (such as calnexin) binding to the dominant dRTA mutant allows the escape of 
the mutant to the plasma membrane (Patterson & Reithmeier, 2010). In recent years, Mumtaz 
and colleagues performed a comprehensive study involving hetero- and homozygous knock-in 
mice carrying the dominant dRTA variant kAE1 R607H which corresponds to the human 
dominant dRTA kAE1 R589H mutant (Mumtaz et al., 2017). A critical finding of the in vivo 
study was the regular targeting of functional kAE1 R607H variant to the basolateral membrane 
of α-intercalated cells, despite a low level of expression. This contradicts the concept of dRTA 
pathophysiology mechanisms previously obtained in MDCK cell studies, which based the 
development of autosomal dominant dRTA on the mistrafficking/mistargeting of the mutant 
(Figure 1.6). Besides, the study on dominant R607H dRTA knock-in mice suggests that the 
compromised pathological state observed in these mice is not caused by targeting or functional 
defects of kAE1, but due to the impaired targeting of V-H+-ATPase and a remarkably reduced 





Figure 1.6: Schematic outline of previous and novel findings for kAE1-mediated dRTA. 
Left schema is showing the observed phenotypes of kAE1 mutants in MDCK cells. In MDCK 
cells, the dRTA causing kAE1 mutants were described as either (1) inactive, (2) intracellularly 
retained, or (3) mistargeted to apical membrane. Right diagram is depicting recent in vivo 
findings of the dominant dRTA kAE1 R607H variant. In kAE1 R607H knock-in mice, the 
missense mutation did not alter the trafficking of functional mutant protein to the basolateral 
membrane, but caused a secondary targeting defect of V-H+-ATPase to the apical membrane 
that potentially responsible for the dramatic loss of α-intercalated cells in the kidney. However, 
the precise reason for the α-intercalated cell depletion is still unknown (modified from Lashhab 
et al., 2019). 
 
As the dominant dRTA knock-in study was conducted in a mouse model, one has to be careful 
to hypothesize that dominant dRTA mutants are not mistrafficked in humans. In this context, 
biopsy data of human kidney tissue from patients suffering from dominant dRTA caused by the 
kAE1 mutation G609R displayed a similar phenotype as knock-in mice, showing a significant 
reduction of α-intercalated cells and a severe targeting defect of V-H+-ATPase (Vichot et al., 
2017). The in vivo patient data were pointing out that the phenotypic explanation of dominant 
dRTA from MDCK cells might not be correct, and the dominant dRTA mutant phenotype is 
based on the different genetic background between the MDCK cells and the α-intercalated cells. 
These findings illustrate the complexity of kAE1-related dRTA and highlight that the molecular 
and cellular mechanism of kAE1-related dRTA still remains obscure. 
 Alternative model systems for investigating kAE1 physiology 
Many mammalian cells have been successfully employed as a model system for the study of 
renal proteins, but there is always the dilemma which cell type is the most suitable model. Since 
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α-intercalated cells could not be immortalized yet, other available kidney cell lines, including 
HEK293 and MDCK cells, were used to characterize dominant or recessive dRTA-causing 
mutations. The recent in vivo data of dominant dRTA patients as well as data from dominant 
dRTA knock-in mice contradict the findings from these kidney cell lines. Thus, the molecular 
mechanisms involved in dRTA need to be further investigated and clarified by using a cell 
model that is maximally close to α-intercalated cells. A promising cellular model system is 
mouse inner medullary collecting duct cells (mIMCD3) which are derived from individual 
tubules of the terminal inner medullary collecting duct (IMCD) in the kidney of transgenic mice 
expressing the early region of simian virus 40 (SV40) (Rauchman et al., 1993). It has been 
reported that, when the kAE1 mutant R589H was expressed in mIMCD3 cells, the mutant 
exhibits unaltered trafficking to the basolateral membrane and a normal ion exchange activity. 
These observations are in line with the results obtained in in vivo knock-in mice (Mumtaz et 
al., 2017). Moreover, these cells are capable of adapting to hypertonic medium 
(~910 mOsmol/kg H2O). This particular characteristic of mIMCD3 cells makes them highly 
favorable for the study of cellular adaptation to osmotic conditions similar to the natural in vivo 
state of the renal medulla (Madsen et al., 1988). Therefore, all the features mentioned above 
highlight that mIMCD3 cells are a well-fitting cellular model for imitating in vivo dRTA 
conditions. In addition to mammalian cell lines, other model systems are available for 
investigating renal proteins, including baculovirus-infected insect cells and Xenopus oocytes. 
The latter are widely used in electrophysiology studies of numerous renal transporters and 
membrane proteins. Still, biochemical techniques utilizing this system are laborious, and the 
number of available materials is also limited (Kolb et al., 2011). The usage of insect cells for 
heterologous gene expression makes it necessary to generate recombinant baculoviruses that 
render this system technically challenging as well (Junge et al., 2008). However, genetic 
manipulation of mammalian cells may not be secure and can be very time-consuming, and since 
the previous section revealed that the molecular basis of dRTA is far more complex than 
initially expected, it is important to comprehend the molecular mechanism of kAE1 trafficking 
in kidney cells in a more specific manner. From this perspective, alternative model organisms 
are useful tools to address various cellular aspects of kAE1-physiology. In this thesis, the 
potential of the yeast Saccharomyces cerevisiae (S. cerevisiae) has been emphasized as a model 
organism to investigate intracellular transport and functionality of kAE1.  
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S. cerevisiae has been widely used to analyze a variety of renal proteins in order to investigate 
their expression, trafficking, structural and functional activity, or to identify interacting partners 
and degradation pathways (Kolb et al., 2011). Several fundamental features make yeast an 
excellent model system to study a renal protein like kAE1. Firstly, most of the cellular processes 
are conserved between S. cerevisiae and higher eukaryotic organisms. Therefore, data obtained 
from studies in S. cerevisiae can be translated into the situation of higher organisms. Secondly, 
yeast is a unicellular organism that can exist in a haploid and a diploid state, giving the 
opportunity for either clonal division or sexual crossing and allowing for genetic manipulation 
and screening. Thirdly, yeast can be cultivated in a large quantity in a speedy and cheap way. 
Fourthly, the transformation of heterologous genes in S. cerevisiae is a straightforward process 
and a given protein of interest can be expressed either from an episomal plasmid or through 
chromosomal integration. In addition, it is a relatively easy process to insert, mutate or delete 
any genomic sequence in yeast because of its highly efficient homologous recombination 
machinery. Fifthly, a wide range of genetic manipulation tools is available for S. cerevisiae in 
comparison with other model systems, such as the collection of non-essential gene knock-out 
mutants (about ~85% of all genes) and the collection of temperature-sensitive mutants which is 
about ~50% of total essential genes. Moreover, S. cerevisiae was the first eukaryotic organism 
whose complete genome was sequenced in 1996 (Goffeau et al., 1996). High-throughput data 
from functional genomic resources including metabolome, transcriptome, proteome and 
lipidome analysis provide the availability of beneficial information that makes it the organism 
with an extensively available dataset. Finally, since genetic modifications can be attained in 
yeast in a facilitated way, large-scale screens of genetic interactions are feasible, which permits 
efficient assessment of genetic interaction maps (Kolb et al., 2011; Petranovic & Nielsen, 
2008).  
Although important discoveries have undoubtedly been made using other model systems, there 
is always a requirement for a faster, cheaper, easier, and more genetically amenable system. 
Notably, the membrane domain of eAE1/kAE1 (361–911 aa, also known as B3mem) has 
already been expressed at high levels in S. cerevisiae and was found functional at the plasma 
membrane (Groves et al., 1996). Therefore, yeast stands out as a prospective model organism 
for investigating trafficking machineries, protein-protein interactions and subcellular 
localization of wild-type kAE1 and its dRTA-causing mutants.
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 Aims of this study 
kAE1 significantly contributes to renal acid secretion by promoting HCO3− reabsorption into 
the blood produced by the renal tubular H+ secretion. Malfunctioning of this protein disrupts 
the renal acid-base regulation process and leads to dRTA. Since it is known that dRTA is not 
simply caused by the mistrafficking of kAE1 but is based on a more complicated process, it is 
necessary to understand the proper maturation and trafficking process of kAE1 under normal 
physiological conditions. The first aim of this study was to dissect the expression and trafficking 
of kAE1 in a fast and inexpensive manner by using S. cerevisiae as a model organism. In order 
to achieve this ambitious goal, a variety of full-length kAE1 variants should be generated. After 
optimizing the expression in yeast, the subcellular localization of kAE1 was extensively 
analyzed by fluorescence-based and confocal laser-scanning microscopy. The functionality of 
the full-length protein was further investigated by the cytosolic pH measurement assay and the 
ion-exchange chromatography. 
Until now, mIMCD3 cells are reported as the closest cellular model for α-intercalated cells. The 
second aim of this thesis was the characterization of dRTA mutants in mIMCD3 cells. For this 
purpose, the half-life of three novel dRTA mutants, one recessive (kAE1 R295H) and two 
dominant mutants (kAE1 Y413H and S525F), were determined in a stably transduced mIMCD3 
cell system. Since defective autophagy was seen in dominant dRTA knock-in mice, the effect 
of these mutants on the autophagy process was investigated by assessing the protein level of its 






2. Materials and Methods 
 Organisms  
In this research project, different cells from distinct species were used to explore the 
localization, function and degradation of wild-type kAE1 and its mutants. 
2.1.1 Bacterial strains 
Escherichia coli strain indicated in Table 1 was taken from the strain collection of the 
Department of Molecular and Cell Biology at Saarland University. 
Table 1: Information of used bacterial strain, its genotype and source 
Strain Genotype Source 
TOP10 F− mcrA Δ(mrr-hsdRMS-mcrBC) Ф80lacZΔM15 
ΔlacX74 recA1 deoR araD139 Δ(ara-leu) 7697 




2.1.2 Yeast strains 
Saccharomyces cerevisiae strains mentioned in Table 2 were taken from the strain collection of 
the Department of Molecular and Cell Biology at Saarland University. 
Table 2: Information of used yeast strains, their genotypes and sources 
Strain Genotype Source 
BY4742 MATα; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0 Open Biosystems/ 
Winzeler et al., 1999  
Δbor1  MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Δbor1 
 
Open Biosystems  
Δend3 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Δend3 
  
Open Biosystems  
 
 33 
2.1.3 Mammalian cell lines 
Mammalian cell lines specified in Table 3 were taken from the cryoculture collection of the 
Department of Physiology at the University of Alberta (UofA), Canada. 
Table 3: Information of used mammalian cell lines, their genotypes and sources 
Cell line Features Source 
mIMCD3 Mouse, transgenic, medulla or collecting duct of 

















pLVX-TRE3G kAE1 S525F, pLVX-Tet3G Cordat lab, UofA, 
Canada 
 
 Growth media and culture condition 
Culture media used in this study were prepared by dissolving particular components in distilled 
water (dH2O), followed by autoclaving at 121 °C for 20 min at 15 psi. For bacteria and yeast, 
liquid and solid media were stored at room temperature (RT) and at 4 °C, respectively. The 
media used for mammalian cell culture were stored at 4 °C. 
2.2.1 Bacteria 
Lysogeny broth (LB) medium composed of the following ingredients was used to culture 
bacterial strains.  
LB Medium 
Components Amount 
Trypton  1.0% (w/v) 
Yeast extract  0.5% (w/v) 
NaCl  0.5% (w/v) 
Agar (only for plates)  1.5% (w/v) 
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Bacterial cultures in liquid media were maintained in a shaking incubator about 220 rpm at 
37 °C, whereas cultures on solid media were kept in an incubator at 37 °C overnight (unless 
otherwise indicated). 
2.2.2 Yeast 
Yeast peptone dextrose (YPD) medium 
YPD medium composed of the following components was used for the maintenance and 
propagation of yeast cells.  
YPD medium 
Components Amount 
Glucose  2% (w/v) 
Peptone  2% (w/v) 
Yeast extract  1% (w/v) 
 
To prepare YPD medium, peptone and yeast extract were dissolved in 800 ml of dH2O, while 
glucose was dissolved in 200 ml of dH2O. Subsequently, both solutions were autoclaved 
separately and mixed. 
Synthetic complete medium (SC-medium) 
SC-medium, commonly utilized for the auxotrophic yeast growth, was prepared by mixing of 
solutions A, B, and C. 
Solution A Solution B Solution C 
Components Amount Components Amount Components Amount 
Glucose / 
Raffinose / 






0.5% (w/v) YNB  0.17% (w/v) 
Agar 
(for plates) 




Components Amount Components Amount Components Amount 
Adenine  0.2 g Leucine  1.0 g Tryptophan  0.2 g 
Arginine  0.2 g Lysine  0.3 g Tyrosine  0.3 g 
Asparagine  1.0 g Methionine  0.2 g Uracil  0.2 g 
Histidine  0.2 g Phenylalanine  0.5 g Valine  1.5 g 
Isoleucine  0.3 g Threonine  2.0 g   
 
Solutions A, B, and C were prepared separately by dissolving the above-mentioned ingredients 
in 700 ml, 250 ml and 50 ml of dH2O, respectively. Then, the solutions A and B were autoclaved 
while the solution C was sterilized by filtration (0.2 µm sterile filter, Merck). The liquid media 
were kept at RT, and the solid media plates containing agar were stored at 4 °C. To prepare a 
particular drop-out (d/o) medium, the appropriate amino acids or bases were omitted in the 
SC-Mix. The SC- or drop-out mix was stored at 4 °C. 
2.2.3 Mammalian cells 
Stably transduced mIMCD3 cells were cultured in Dulbecco’s Modified Eagle 




DMEM/F12 500 ml 
FBS 10% (v/v) 
Penicillin/Streptomycin 1% (v/v) 
G418 2 mg/ml 
Puromycin 4 µg/ml 
 
DMEM/F12 medium was supplemented with 10% fetal bovine serum (FBS), 1% 
penicillin/streptomycin, 2 mg/ml G418 and 4 µg/ml puromycin for maintaining the stably 
transduced mIMCD3 cells. The cells were incubated in culture flasks, dish or well-plates at 
37 °C with 5% CO2. To split confluent cells, culture medium was removed and the adherent 
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cell monolayer was washed with 1x PBS. The cells were detached by adding 1x Trypsin/EDTA 
solution and subsequent incubation in the incubator for the duration of 2–5 min, depending on 
the cell line. The reaction was stopped by adding two volumes of cell culture medium. The cells 
were then resuspended, and a portion of the cell suspension (depending on the proliferation rate 
of cells) was transferred into a cell culture flask with fresh medium. 
 Cryopreservation  
Cryopreservation technique is used to store structurally intact living cells or tissue at very low 
temperatures. Cryoprotectants like glycerol or DMSO were added to protect the intact cells or 
subcellular structures (Day & McLellan, 1995). 
2.3.1 Cryopreservation of bacteria and yeast 
Bacteria and yeast cells were grown overnight in a 5 ml culture tube. 1 ml of a fresh overnight 
culture was then mixed with 1 ml sterile glycerol (99% v/v). The tubes were then kept at −80 °C 
in the freezer. 
2.3.2 Cryopreservation of mammalian cells 
Cryopreservation samples were prepared from freshly grown cells with a confluency of about 
70–80%. Cells were washed with 1x PBS and detached by applying 1x trypsin/EDTA solution. 
Next, cell density was counted by a hemocytometer and an appropriate amount was centrifuged 
at 300 g for 5 min at 4 °C. After aspiration of the supernatant, the cell number was adjusted to 
1 x 106 cells/ml in an equal part of both DMEM/F12 and freezing medium (composition listed 
below). Afterward, 1 ml of cell suspention was transferred to a cryotube. A freezer box 
(CryoSaveTM, Scienceware) was utilized for controlling the freezing rate of the cells 
(−1 °C/min) by placing at −80 °C for 24 h. Finally, to ensure the long-term preservation of the 









Plasmids used in this study and their characteristics are described in Table 4. 
Table 4: Information of plasmids used in yeast, their characteristics and sources 
Plasmid Characteristics Source 
pYES2.1  
V5-His-TOPO  
S. cerevisiae expression vector, GAL1 promoter, URA3 and 
AmpR gene, TOPO-Cloning site, V5-epitope (C-terminus), 







pYES2.1 with a human wild-type kAE1 sequence containing 





pYES2.1 with a human wild-type kAE1 sequence containing 






pYES2.1 with a yeast codon-optimized sequence of wild-type 











pYES2.1 with a yeast codon-optimized wild-type kAE1 




pYES2.1 with a yeast codon-optimized wild-type kAE1 
sequence connected to a yeGFP at the N-terminus through a 





pYES2.1 with a yeast codon-optimized wild-type kAE1 
sequence containing a HA tag within third extracellular loop 







pYES2.1 with a yeast codon-optimized kAE1 sequence 
containing the G701D mutation and a FLAG tag within third 





pYES2.1 with an untagged yeast codon-optimized kAE1 
sequence containing the E681Q mutation  
This study 






YIplac128 with a yeast proton pump sequence attached to a 





S. cerevisiae expression vector, PGK1 promoter, URA3 and 
AmpR gene, polyhistidine (6xHis) -tag (C-terminus), GST-tag 
(C-terminus). 
 




pPGK with an untagged wild-type yeast codon-optimized 




pMS109 HAC1 gene of S. cerevisiae inserted between the promoter 
and terminator of PGK1 gene into the S. cerevisiae 





pAct1-GEV β-estradiol inducible activator Gal4dbd.ER.VP16 (GEV) 
sequence inserted in the S. cerevisiae plasmid vector pAGL 





 Polymerase chain reaction (PCR) 
kAE1 variants were constructed by using polymerase chain reaction (PCR). For that purpose, 
the FastStart High Fidelity PCR system (Merck) was used which contains a proof-reading Taq 
polymerase. PCR was performed by using a thermocycler (Mastercycler nexus, Eppendorf) 
with adapting specific parameters according to the length of the product, the annealing 
temperature of the primers, or both. Amplified products were then checked by agarose gel 




10x PCR buffer  5.0 µl 
Primer forward (100 mM) 0.25 µl 
Primer reverse (100 mM)  0.25 µl 
Template-DNA  100 ng 
dNTPs (10 mM)  1.0 µl 
DNA Polymerase (5 U/µl) 0.5 µl 
dH2O (sterile) Up to 50 µl 
 
PCR reactions were carried out by following subsequent parameters in the thermocycler. 
Cycle steps Temperature (ºC) Time Cycle 
Initial denaturation 95 2 min 1 
Denaturation 95 30 sec 
30 Annealing 55 30 Sec 
Elongation 72 3 min 
Final elongation 72 7 min 1 
Cooling 4 ∞  
 
Primers were used to generate untagged ykAE1 (ykAE1) and N-terminus yeGFP fused ykAE1 
(yeGFP-ykAE1), and are listed in Table 5. Primer sequences written with capital letters 
represent the target DNA sequence, small letters refer to the restriction sites, and small 
underlined letters indicate the linker sequence (GGGGS). 
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5' ykAE1 pYES2.1 CGACTCACTATAGGGAATATTAAGCTCGCctcgaggaattc 
ATGGACGAAAAGAATCAAGAATTGAGATG 
 
3' ykAE1 pYES2.1 ACCTTCGAATGGGTGACCTCGAAGCTCGCCgtcgacggatcc 
TTAAACTGGCATAGCAACTTCATCGTATTC 
 
5' yeGFP pYES2.1 ACTATAGGGAATATTAAGCTCGCctcgag 
ATGTCTAAAGGTGAAGAATTATTCAC 
 
3' yeGFP 5' ykAE1 CATCTCAATTCTTGATTCTTTTCGTCactaccaccaccacc 
TTTGTACAATTCATCCATACCA 
 
kAE1 variants generated by PCR were routinely sequenced by Eurofins Genomics and data 
were analyzed using DNASTAR Lasergene 7.0 software.  
 Site-directed mutagenesis 
Site-directed mutagenesis is a widely used method for introducing a point mutation in a DNA 
sequence (Hutchison et al., 1978). This technique is very beneficial for generating DNA 
sequences with mutated codons, insertions and sequence deletions. In this study, mutants were 
generated by using the “Q5 site-directed mutagenesis kit” (NEB) with the mutagenic primers 
listed in Table 6. Primer sequences shown as capital letters refer to the target DNA sequence. 
The nucleotides altered from the native sequence are marked in red and mutated codons are 
underlined.  
Table 6: Mutagenic primers (for yeast codon-optimized sequence of kAE1) 
Primer name Sequence 5´–3´ 
5´ E681Q GAT ATT CTT GCA ATC CCA AAT CAC 
3´ E681Q AAG ATA AAA ACC AAT AAA GCT G 
5´ G701D AAG GGT TCT GAT TTT CAC TTG 
3´ G701D GAC CAT CTT TCT TTC AGG 
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First, PCR was accomplished with the Q5 Hot Start High-Fidelity DNA Polymerase for 
introducing the particular mutation in the kAE1 sequence. Later on, the amplified PCR product 
was incubated with the Kinase-Ligase-DpnI (KLD) enzyme-mix at RT for 5 min. The kinase 
phosphorylates the amplified PCR product at the 5' end enabling the product to be circularized 
by the ligase. The DpnI restriction enzyme then removed the template DNA by cleaving 
methylated DNA. Finally, the obtained product was transformed into high-efficiency NEB 5-α 
competent E coli cells. The PCR cycles were performed by applying the following parameters 
in the thermocycler. 
Cycle steps Temperature (ºC) Time Cycle 
Initial denaturation 98 30 sec 1 
Denaturation 98 10 sec 
25 Annealing 57 30 Sec 
Elongation 72 4 min 
Final elongation 72 7 min 1 
Cooling 4 ∞  
 
 TOPO TA cloning  
pYES2.1 (Thermo Scientific) expressing vector was used for the yeast expression of kAE1 
variants. A synthetic cDNA string of human or yeast codon-optimized kAE1 sequence was 
inserted into pYES2.1 by TOPO cloning. TOPO cloning reaction was accomplished using the 
following components. 
Components Amount 






Salt solution  




As the plasmid vector is linearized and has thymidine (T) overhangs, the insert should have 
3' adenine (A) overhangs for ligation. Extension of 3' poly-A overhangs at cDNA string was 
carried out with Taq polymerase using the following reaction mixture.  
Components Amount 
Synthetic cDNA (20 ng/µl) 8.0 µl 
Taq polymerase 1.0 µl 
10x reaction buffer 1.0 µl 
dATP  0.1 µl 
 
The reaction was performed in PCR tubes in a thermocycler (Mastercycler nexus, Eppendorf) 
at 72 °C for 15 min. Then, tubes were placed on ice for subsequent DNA precipitation. After 
the addition of the poly-A overhangs, DNA strings were sedimented using phenol-chloroform 
extraction by adding 10 µl of phenol:chloroform:isoamyl alcohol (25:24:1) solution with gentle 
mixing. Next, 2 µl of 3 M sodium acetate and 44 µl of absolute ethanol were added, followed 
by gently mixing. The mixture was centrifuged at 13,000 rpm for 5 min. After the supernatant 
was aspirated, the pellet was rinsed with 80% ethanol and air-dried. Finally, DNA the pellet 
was resuspended into 5 µl dH2O. 
 Restriction digestion 
Restriction cloning is the insertion of a gene of interest within a plasmid vector. An expression 
vector usually carries the information of replication and expression for the target gene. A variety 
of endonucleases is used to create sticky ends of the vector and insert fragments that 
subsequently ligate by utilizing the ligase enzyme. For the constitutive expression of kAE1 in 
S. cerevisiae, the unmodified kAE1 (ykAE1) sequence was inserted into the pPGK vector 
through XhoI and BamHI restriction sites. ykAE1 insert and pPGK vector were individually 
double digested with the relevant restriction enzymes for 3 h at 37 °C. 50 µl digestion mixture 
for both vector and insert were arranged as indicated below.  
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Components Amount 
10x buffer 5.0 µl 
BamHl (10 unit/µl) 1.0 µl 
XhoI (10 unit/µl) 1.0 µl 
RNase A 0.5 µl 
Vector/Insert DNA 5.0 µg  
dH2O add 50 µl 
 
Digested DNA fragments were separated by agarose gel electrophoresis and extracted by using 
the “Gel Extraction Kit” (Omega Bio-tek) following the manufacturer’s protocol. Both vector 
and insert were separately eluted in nuclease-free water. Purified digested insert and vector 
were then ligated by using “T4 DNA ligase kit” (Roche). The amount of insert and vector can 
differ depending on the length of the insert. Ligation was carried out into a total volume of 20 µl 
containing the following components. 
Components Amount 
Insert 8 µl (variable) 
Vector 8 µl (variable) 
Buffer 10x 2 µl 
T4 DNA ligase 1 µl 
dH2O Up to 20 µl 
 
Reaction mixture was incubated overnight at 16 °C. To remove salt from the mixture, the 
ligated product was dialyzed by using a dialysis filter (0,025 µm, Millipore) floating on 10% 
glycerin solution for 1 h. The dialyzed ligation mixture was then used for electroporation. 
 Agarose gel electrophoresis 
Amplified PCR products or digested plasmids were analyzed by agarose gel electrophoresis. 
For the sample preparation, 20 µl PCR product or digested plasmid were mixed with 5 µl of 
5x GLB (gel loading buffer) solution and loaded into the wells of an agarose gel (1%) together 
with 5 µl of HyperLadder™ 1kb (Bioline) DNA marker. The electrophoresis was performed at 
160 V, 400 mA and 45 min with 1x TBE as the electrophoresis buffer using BlueMarineTM 
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100 system (Serva Electrophoresis GmbH). To visualize DNA fragments, gels were soaked in 
ethidium bromide solution (2.5 µg/ml) for 10–15 min, and respective DNA bands were detected 
by using the ChemiDoc XRS system (Bio-Rad). Captured images were analyzed by the 
Quantity One 4.6.2 (Bio-Rad) software. Following electrophoresis, the DNA fragments were 
reisolated by using “E.Z.N.A. gel extraction kits” (Omega) according to the manufacturer’s 
protocol. 10x TBE buffer and 5x GLB buffer were prepared as mentioned below. 
10x TBE buffer 
Component Amount 
Tris-HCl, pH 8,0  0.89 M 
Boric acid  0.89 M 
Na2EDTA  0.02 M 
 
5x GLB buffer 
Component Amount 
Glycerin 50% (v/v) 
SDS 1% (w/v) 
Na2EDTA 125 mM 
Bromophenol blue 0.05% (w/v) 
Xylene cyanol  0.05% (w/v) 
 
 Transformation of microorganisms  
2.10.1 Electroporation of E. coli 
Preparation of electrocompetent cells 
To prepare electrocompetent TOP10 cells, 200 ml of LB medium was inoculated with 1% of a 
fresh overnight culture and incubated at 37 °C until culture density reached OD600 = 0.7. 
Afterward, cells were placed on ice for 15 min and then centrifuged at 8,000 rpm for 5 min at 
4 °C. Cells were then washed two times by using 10% sterile glycerin and the cell pellet was 
resuspended in the remaining liquid. The cell suspension was transferred into a new reaction 
tube and centrifuged in a similar procedure. Supernatant was aspirated and pellet was 
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resuspended in an equal volume of 10% glycerol. Finally, 40 µl of cell suspension were 
aliquoted in a microcentrifuge tube and stored at −80 °C.  
Electroporation 
The recombinant plasmids were transformed in TOP10 competent cells via electroporation. 
One aliquot (40 µl) of electrocompetent cells was thawed and mixed gently with the ligated 
product. After 5 min incubation on ice, the mixture was placed into an electroporation cuvette 
(Bio-Rad). Electroporation was carried out using the “Gene Pulser XcellTM” (Bio-Rad) at 
200 Ω, 2.5 kV/cm and 2.5 µF. Immediately after the pulse, cells were resuspended in 1 ml SOC 
medium (composition provided below) and incubated for 1 h at 37 °C. Later on, cells were 
plated on LB-agar plates containing antibiotics as a selection marker for positive transformants 
and cultivated overnight at 37 °C. 
SOC medium 
Component Amount 
Yeast extract  0.5% 
Peptone  2.0% 
Sodium chloride  10 mM 
Glucose  20 mM 
Potassium chloride  10 mM 
Magnesium chloride  10 mM 
Magnesium sulfate 2.5 mM 
 
Plasmid selection 
Antibiotic used for bacterial strain selection is specified in the list below. Sterilization was 
accomplished by filtering the solution through 0.2 µ filter.  
Substance Concentration Solvent 
Ampicillin  50 mg/ml 50% (v/v) ethanol 
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Selection for positive bacterial transformants was achieved by adding 400 µg/ml Ampicillin in 
liquid or solid medium. 
2.10.2 Transformation of S. cerevisiae 
2.10.2.1 Lithium acetate transformation 
Lithium-acetate transformation is a simple and fast method to introduce exogenous DNA into 
S. cerevisiae (Gietz et al., 1995; Ito et al., 1983). To accomplish the procedure, four elements 
are necessary: divalent alkali cations, polyethylene glycol (PEG), single-stranded carrier DNA 
(Herring sperm), and a heat shock at 42 °C. In order to perform a single transformation, 2 ml 
fresh overnight yeast culture were centrifuged at 8,000 rpm for 5 min. Supernatant was 
aspirated and pellet was then washed two times with 500 µl of 1x LiAc/TE solution. After the 
wash, cells were finally resuspended in 100 µl of 1x LiAc/TE. Yeast cell suspension was mixed 
with 10 µl denatured carrier DNA (Herring sperm), 1 µg plasmid DNA and 600 µl PEG 
solution. After incubation for 30 min at 30 °C, the heat shock was performed in a water bath 
for 15 min at 42 °C. Cells were then centrifuged at 13,000 rpm for 1 min, and the pellet was 
washed two times with 500 µl of 1x TE solution. Finally, cells were resuspended in 500 µl 
1x TE solution and the cell suspension was plated onto a suitable d/o glucose-agar plate. Plates 
were incubated at 30 °C for 3 d and checked for the growth of the appropriate yeast colonies. 
Reagents used for yeast transformation were prepared as mentioned below. 
Polyethylene glycol (PEG 50%) 
Component Amount 
PEG-4000  50% (w/v) 
 
TE-Buffer (10x) Lithium acetate (10x LiAc) 
Components Amount Components Amount 
Tris  100 mM Lithium acetate 1.0 M 
Na2EDTA 10 mM   
 
pH of TE-buffer and LiAc solution was adjusted to 7.5 with acetic acid. 
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PEG solution LiAc-TE solution 
Components Amount Components Amount 
PEG (50%) 80% (v/v) 10x TE buffer 10% (v/v) 
10x TE buffer 10% (v/v) 10x LiAc 10% (v/v) 
10x LiAc 10% (v/v) dH2O (sterile) 80% (v/v) 
 
2.10.2.2 In vivo recombination in yeast 
S. cerevisiae has a unique feature of combining ectopic linear DNA fragments inside the cell 
(Gibson et al., 2008; Jinks-Robertson et al., 1993). In this process, the fragment of DNA 
requires to bear homology of the plasmid sequence that can be directly ligated with the 
linearized vector sequence. Previously, Manivasakam and his colleagues reported that 15 bp of 
the overlapping region of DNA fragments are sufficient for effective integration in yeast 
(Manivasakam et al., 1995). It is a straightforward cloning method that avoids multiple-steps 
involved in restriction cloning, such as enzymatic digestion, and subsequent ligation of insert 
and vector. In this study, two expression plasmids pYES2.1-ykAE1 and pYES2.1-yeGFP-
ykAE1 were generated via in vivo recombination. Primers were designed with a homologous 
region between 25–30 bp of the pYES2.1 vector and the kAE1 yeast codon-optimized sequence 
(Table 5). Unmodified kAE1 (ykAE1) was amplified by performing PCR, using 
pYES2.1-ykAE1-yeGFP as template and appropriate forward and reverse primers. Next, the 
pYES2.1-yeGFP plasmid was enzymatically digested with XhoI and BamHI. Finally, the PCR 
fragment (ykAE1) and linearized vector (pYES2.1) were transformed by Li/Ac transformation 
technique into yeast cells. The ligation of pYES2.1-ykAE1 plasmid was carried out by yeast 
itself through in vivo recombination. For pYES2.1-yeGFP-ykAE1 plasmid, yeGFP was 
generated by PCR with the designated primers (Table 5) using pYES2.1-yeGFP as a template. 
In the end, the PCR product and linearized pYES2.1-ykAE1 plasmid (digested with XhoI) were 
transformed into yeast and DNA fragments ligated via in vivo recombination. 
2.10.2.3 GEV yeast strain construction 
The BY4742-GEV strain was generated by transforming cells with the linearized plasmid 
pAct1-GEV digested with EcoRV. Clones with successful homologous recombination were 
selected on leucine d/o plates. The positive transformants were finally transformed with 
 48 
pYES2.1-ykAE1 to generate BY4742-GEV [pYES2.1-ykAE1] strain, in which kAE1 was 
expressed upon β-estradiol induction. 
 Lentiviral transduction of mammalian cells 
Transduction is a process where a foreign DNA molecule is introduced to host cells by a virus 
or viral vector. In recent years, the lentiviral transduction system becomes a very efficient tool 
for delivering transgenes into mammalian cells to create stable cell lines for robust expression 
of target proteins. The system uses a recombinant lentivirus, incorporating the genetic materials 
of human immunodeficiency viruses (HIV) to deliver the target gene. By exploiting the host’s 
cellular machinery, viruses are amplified and packed their genetic material together with the 
transgene. The packed transgene is then transported via membrane fusion to the target cells 
(Elegheert et al., 2018; Naldini et al., 1996). The Lenti-X™ Tet-On® 3G (Clontech) Inducible 
Expression System uses a regulator vector, pLVX-Tet3G and a response vector, pLVX-
TRE3G. The regulator plasmid is responsible for constitutive expression of the Tet-on 3G 
transactivator protein under the control of the PCMV promoter (Figure 2.1 A). In contrast, the 
response plasmid contains an inducible promoter PTRE3GV which controls transcription of the 
gene of interest (Figure 2.1 B). Plasmid vectors map are depicted below: 
  
Regulator vector Response vector 
 
Figure 2.1: Overview of vectors used in lentiviral transduction system. 
(A) pLVX-Tet3G regulator vector consisting of markers (Neor and Ampr), origin of replication 
(pUC ori), promoter (PCMV) and viral elements (5’ LTR, 3’ LTR, WPRE, RRE, IRES).  
A) B) 
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Continued Figure 2.1: (B) pLVX-TRE3G response vector comprising of markers (Puror and 
Ampr), promoter (PTRE3V and PPGK), origin of replication (pUC ori), MCS (multiple cloning site) 
and viral elements (5’ LTR, 3’ LTR, WPRE, RRE, IRES). Besides MCS, restriction sites are 
indicated on the vector map (Clontech). 
 
In the presence of doxycycline, the Tet-on 3G protein undergoes for structural modification and 
then binds at the tet-operator sequence located in the PTRE3GV promoter, which initiates the 
transcription process. The PTRE3GV promoter ensures not only the least basal expression but also 
delivers the highest degree of target protein expression after induction (Loew et al., 2010; Zhou 
et al., 2006). Thus, the lentivirus transduction system classifies as an effective tool for 
heterologous protein expression in mammalian cells. In this study, all response plasmids 
containing kAE1 variants and the stably transduced mIMCD3 cell lines were generated in 
cooperation with the Cordat’s lab at the University of Alberta, Canada. 
2.11.1 Construction of the response plasmid 
The pLVX-TRE3G kAE1 plasmid was constructed by inserting the human cDNA of kAE1 
carrying a HA tag within the third extracellular loop between Val557 and Leu558 into the vector 
pLVX TRE3G. The insert was enzymatically digested in 3′ and 5′ of the open reading frame 
with MluI. Vector was linearized with the same restriction enzyme and ligated with the insert 
utilizing the T4 DNA ligase enzyme (5 U/µl; Thermo Scientific) according to the 
manufacturer’s protocol. The kAE1 R295H, kAE1 Y413H and kAE1 S525F mutants were 
constructed by using “Q5 site-directed mutagenesis kit” (NEB) with the mutagenic primers 
(shown in Table 7). The cDNA of HA-tagged kAE1 was used as the template. In Table 7, the 
primer sequences denoted in capital letters referring to the target DNA sequence, modified 
nucleotides are labeled in red, and mutated codons marked as underlined. 
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Table 7: Mutagenic primers (for human sequence of kAE1) 
Primer name Sequence 5´–3´ 
5´ R295H AGG GTG TTC CAC ATA GAT GCC 
3´ R295H CTC TGA CAT GAG GGT GGC 
5´ Y413H CAT CTT CAT CCA CTT TGC TGC ACT GTC ACC 
3´ Y413H ACG GCA GCC AGG ACC TGG 
5´ S525F GAG ATC TTC TTC TTC CTC ATT TCC C 
3´ S525F CTG GGT ATA GCG GGA GAT G 
 
Plasmids generated for mIMCD3 cells are listed in Table 8. 
Table 8: Plasmids used in mammalian cells 
Plasmid Characteristics Source 
pLVX-TRE3G  
kAE1 
pLVX-TRE3G with human wild-type kAE1 sequence 
containing a HA tag within third extracellular loop between 






pLVX-TRE3G with human kAE1 sequence containing the 
R295H mutation and a HA tag within third extracellular loop 






pLVX-TRE3G with human kAE1 sequence containing the 
Y413H mutation and a HA tag within third extracellular loop 






pLVX-TRE3G with human kAE1 sequence containing the 
S525F mutation and a HA tag within third extracellular loop 





2.11.2 Generation of stable mIMCD3 cell lines 
The “Lenti-X™ Tet-On® 3G” (Clonetech) transducing kit was used to produce a stable cell 
line of mIMCD3 which inducibly expressed kAE1 in the presence of doxycycline. In the 
beginning, ~70% of fresh confluent Lenti-X 293T cells (Clontech) were separately transfected 
with 7 µg of either pLVX-Tet3G (regulator plasmid), pLVX-TRE3G-kAE1, pLVX-TRE3G-
kAE1 R295H, pLVX-TRE3G-kAE1 Y413H or pLVX-TRE3G-kAE1 S525F (response 
plasmids) using the Lenti-X HTX Packaging mix and Xfect Transfection Reagent (Clontech). 
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Afterward, transfected cells were incubated in serum-free OptiMEM medium (Gibco) at 37 °C 
and 5% CO2 for 48 h. Following incubation, supernatants containing lentiviruses were collected 
from each Lenti-X 293T cell culture and sterilized by using 0.45 µm filters. After that, ~70% 
confluent mIMCD3 were co-infected with lentiviruses containing both regulator (pLVX-
Tet3G) and response (pLVX-TRE3G-kAE1, pLVX-TRE3G-kAE1 R295H, pLVX-TRE3G-
kAE1 Y413H or pLVX-TRE3G-kAE1 S525F) plasmids plus 4 µg/ml of polybrene (Sigma, 
USA) for 48 h. Infected cells were selected by adding 4 µg/ml of Puromycin and 2 mg/ml of 
G418 into the growth medium. Finally, after 24 h of incubation with 1 µg/ml of doxycycline, 
robust expression of kAE1 protein was detected by Western blot analysis.  
 Plasmid isolation from microorganisms 
2.12.1 Plasmid isolation from E. coli 
Alkaline lysis 
Alkaline lysis is a fast and simple method to extract plasmid DNA from bacteria (Bimboim & 
Doly, 1979). Initially, the overnight bacterial culture was prepared, and 1.5 ml of the sample 
was taken into a 2 ml tube for centrifugation at 13,000 rpm for 1 min. After centrifugation, the 
supernatant was removed and the pellet was resuspended in 100 µl of GTE-solution (glucose-
tris-EDTA solution). Next, 200 µl of NaOH/SDS-solution were added, mixed by inversion, and 
the suspension was incubated at RT for 5 min. Afterward, 150 µl of potassium acetate-solution 
were added into the tube, and appropriately mixed. After an incubation of 3 min on ice, cellular 
debris was removed by centrifugation at 13,000 rpm for 10 mins. Supernatant was then 
collected and 800 µl ethanol were added to precipitate plasmid DNA. After centrifuging the 
solution, supernatant was discarded, and the pellet was air-dried. Finally, 20 µl dH2O were 
added and plasmid DNA was stored at −20 °C. 
GTE-Solution NaOH/SDS-Solution 
Component Amount Component Amount 
Glucose  50 mM NaOH 0.2 M 
Tris-HCl pH 8,0  25 mM SDS 1% (w/v) 





Acetic Acid  29.5 % 
 
pH of the Potassium acetate-solution was adjusted with NaOH to 4.8. Solutions were 
subsequently autoclaved.  
Plasmid Miniprep 
Miniprep plasmid isolation was performed by using the “innuPREP Plasmid Mini Kit” 
(Analytik Jena) as per manufacturer’s instruction to have highly purified plasmid DNA from 
bacteria. The method is based on alkaline lysis with subsequent binding of plasmidal DNA to 
silica membranes. The obtained plasmid DNA was stored at −20 °C. 
2.12.2 Extraction of plasmid from yeast 
The recombinant plasmid generated from in vivo recombination were extracted by using 
“ZymoprepTM yeast plasmid Miniprep 1” (Zymo Research) following the manufacturer’s 
protocol. The isolated plasmid was then amplified by transforming it again into competent 
E. coli and re-isolated by using “innuPREP Plasmid Mini Kit”.  
 Determination of DNA concentration 
Spectrometric assessment of isolated plasmids or fragmented DNA was carried out by using 
the NanoDrop 2000c (PEQLAB biotechnology). 
 Protein biochemical methods 
2.14.1 Lysis of yeast cells 
To collect the expressed kAE1 protein in yeast, overnight grown cells corresponding to 
OD600 = 5 or 10 were centrifuged at 8,000 rpm for 5 min. Cell pellet was washed twice with 
sterile water. After washing, 160 µl of lysis buffer (SUMEB buffer) and 40 µl of protease 
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inhibitor cocktail solution were added to the cell pellet, and the suspension was transferred into 
cell disruption tubes. Cell disruption was carried out in a homogenizer (Precellys® Evolution) 
by using 0.2 g of 0.7–1.0 mm diameter glass beads at 6,000 rpm for 2.5 min with 30 s pause 
after a 20 s cycle. Following cell lysis, the mixture was placed on ice for 15 min. Later, cell 
debris was removed by centrifuging at 13,000 rpm for 5 min and supernatants were used for 
further downstream analysis by SDS-PAGE mixed with 3x SDS sample buffer. 
SUMEB Buffer 
Component Amount 
SDS  1.0% 
Urea  8.0 M 
MOPS pH 6,8  10 mM 
EDTA  10 mM 
Bromophenol blue  0.01% (w/v) 
 
MOPS (3-(N-morpholino)propanesulfonic acid) was sterilized by filtration and then added to 
the autoclaved buffer solution. The protease inhibitor cocktail solution was prepared by 
dissolving one tablet of EDTA-free Protease Inhibitor Cocktail (Roche) in 2 ml dH2O (25x 
concentration).  
3x SDS sample buffer 
Components Amount 
dH2O 4.0 ml 
Tris-HCl pH = 6.8 (0.5 M)  2.0 ml 
Glycerin 99% (v/v) 2.4 ml 
SDS 10% (w/v)  1.0 ml 
Coomasie blue 0.05% (w/v)  0.4 ml 
 
2.14.2 Lysis of mammalian cells 
mIMCD3 cells were grown in cell culture dishes/well-plates to 80–90 % confluency. Next, 
medium was aspirated and attached cells were washed with 1x PBS for one time. After washing, 
PBS was aspirated and 100–500 µl of cell lysis buffer was added into the dish/well-plates 
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(depending on the plate size and desired protein concentration). Following 15 min incubation 
on ice, the cells were scraped from the bottom by using a cell scraper and the cell suspension 
was transferred into microcentrifuge tubes. The solutions were centrifuged at 14,000 rpm for 
15 min at 4 °C and supernatants were aspirated to new microcentrifuge tubes. If desired, the 
total protein concentration was determined by PierceTM BCA protein assay kit (Thermo 
Scientific) following manufacturer’s protocol and the samples were stored at −80 °C for further 
analysis. 
mIMCD3 cell lysis buffer 
Components Amount 
PBS 1x 
Triton X-100 0.1% (v/v) 
EDTA-free Protease 
Inhibitor Cocktail (Roche) 
1 tablet in 10 ml 
 
2.14.3 SDS-PAGE 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is extensively used 
to separate proteins from the mixture based on their molecular weight (Shapiro et al., 1967). 
SDS functions as an anionic surfactant, and the combination of SDS and polyacrylamide gel 
allows to exclude the influence of structure and charge of the protein during separation. In the 
SDS-PAGE, the linearized proteins migrate from the cathode towards the anode and high 
molecular weight proteins move slower than the smaller ones (Weber & Osborn, 1969). To 
analyze samples by SDS-PAGE, cells were lysed and supernatants were collected (as described 
in section 2.14.1 and 2.14.2). Samples were run on a 10% tris-tricine gel. Gels and buffers were 
prepared using the recipe stated below. 
Tris-HCl/SDS 
Component Amount 
Tris 3.0 M 
SDS  0.3% 
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pH of the solution was adjusted to 8.45 by using hydrochloric acid (HCl), and the solution was 
stored at RT.  
Resolving gel (10%) Stacking gel 
Component Amount (2 gels) Components Amount (2 gels) 
Rotiphorese® gel 30 4.0 ml Rotiphorese® gel 30 1.6 ml 
Tris-HCl/SDS 5.0 ml Tris-HCl/SDS 3.1 ml 
dH2O 4.0 ml dH2O 7.8 ml 
Glycerin 80% (v/v) 2.0 ml APS 10% (w/v) fresh 80 µl 
APS 10% (w/v) fresh 80 µl TEMED 25 µl 
TEMED 25 µl   
 
Polyacrylamide gels were prepared by pouring the resolving gel solution into the Mini-
PROTEAN® Tetra (Bio-Rad) hand-cast system. To remove bubbles and avoid drying of the 
upper surface, resolving gels were covered with 2-propanol. The isopropanol was removed 
completely after polymerization and stacking gel solution was poured over the resolving gel. 
Immediately, a comb was placed at the top of the cast system to form the desired number of 
wells for sample loading. Electrophoresis was conducted using a Mini-PROTEAN® 3 Cell 
(Bio-Rad) system. The inner chamber was filled with 1x cathode buffer and the outer chamber 
was filled with 1x anode buffer up to the mark on the chamber. Initially, the electrophoresis 
was accomplished at 80 V and 10 min to concentrate samples providing better resolution. After 
that, the electrophoresis settings were changed to 140 V for 50 min, or the required time to 
achieve desired protein separation. The samples were loaded with 7 µl of PageRuler™ 
Prestained protein marker (Thermo Scientific). 
5x Anode buffer 5x Cathode buffer 
Components Amount Components Amount 
Tris-HCl, pH = 8.9 1.0 M Tris  0.5 M 
  Tricin 0.5 M 
  SDS 0.5% (w/v) 
 
pH of the 5x anode buffer was adjusted to 8.9 by using HCl and both buffers were stored at 
4 °C. 
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Tris-glycine gels used for wet electroblotting were prepared as followed. 
Resolving gel (8%) Stacking gel 
Component Amount (2 gels) Component 
Amount 
(2 gels) 
Acrylamide solution 30% 5.3 ml Acrylamide solution 30% 1.3 ml 
Tris 1.5 M pH = 8.8, (Bio-Rad) 5.0 ml Tris 0.5 M pH = 6.8, (Bio-Rad) 2.5 ml 
dH2O 9.5 ml dH2O 6.1 ml 
SDS 10% (w/v) 200 µl SDS 10% (w/v) 100 µl 
APS 10% (w/v) fresh 100 µl APS 10% (w/v) fresh 100 µl 
TEMED 10 µl TEMED 10 µl 
 
10x Laemmli running buffer 
Components Amount 
Tris  25 mM 
Glycine 192 mM 
SDS 0.1% (w/v) 
 
2.14.4 Silver staining 
Silver staining was performed using the “Pierce silver staining kit” (Thermo Scientific) to detect 
proteins in polyacrylamide gels. In brief, a gel was first washed with distilled water and fixed 
with a fixation solution (30% ethanol, 10% acetic acid, and 60% distilled water). After fixing, 
the gel was washed two times with 10% ethanol and two times with distilled water. Gel was 
then sensitized with a sensitizing working solution for 1 min (0.5 µl Sensitizer with 25 ml 
distilled water). Subsequently, the gel was washed two times with distilled water for 1 min and 
then stained with the stain working solution for 30 min (0.5 ml Enhancer with 25 ml Stain). 
Before detection, gel was washed again two times with distilled water. The protein bands were 
visualized with the developer working solution for 2–3 min (0.5 ml Enhancer with 25 ml 
Developer). Once the bands were clearly visible, the development was stopped by an incubation 
for 10 min with 5% acetic acid. Finally, image of the gel was acquired by 
Amersham Imager 600 (GE Healthcare). 
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2.14.5 Western blot analysis 
Qualitative and quantitative detection of proteins after SDS-PAGE was determined by Western 
blot analysis (Towbin et al., 1979). Target proteins were detected by respective antibody 
treatment and further visualized by the chemiluminescent detection produced from a substrate-
conjugate reaction. In this study, Western blot was performed by using both semi-dry and wet 
transfer methods.  
2.14.5.1 Semi-dry electrotransfer 
The semi-dry blotting technique was used to transfer proteins from the SDS-PAGE gel matrix 
on a PVDF membrane. The membrane was incubated with methanol for 1 min prior to further 
use. Membrane, SDS-gel, and blotting paper were equilibrated with transfer buffer for 10 min. 
For a single transfer, a sandwich was prepared by sequential placement of blotting paper, 
membrane and gel. Protein transfer was carried out by using Trans-Blot Semi-Dry 
Electrophoretic Transfer Cell system (Bio-Rad). During a single blotting, a constant 54 mA 
current was applied for 1.5 h. 
Transfer buffer 
Component Amount 
Tris  3.03 g 
Glycine  14.4 g 
SDS 0.1% (w/v) 
Methanol 20% (v/v) 
dH2O volume up to 1.0 L 
 
2.14.5.2 Wet electrotransfer 
To perform wet electroblotting, the SDS-PAGE was carried out according to Laemmli method 
(Laemmli, 1970). 8% SDS gels were made while the samples were mixed with 2x or 4x 
Laemmli sample buffer (Bio-Rad) containing 5% or 10% 2-mercaptoethanol, respectively. 
Afterward, samples were loaded into the gel alongside 5 µl of BLUelf prestained protein ladder 
(FroggaBio). Electrophoresis was performed at 200 V, 400 mA and 35 min with 1x Laemmli 
running buffer.  
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10x Transfer buffer 
Components Amount 
Tris  25 mM 
Glycine 192 mM 
Methanol 20.0% (v/v) 
 
2.14.5.3 Immunodetection 
Following transfer, the PVDF membrane was incubated with blocking solution at 20 °C for 1 h 
to prevent unspecific antibody binding. Then, the membrane was incubated with primary 
antibody (dissolved in blocking solution) for overnight at 4 °C. The membrane was washed 
three times (10 min each) with wash buffer for removal of unbound antibodies and subsequently 
incubated with the secondary antibody conjugated with HRP at 20 °C for 1 h. Following 
incubation, the membrane was washed again with the washing solution for three times (10 min 
each). The target protein was visualized using the SuperSignalTM West Femto Maximum 
Sensitivity Substrate (Thermo Scientific), and signals were detected by using the Amersham 
Imager 600 (GE Healthcare). 
10 x TBS 
Component Amount 
Tris 1.0 M 
NaCl  1.0 M 
 
pH of the solution was adjusted to 7.5 by using HCl and stored at RT.  
Wash buffer Blocking solution 
Components Amount Components Amount 
TBS 10x 10.0% (v/v) Non-fat dried milk 5.0% (w/v) in 
wash buffer 
Tween 20  0.05% (v/v)   
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Primary and secondary antibodies used for Western blotting are shown in table 9. 
Table 9: Primary and secondary antibodies, their dilution and sources used for 
Western blotting  
Antibody Dilution Source 
anti-PGK1, mouse 
 






1:1,000 AbD SeroTec 
anti-kAE1Nter, rabbit 
 

















2.14.6 Determination of protein half-lives 
Half-life of kAE1 mutants was determined from a densitometry analysis of immunoblots. 
Initially, relative kAE1 amount was calculated from the intensity ratio of the respective kAE1 
band and β-actin band. Then, the starting time point was set as 100% and used to normalize the 
subsequent time points. A scatter plot was constructed by plotting time versus the percentage 
of relative kAE1 amount, and data were fitted by exponential regression. The half-life of 
mutants was estimated on the basis of the obtained equation shown below, where y = 50 h, A = 





2.14.7 Cell surface biotinylation 
Biotinylation is a common technique to determine protein located at the plasma membrane 
(PM). In order to attach biotin to a protein, a sulfo NHS-SS crosslinker was used that covalently 
binds primary amines present in peptides. Biotinylated proteins can then be isolated with avidin 
coated beads (Tarradas et al., 2013). To perform cell surface biotinylation, yeast cells 
expressing wild-type kAE1 were grown to late log phase (OD600 = 1–1.5) and subsequently 
harvested. The experimental setup was performed as per previously reported protocol (Becker 
et al., 2016). In brief, cells were first washed with cold PBS (pH 7.2) and labeled with EZ-link 
Sulfo-NHS-SS-Biotin (1 mg/ml in PBS) at 4 °C for 90 min. Then, cells were lysed after 
quenching the biotinylation reaction using quencher solution, and their lysates were 
immediately used for pull-down with avidin agarose beads (Pierce) with subsequent multiple 
washing steps with wash buffer (Pierce). Bound proteins (membrane fraction) were eluted in 
3x SDS buffer containing 50 mM DTT and 5% 2-mercaptoethanol. Finally, the membrane 
fraction and aliquots of the cell lysate (input) were used for SDS-PAGE followed by Western 
blot analysis. The cellular integrity during the labeling step was checked by using antibodies 
against phosphoglycerate kinase 1 (Pgk1p), and the PM labeling of kAE1 was detected by using 
an anti-kAE1Nter antibody. 
2.14.8 Enzymatic deglycosylation 
For the enzymatic deglycosylation, yeast cells were grown overnight and an aliquot of cells 
corresponding to OD600 = 5 was subsequently collected via centrifugation at 8,000 rpm for 
5 min. Cells were lysed in a similar procedure as described in section 2.14.1 but using 
Tris-EDTA buffer as the lysis buffer. For one enzymatic digestion, 18 µl of cell extract was 
incubated with 2 µl of 10x denaturing buffer for 10 min either at RT for kAE1 protein or boiled 
at 100 °C for RNase B. After incubation, solutions were treated with either 1 µl 
endoglycosidase Hf (Endo Hf; NEB) or 1 µl Peptide:N-glycosidase F (PNGase F; NEB) with 
the respective Glycobuffer as indicated in the list below. Mixtures were then incubated at 37 °C 
for 1 h. The digested protein was analyzed by SDS-PAGE, followed by Western blot analysis. 
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Endo Hf digestion PNGase F digestion 
Component Amount Component Amount 
Denatured protein mix 10 µl Denatured protein mix 10 µl 
10x Glycobuffer 3 2 µl 10x Glycobuffer 2 2 µl 
Endo Hf  
(1,000,000 units/ml) 1 µl 
PNGase F 
(500,000 units/ml) 1 µl 
dH2O 7 µl NP 40 2 µl 
  dH2O 5 µl 
 
Tris-EDTA buffer  
Component Amount 
Tris  10 mM 
EDTA  1 mM 
2-mercaptoethanol  0.1% (v/v) 
PMSF  1 mM 
Triton X-100 0.1% (v/v) 
 
Phenylmethylsulfonyl fluoride (PMSF) is quickly degraded in aqueous solution. In order to 
solve this matter, a 100 mM stock solution of PMSF in absolute ethanol was prepared separately 
and mixed with other components just before the application. 
 Boric acid tolerance assay 
The wild-type yeast strain BY4742 and its isogenic Δbor1 mutant containing either 
pYES2.1-ykAE1V5 or pYES2.1 (vector control) plasmid were grown to the stationary phase in 
uracil d/o glucose medium. Then, 1 ml of cell suspension was taken from the cultures, washed 
two times with uracil d/o raffinose medium, and the cell density was adjusted to OD600 = 0.7. 
These density-adjusted cultures were further decreased by performing a ten-fold serial dilution 
with uracil d/o raffinose medium. Afterward, 5 µl of cell suspension from each dilution were 
spotted on uracil d/o galactose agar plates containing 0, 10, 20, 40, and 80 mM boric acid. Cells 
were grown at 30 °C for 3 d and subsequently documented. To analyze boric acid tolerance in 
liquid culture, yeast cells were grown to the stationary phase. 1 ml of cell suspension was 
collected, washed twice, and diluted to OD600 = 0.2 in uracil d/o galactose medium containing 
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0, 10, 20, 30, and 40 mM boric acid. 200 µl of cell suspension from the diluted cultures were 
then placed in a 96-well plate. The plate was incubated at 30 °C, and the cell growth was 
measured at 600 nm by using a multi-mode plate reader (Molecular Devices). 
 Indirect immunofluorescence 
The cell wall of yeast typically blocks the access of antibodies to the plasma membrane or 
intracellular organelles. Thus, cells were first spheroplasted via enzymatic treatment with 
Zymolase for the indirect immunofluorescence. To achieve spheroplasted cells, a fresh yeast 
culture was cultivated to OD600 = 1. Then, a final OD600 = 10 was harvested by centrifugation 
(8,000 rpm, 5 min at RT), washed twice with 1x PBS (0.1 M) and fixed with 3.7% 
formaldehyde for 1 h on a roller drum at 20 °C. After three washing steps with 0.1 M PBS, cells 
were washed two times with 1.2 M sorbitol, resuspended in 1 ml 1.2 M sorbitol supplemented 
with 10 µl β-mercaptoethanol and 20 µl zymolyase (5 mg/ml zymolyase 100T), and incubated 
at 30 °C for 45 min. Finally, cells were centrifuged at 2,000 rpm for 5 min, washed two times 
with 1.2 M sorbitol and used for antibody staining. 
Prior to antibody staining, cells were permeabilized with 0.1% SDS at RT for 10 min. Then, 
30 µl of the sample were spotted on poly-L-lysine-coated coverslips, pre-incubated for 20 min, 
washed once with 1% BSA (dissolved in 1x PBS) and blocked for 30 min in 1% BSA. For 
detecting kAE1, cells were incubated at 20 °C for 1 h with primary antibodies and secondary 
antibodies conjugated with FITC for 1 h. After three washing steps with 1% BSA, cells were 
analyzed by fluorescence microscopy. Primary and secondary antibodies used for indirect 
immunofluorescence are shown in table 10. 
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Table 10: Primary and secondary antibodies, their dilution and sources used for 
indirect immunofluorescence  
Antibody Dilution Source 
anti-V5, mouse 
 
1:40 AbD SeroTec 
anti-kAE1Nter, rabbit 
 
1:40 Against N-terminal region of kAE1 (65 to 80 aa) (Wu 

















 Microscopy techniques 
2.17.1 Fluorescence microscopy 
Dual-color images of proteins fused to yeGFP and mRFP were obtained by utilizing a Keyence 
BZ-8000 fluorescence microscope (100x Oil immersion Plan Apo VC objective [1.4 NA]). 
yeGFP signals were detected by BZ-X GFP filter (470 nm excitation, 535 nm emission) and 
mRFP signals were detected via using BZ-X TexasRed filter (560 nm excitation, 630 nm 
emission). To prevent cell movement, samples were spotted on poly-L-lysine-coated cover slips 
and pre-incubated for 15 min.  
2.17.2 Confocal laser scanning microscopy 
Confocal images of yeast cells were obtained by using inverted microscopy (CLSM 710 META, 
Carl Zeiss). Cell specimens were analyzed with a 100x Oil EC Plan-Neofluar objective. For 
yeGFP detection, GFP ChS1:496-554 channel was used. Captured images were further 
analyzed by using Zen 2.1 (Zeiss) image processing software.  
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2.17.3 Spinning disc confocal microscopy 
Confocal images were captured using an inverted microscope (Ti-Eclipse, Nikon) fitted with a 
Yokogawa spinning disk unit (CSU-W1, Andor Technology). 100x Oil Plan Apo TRIF 
objective (Nikon) was used during image acquisition and recorded on a digital CSMOS camera 
(Orca-Flash 4.0, Hamamatsu). Finally, image analysis was carried out with Fiji software 
(Schindelin et al., 2012). The figures were processed by separating the channels of each image 
and optimizing the signal level for better observation of dim structures. 
 pH measurement of the kAE1 expressing yeast cells 
Intracellular pH (pHi) measurements of yeast cells were performed with the ratiometric 
pH-sensitive dye SNARF-5F AM (SNARF-5F 5-(and-6)-carboxylic acid, acetoxymethyl ester, 
acetate; Thermo Scientific). SNARF-5F is a naphthofluorescein derivative conjugated with an 
acetoxymethyl (AM) ester. The AM derivative easily penetrates the plasma membrane. It is 
then hydrolyzed by the nonselective esterases present in the cytosol and forms a nonpermeable 
charged fluorescence dye (Han & Burgess, 2010). In response to a single excitation wavelength, 
SNARF-5F AM has a dual emission property. Excitation of the dye at 543 nm generates both 
pH-sensitive (640 nm) and pH-insensitive (580 nm, isosbestic point) emission wavelengths. 
The elevation or reduction of fluorescence intensity depends upon the change in intracellular 
pH. This means that a pH increase causes a rise in SNARF-5F fluorescence emission at 640 nm 
with a corresponding decrease or constant fluorescence at 580 nm (Beane et al., 2019). Finally, 
intracellular pH can be determined by the ratio of these two wavelengths. Figure 2.2 illustrates 





Figure 2.2: A simplified illustration of pHi measurement in yeast expressing kAE1. 
kAE1 expressing yeast cells were grown overnight. A certain number of cells were taken from 
the culture and washed to remove culture medium. Then, cells were incubated with the 
pH-sensitive dye SNARF-5F AM for 1 h at 30 °C and shaking. After incubation, cells were 
washed carefully to remove excess amounts of extracellular dye. To determine cytosolic pH, 
calibrated sample cells were prepared by incubating cells with Nigericin and buffers with 
specific pH values for 1 h at 30 °C and shaking. Finally, a ratio of fluorescence from sample 
cells and calibrated cells were measured using a fluorometer. 
 
In order to execute pHi measurement, 50 ml of yeast cells transformed with empty vector pPGK 
(negative control) or pPGK-ykAE1 were grown overnight in SC medium (pH = 6.4, 50 mM 
NaCl) to the stationary phase (OD600 = 3–4) and an aliquot of cells corresponding to OD600 = 20 
was subsequently harvested by centrifugation at 8,000 rpm for 5 min. After washing the cells 
in 0.1 M potassium phosphate buffer (pH = 6.4, pH was adjusted by mixing specific volumes 
of 1.0 M K2HPO4 and KH2PO4 solutions), cells were incubated in 0.1 M potassium phosphate 
buffer containing 10 µM SNARF-5F AM for 1 h at 30 °C and 220 rpm. To get rid of excess 
amounts of SNARF-5F AM, cells were washed three times with 0.1 M potassium phosphate 
buffer and resuspended in 400 µl 0.1 M potassium phosphate buffer. 40 µl aliquots (OD600 = 2) 
of cells expressing kAE1 or negative control were mixed with 160 µl 0.1 M potassium 
phosphate buffer and placed into black 96-well plates (Nunc F96, Thermo Scientific) and 
fluorescence was measured by a fluorometer (Safire2, Tecan). For preparing an additional 
calibration curve, 40 µl aliquots (OD600 = 2) were also taken from the 400 µl cultures, 
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centrifuged at 8,000 rpm for 5 min and washed two times with the different calibration buffers 
with distinctive pH values (5.6, 6.4 and 7.2). Then, samples were incubated in 200 µl of the 
corresponding calibration buffers supplemented with 40 µM nigericin (Sigma) at 30 °C for 1 h 
(220 rpm). Finally, fluorescence of 200 µl aliquots of the different calibration samples was 
measured in 96-well plates as described above. Excitation wavelength was set to 543 nm and 
dual emission was determined at 580 nm and 640 nm. Afterward, fluorescence emission ratios 
(640 nm/580 nm) and the corresponding mean fluorescence values were calculated for each 
sample (n ≥ 3). A calibration curve was formulated by plotting the fluorescence ratio of 
calibrated samples versus corresponding extracellular pH and the data were fitted by a 
second-order polynomial regression. The quadratic equation is shown below: 
𝑦 = 𝑎𝑥( + 𝑏𝑥 + 𝑐 
where, a, b and c are constants. To calculate unknown x (here, x corresponding to pHi and 
y refers to 640 nm/580 nm emission ratio), subsequent equation was used:  
𝑥 =
44𝑎(𝑦 − 𝑐) + 𝑏(	 − 𝑏
2𝑎 			𝑎𝑛𝑑	𝑎 ≠ 0 
Intracellular pH values of kAE1 expressing samples were determined by using the obtained 
equation from the calibration curve. All the samples were light-protected throughout the 
experiment to ensure the probe’s stability. 
 Anion exchange chromatography 
Intracellular and extracellular Cl− concentration of BY4742 cells was measured by utilizing an 
anion exchange chromatography. BY4742 cells transformed with an empty vector control 
(pPGK) or expressing untagged wild-type kAE1 (pPGK-ykAE1) were grown to the stationary 
phase (OD600 = 3–4). To prevent kAE1 mediated chloride transport, constitutively ykAE1 
expressing cells were pre-treated with 200 µM DIDS (disodium 4,4′-diisothiocyanatostilbene-
2,2′-disulfonate) dissolved in 10 mM HEPES buffer (pH = 7.4) for 30 min at 30 °C with shaking 
at 220 rpm. Afterward, empty vector expressing cells and ykAE1 expressing cells either 
pre-treated or non-treated with DIDS were collected with a final OD600 = 200. Cells were then 
incubated in 5 ml of HEPES buffer with 150 mM NaCl with or without DIDS for 1 h at 30 °C 
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with shaking. The cell density was measured again to confirm the number of cells present in 
each sample. Finally, an aliquot of each cell sample was taken for individual analysis of 
intracellular and extracellular Cl− concentration. 
Sample preparation for measuring extracellular Cl− concentration: To collect supernatant for 
extracellular Cl− ([Cl−]ex) determination, 1 ml cell suspension was centrifuged after 1h (t1h). The 
collected supernatants were then diluted at a ratio of 1:10 with MiliQ water. Finally, 2 µl diluted 
supernatant were injected into an anion exchange chromatography for analyzing Cl− 
concentration (Dionex Integrion HPLC system installed with a Dionex IonPacTM AS9-HC 
anion-exchange column, Thermo Scientific).  
Sample preparation for measuring intracellular Cl− concentration: The intracellular Cl− 
concentration of yeast cells [Cl−]in was determined using 1 ml of cell suspension. Cells were 
harvested by centrifugation, washed two times with wash buffer (150 mM sodium gluconate 
and 100 µM DIDS in HEPES buffer), and finally resuspended the cells into 1 ml of HEPES 
buffer. Cells were then lysed using a homogenizer (Precells Evolution, Bertin Corp.). Cellular 
debris was removed by centrifugation and the supernatant was collected for measuring Cl− 
concentration. Lastly, 10 µl collected supernatants were injected into anion-exchange 
chromatography for analysis.  
Calculation of Cl− influx as well as intracellular Cl− concentration: A chloride standard curve 
was prepared from standard solutions having Cl− concentration of 0 mM, 50 mM, 100 mM, 
150 mM and 200 mM for each experiment, and fitted with linear regression. Consequently, Cl− 
concentration of the samples was determined by plotting the peak area of the samples against 
the peak areas of the chloride standards. To measure the total amount of Cl− influx per hour into 
yeast cells, the extracellular Cl− concentration at the beginning (t0h) was additionally measured 
and calculated by following equation: [Cl−]ex(t0h) − [Cl−]ex(t1h). The obtained values were 
subsequently normalized to the total cell number where OD600 = 1 was set to ~1 x 107 cells and 
depicted as Cl− influx per cell per hour. To measure intracellular Cl− concentration, the total 
intracellular Cl− concentration [Cl−]in as well as OD600 value were calculated from 1 ml aliquots, 
and then the intracellular Cl− concentration was determined for a single cell. 
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 MTS assay  
2.20.1 Cell counting by hemocytometer 
To achieve a certain cell concentration in culture dishes/well-plates, mammalian cells were 
counted by using a hemocytometer. In brief, ~70–80% confluent cells were trypsinized after 
washing with sterile 1x PBS and collected in a tube with 5 ml fresh culture medium. From the 
collection tube, 100 µl of cell suspension were transferred to a new microcentrifuge tube and 
diluted with the respective culture medium. Then, 10 µl of cell suspension were placed on the 
hemocytometer and cell density was calculated from the equation mentioned below:  
𝑐𝑒𝑙𝑙	𝑑𝑒𝑛𝑠𝑖𝑡𝑦	 ?
𝑐𝑒𝑙𝑙𝑠




2.20.2 MTS assay for investigating mIMCD3 cell proliferation 
To observe the effect of the kAE1 mutants on mIMCD3 cell proliferation, an MTS assay was 
performed by utilizing CellTiter 96® AQueous One-Solution Reagent (Promega). MTS is a 
tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium] which is reduced to a soluble formazan by the enzymatic activity 
of dehydrogenase enzymes, mainly involved in cellular metabolism. The solubilized formazan 
has a maximum absorbance of 490 nm (Cory et al., 1991). One-Solution additionally consists 
an electron coupling reagent phenazine ethosulfate (PES) that helps to increase the stability of 
the solution combining with MTS. 
First, mIMCD3 cells inducibly expressing wild-type and mutated kAE1 were grown to ~80% 
confluency. Cells were detached and 50,000 cells/well were split in 12-well plates containing 
growth medium in presence or absence of 1.0 µg/ml doxycycline. After 24 h, the culture 
medium was changed and cells were incubated into three different types of media: 1) standard 
growth medium, 2) growth medium containing 100 mM NaCl, and 3) growth medium 
containing of 200 mM Mannitol. The standard growth medium contains an osmolarity of 
~300 mOsmol/kg H2O. When 100 mM NaCl or 200 mM mannitol was added to the medium, 
its osmolarity was increased to ~500 mOsmol/kg H2O and labeled as a hyperosmotic condition. 
In order to maintain a constant expression level of the kAE1 variants in the induced cells, 
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doxycycline was added into these three media. The initial time point of transferring cells into 
different media was counted as 0 h and cells were incubated until 72 h in the CO2 incubator at 
37 °C. MTS assay was performed at 0 h, 48 h and 72 h for determining the viability of mIMCD3 
cells. For each measurement, cells were washed twice with fresh growth medium to remove 
dead cells and 240 µl of MTS-medium solution was added in each well. The MTS-medium 
solution was prepared by adding One-Solution into the growth medium at 1:5 ratio 
(One-Solution : growth medium) following the manufacturer’s protocol. Then, cells were 
incubated for 20 min in a CO2 incubator. Following incubation and gently mixing of the 
supernatant, 200 µl supernatant from each well was transferred to a new 96-well plate. The 
absorbance of the produced formazan was measured at 490 nm by using a Synergy Mx Plate 
Reader (BioTek). 
For background correction, MTS-medium solution was added into empty wells (negative 
control) and incubated under identical conditions as samples. Finally, the relative absorbance 
of samples was calculated using the equation below, where the absorbance value of empty well 
was subtracted from the absorbance value of the sample. 
Corrected absorbance = Absorbance Sample – Absorbance Negative control 
 Data analysis and statistics 
Statistical analysis was carried out in Graphpad Prism 8. All pooled data were given as mean 
values ± standard error of the mean (SEM). Statistical significance was determined using either 
unpaired t-test, One-way or Two-way ANOVA based on biological replicates and at sample 
sizes of n ≥ 3 (ns, not significant; *, p <0.05; **, p <0.01; ***, p <0.001).
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3. Results 
Mutations in the kAE1-encoding gene SLC4A1 lead to dRTA, a pathological condition 
characterized as a defect in urine acidification. Based on hereditary transmission, two types of 
dRTA can be clinically differentiated, an autosomal dominantly and an autosomal recessively 
variant. The mutations are typically found in a heterozygous state in the case of the former, 
whereas homozygous and heterozygous mutations of the affected gene can be observed for 
autosomal recessive dRTA (Yenchitsomanus et al., 2005). For characterizing kAE1-mediated 
dRTA mutants, many studies were previously carried out in MDCK cells, which are used as a 
model for renal intercalated cells (Gekle et al., 1994). Studies in MDCK cells proposed that 
dRTA originates from either a complete dysfunction of kAE1 or a mistargeting of the respective 
mutated proteins to the apical membrane or the intracellular compartments (Cordat et al., 2006). 
However, recent in vivo findings of dominant dRTA knock-in mice and biopsy data of dominant 
dRTA patients suggest that the origin of the disease is far more puzzling than anticipated. For 
example, in a kAE1 R609H knock-in mouse model, the mutant, although just expressed in 
minor amounts, was found to be correctly targeted to the basolateral membrane (Mumtaz et al., 
2017; Vichot et al., 2017). These in vivo findings were in contrast to previous data obtained in 
MDCK cells on dRTA-causing kAE1 mutants, which eventually highlighted that the molecular 
mechanism of kAE1-mediated dRTA is still poorly understood. 
To decipher the underlying reasons of kAE1-mediated dRTA, it is essential to address 
kAE1-related physiological questions in more detail. This study focused on the investigation of 
the intracellular trafficking and functionality of the anion exchanger and its mutant variants in 
yeast and mammalian cells. To achieve this goal, the capability of Saccharomyces cerevisiae 
to express full-length kAE1 was analyzed. A wide range of tagged and untagged full-length 
kAE1 variants was generated in order to attain a robust expression. After achieving an optimal 
expression level, intracellular localization and biological activity of full-length kAE1 variants 
in S. cerevisiae were determined. Moreover, the expression and localization of two kAE1 
mutants (E681Q and G701D) were also investigated in yeast. Additional experiments were 
performed in mIMCD3 cells, the closest cellular model for α-intercalated cells at the moment. 
Three newly found dRTA mutants (kAE1 R295H, Y413H, and S525F) were characterized in 
this model cell line to investigate their half-life, effect on the cellular autophagy process and 
influence on cell proliferation. 
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 Construction of different kAE1 derivatives for S. cerevisiae 
Numerous attempts were previously made to express full-length human kAE1 (hkAE1) in yeast, 
but those efforts either failed or resulted in an inactive protein that did not get transported to the 
cell surface (Bonar & Casey, 2010; Groves et al., 1999). In order to obtain a successful 
expression of full-length kAE1 in S. cerevisiae, two main approaches were applied in this study. 
First, the signal sequence of the fungal ER chaperon Kar2p was attached to the N-terminus of 
the human kAE1 sequence (Kar2SS-hkAE1). This approach is commonly used to efficiently 
translocate heterologous proteins into the yeast ER (Chalfant et al., 2019). Native hkAE1 and 
hkAE1 bearing the adapted ER import sequence were C-terminally fused with a V5 tag 
(hkAE1V5, Kar2SS-hkAE1V5) to ease the detection process. Secondly, an adaptation of the 
human kAE1 cDNA sequence to yeast codon usage was conducted, and this untagged version 
of kAE1 was designated as ykAE1. The codon optimization technique is frequently used to 
facilitate recombinant protein production in S. cerevisiae, potentially overcoming inefficient 
translation due to the presence of rare codons in the target DNA sequence (Bai et al., 2011; 
Quax et al., 2015). In addition to an untagged ykAE1 derivative, two other variants were cloned 
carrying either a V5 tag (ykAE1V5) or a yeast-optimized enhanced GFP (yeGFP) tag 
(ykAE1-yeGFP) at the C-terminus. A GFP tag can often simplify the visualization of proteins 
in living cells. In order to facilitate the cloning of all these constructs into different yeast 
expression vectors, XhoI and EcoRI restriction sites were inserted at the 5'-end, and BamHI and 
SalI restriction sites were introduced at the 3'-end of each construct. The vector pYES2.1 was 
used for expression of these constructs in the S. cerevisiae carrying AmpR and URA3 markers 
for positive selection in E. coli and S. cerevisiae, respectively. 2 µ origin of replication permits 
multi-copy autonomous replication of the plasmid in yeast, and the strong galactose-inducible 




Figure 3.1: Schematic diagram of the kAE1 variants used for expression in S. cerevisiae.  
The native cDNA sequence of kAE1 (hkAE1) were C-terminally fused with a V5 tag 
(hkAE1V5), whereas one variant was additionally carrying the ER signal sequence of yeast 
Kar2p at the N-terminus (Kar2SS-hkAE1V5). Further, an untagged yeast codon-optimized 
version (ykAE1), as well as its two derivatives with either a V5 tag (ykAE1V5) or a yeast-
optimized eGFP fusion at the C-terminus (ykAE1-yeGFP), were constructed. Calculated length 
of the variants is indicated (bp). Restriction sites: XhoI and EcoRI (5'), BamHI and SalI (3'). 
 
3.1.1 Expression profiles of the different kAE1 variants  
The uracil auxotrophic S. cerevisiae BY4742 strain was used to investigate the expression of 
modified full-length kAE1 versions. The different recombinant plasmids pYES2.1-hkAE1V5, 
pYES2.1-Kar2SS-hkAE1V5, pYES2.1-ykAE1V5, pYES2.1-ykAE1 or pYES2.1-ykAE1-yeGFP 
were transformed into wild-type BY4742 cells by lithium-acetate transformation method 
(section 2.10.2.1). Expression of kAE1 variants was then initiated by culturing cells in medium 
with galactose as a carbon source (uracil d/o galactose medium). To analyze kAE1 expression, 
yeast cells were disrupted by using a cell homogenizer, and Western blotting analyses were 
performed. Depending on the type of protein tag in the different kAE1 constructs, blots were 
probed with an anti-V5 or anti-GFP primary antibody. The untagged ykAE1 variant was 
detected using an antibody that recognizes the N-terminus of the protein (anti-kAE1Nter). 
Moreover, all blots were also incubated with anti-PGK1 antibody for identifying the loading 




Figure 3.2: Expression analysis of different tagged and untagged kAE1 variants in 
S. cerevisiae.  
Wild-type BY4742 cells were transformed with various kAE1 derivatives, expression was 
induced by incubation of the respective transformants in 3% galactose for 24 h. After cell lysis, 
Western blot analysis was conducted using the indicated primary antibodies. (A) Untagged 
ykAE1 was analyzed with an antibody recognizing the kAE1 N-terminus (anti-kAE1Nter). (B) 
A V5-antibody was used for the respective V5-tagged constructs hkAE1V5, Kar2SS-hkAE1V5, 
ykAE1V5. (C) The expression of the yeGFP-fused variant (ykAE1-yeGFP) was detected with 
an anti-GFP antibody. The house-keeping protein Pgk1p was used as a loading control, and an 
HRP-coupled anti-mouse antibody was used as secondary antibody in all cases. Molecular 
weight marker is indicated (M). (D) Densitometry analysis of the different kAE1 variants. Each 
signal for the respective kAE1 variant was normalized to the corresponding signal of Pgk1p 
and the relative kAE1 signal was calculated. Data represent n = 2 separate experiments. The 
results are shown as mean ± SEM, (partially published in Sarder et al., 2020). 
 
In contrast to the untagged and V5-tagged yeast codon-optimized kAE1 constructs, no kAE1 
signal could be detected for yeast cells expressing hkAE1V5 construct (Figure 3.2 A, B). 
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Untagged ykAE1 displayed a less intense band signal, which is possibly due to inefficient 
solubilization of the membranes during lysis. Notably, the addition of Kar2pSS could not 
drastically increase the hkAE1 signal, although a faint signal of kAE1 at ~94 kDa was detected 
on the blot (Figure 3.2 B). Surprisingly, a very strong band signal of the ykAE1V5 variant at ~94 
kDa size was observed that corresponds to the expected size of the V5-tagged kAE1. Similarly, 
a significant band at ~110 kDa was detected for the ykAE1-yeGFP variant equivalent to the 
expected size of the chimeric protein (Figure 3.2 C). Quantification of the bands by 
densitometric analysis also confirmed the strong expression of yeast-codon optimized ykAE1 
variants comparing to both hkAE1V5 and Kar2SS-hkAE1V5 (Figure 3.2 D). In addition, an 
increased level of expression for the ykAE1-yeGFP variant was observed compared to the 
ykAE1 and ykAE1V5 variants. 
Altogether, these data suggested that the key factor for full-length kAE1 expression in yeast 
was the re-engineering of the human kAE1 cDNA sequence for yeast preferred codons. Based 
on these initial findings, only constructs optimized to yeast codon usage were used for further 
experiments.  
3.1.2 Improvement of protein extraction 
Since the signal intensity of untagged ykAE1 was not optimal on the immunoblots, different 
conditions for cell lysis buffers were tested. In general, membrane proteins are poorly soluble 
in aqueous solutions due to their hydrophobic nature (Seddon et al., 2004). It was previously 
described that lysis buffer with Triton X-100 efficiently solubilizes kAE1 from mIMCD3 cell 
membranes (Lashhab et al., 2019). Triton X-100 is a non-ionic detergent and extensively used 
to solubilize kAE1 variants expressed in mammalian cells. On the contrary, SDS combined 
with urea is used to solubilize yeast proteins (von der Haar, 2007). SDS is an anionic detergent 
commonly used to extract membrane proteins, whereas urea disrupts the secondary structure of 
proteins. To determine a suitable condition for protein extraction, BY4742 cells expressing 
untagged ykAE1 (ykAE1) were grown overnight at 30 °C in under inducing conditions (uracil 
d/o galactose medium) and subsequently three aliquots of cells (OD600 = 5) were prepared. Cells 
were then lysed using three different SUMEB lysis buffer compositions (A, B and C) which 
additionally contained 20% of a protease inhibitor cocktail solution to inhibiting protein 
degradation. In condition-A, proteins were extracted using SUMEB buffer that was 
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supplemented with 1% SDS. In condition-B and -C, 2% dodecyl-β-d-maltopyranoside (a non-
ionic detergent) and 1% Triton X-100 were added, respectively. Afterward, the solubilized 
protein was separated from insoluble cell debris by centrifugation at high speed. The amount 
of kAE1 present in the supernatant was compared to that in the pellet fraction via Western 
analysis using the polyclonal anti-kAE1Nter antibody, and the results are shown in Figure 3.3. 
 
 
Figure 3.3: Comparison of yeast expressed ykAE1 solubility under different conditions. 
Wild-type BY4742 cells expressing the ykAE1 variant were incubated with 3% galactose for 
24 h before lysis. To solubilize kAE1, three different compositions of SUMEB lysis buffer were 
compared: (A) 1% SDS, (B) 1% SDS plus 2% docyl-β-d-maltopyroanoside and (C) 1% SDS 
plus 1% Triton X-100. The supernatant and pellets from each condition were collected and 
analyzed via Western blot. ykAE1 was identified by incubation with anti-kAE1Nter and an 
appropriate secondary anti-rabbit antibody coupled with HRP. Protein bands referring to kAE1 
on the blot are marked by black arrows. BY4742 cells expressing pYES2.1 were used as 
negative control. 
As illustrated in Figure 3.3, samples treated with a SUMEB buffer containing only SDS showed 
the highest signal intensity correlating to kAE1 in the supernatant fraction compared to samples 
of the other two conditions (condition-B and -C). Moreover, a faint signal of kAE1 was detected 
in the pellet fraction among all three conditions. BY4742 cells expressing the corresponding 
empty vector (pYES2.1) were lysed, analyzed as a negative control, and as expected no 
kAE1-related signals could be determined. The data of these Western blot analyses suggest that 
the complete solubilization of kAE1 from yeast membranes could not be achieved by using 
these detergents. Nevertheless, the protein signal for yeast cells lysed under condition-A 
(1% SDS in SUMEB buffer) implied a slightly increased solubility of kAE1 in the supernatant 
than the other two conditions. Consequently, SUMEB buffer with 1% SDS was used as lysis 
buffer in the following experiments unless otherwise mentioned. 
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 Intracellular localization of the kAE1 derivatives in S. cerevisiae 
3.2.1 Localization of untagged ykAE1 
To establish S. cerevisiae as an experimental system, an important criterion was the proper 
trafficking of kAE1 protein to the cell surface. A previous study reported that the detection of 
full-length AE1/kAE1 at the yeast cell surface was unsuccessful, and only the untagged 
membrane domain of AE1 (B3mem; further referred as AE1361–911) could be targeted to the PM 
of yeast cells. In addition, AE1361–911 protein was not carrying any tag within its sequence 
(Groves et al., 1996). Therefore, the potential targeting of the untagged ykAE1 variant to the 
yeast plasma membrane was determined via indirect immunofluorescence. BY4742 cells 
expressing ykAE1 were analysed by fluorescence microscopy and subcellular localization of 
ykAE1 was detected with a primary anti-kAE1Nter antibody succeeded by a secondary anti-
rabbit antibody coupled with FITC (Figure 3.4). 
Bright field FITC Merge 
   
 
Figure 3.4: Indirect immunofluorescence images of wild-type yeast cells expressing 
ykAE1. 
Wild-type BY4742 cells expressing the ykAE1 variant were incubated with 3% galactose for 
24 h. Subcellular localization of kAE1 protein was detected by using anti-kAE1Nter and a 
FITC-coupled secondary anti-rabbit antibody. The cells were analyzed via fluorescence 
microscopy (Keyence). Peripheral localized kAE1 signals are marked by white arrows. 
Objective: PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X GFP (470 nm 
excitation, 535 nm emission); Scale bar: 10 µm. 
 
Figure 3.4 shows the subcellular localization of untagged ykAE1 protein in wild-type BY4742 
cells. The green fluorescence signal corresponding to kAE1 was observed in intracellular 
structures and at the cell periphery. The intracellular signals likely resemble the localization of 
kAE1 in membranes of different organelles. In contrast, the obtained peripheral signals 
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correspond to the PM-localized kAE1 protein. Interestingly, the peripheral signals did not form 
a continuous ring-like structure, commonly noticed for PM located proteins, but a more 
punctured or dotted pattern. These observations suggest that only a minor pool of kAE1 can 
reach to the yeast cell surface. 
3.2.2 Localization of tagged ykAE1 variants 
Next, subcellular localization of the ykAE1V5 variant in S. cerevisiae was investigated by 
perfoming indirect immunofluorescence. BY4742 cells expressing ykAE1V5 were analyzed 
with a fluorescence microscope, and the subcellular localization of ykAE1V5 variant was 
detected with an anti-V5 antibody followed by a FITC conjugated anti-mouse antibody 
(Figure 3.5). 
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Figure 3.5: Indirect immunofluorescence images of wild-type yeast cells expressing the 
ykAE1V5 variant. 
Wild-type BY4742 cells expressing ykAE1V5 variant (green) in an inducible manner were 
incubated with 3% galactose for 24 h. Then, cells were spheroplasted, fixed and permeabilized. 
Subcellular localization of kAE1 protein was detected by probing the cells with anti-V5 and 
anti-mouse coupled with FITC antibody. Cells were analyzed by fluorescence microscopy 
(Keyence). Merged image is showing the overlay of bright field and FITC channel. Objective: 
PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X GFP (470 nm excitation, 535 nm 
emission); Scale bar: 10 µm. 
 
After visualizing cells by fluorescence microscopy, a completely intracellular kAE1 signal 
(green) was observed rather than a ring-like structure which would indicate a proper 
PM localization (Figure 3.5). Naturally, yeast-ER has two distinctive domains, the perinuclear 
ER and the cortical ER. Perinuclear-ER resides around the nucleus and cortical ER locates 
closely to the PM (West et al., 2011). From the pattern of the detected signal, it could be 
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speculated that the majority of the expressed ykAE1V5 variant was trapped/accumulated at the 
perinuclear ER. Although, few peripheral kAE1 signals were found, which is most likely 
coming from the proteins resided in the cortical ER. However, to overcome the limitation of 
indirect immunofluorescence such as removal of the cell wall and to detect subcellular protein 
localization in living cells, a yeGFP was fused to the C-terminus of ykAE1 (ykAE1-yeGFP). 
The ykAE1-yeGFP variant was expressed in wild-type BY4742 cells upon galactose induction 
and localization of kAE1 was analyzed by CLSM (Figure 3.6). 
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Figure 3.6: Live-cell imaging of wild-type yeast cells expressing ykAE1-yeGFP fusion 
protein. 
Wild-type BY4742 cells expressing the ykAE1-yeGFP variant in an inducible manner were 
incubated with 3% galactose for 24 h. Live cells were incubated with DAPI for 15 min to stain 
DNA. After DAPI staining, cells were placed on poly-L-lysin coated glass slide to analyzed in 
CLSM microscopy (CLSM710, Zeiss). Green staining represents ykAE1-yeGFP protein and 
blue staining indicates the nucleus Objective: C-Apochromat 63x; Filter: EGFP Ch2:500-582, 
DAPI Ch1:391-461. Scale bar: 5 µm. 
 
Figure 3.6 shows the subcellular localization of ykAE1-yeGFP variant. DAPI (blue) was used 
to stain the nuclei of yeast cells. The green fluorescence signals corresponding to ykAE1-yeGFP 
were surrounding the nucleus resembling perinuclear ER-localized kAE1 protein. In addition, 
the green signals captured from the outer edge of cells were indicating the cortical ER-localized 
kAE1 protein. The distribution of ykAE1-yeGFP signal in BY742 cells was similar to the 
ykAE1V5 variant. Therefore, these results suggest that C-terminal yeGFP fusion also leads to 
intracellular retention of kAE1 in yeast. In sum, these data show that kAE1 is predominantly 
located in the yeast ER when its C-terminus is masked by either V5 tag or yeGFP and is not 
able to reach the PM of S. cerevisiae. 
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 Colocalization of kAE1 with the yeast plasma membrane protein Pma1p 
3.3.1 Construction of N-terminally and intramolecularly tagged ykAE1 variants 
It was previously reported that the cytosolic C-terminal domain of kAE1 interacts with different 
proteins such as GAPDH and AP-1 mu1A while being transported to the basolateral membrane 
(Junking et al., 2014; Su et al., 2011). In fact, the removal of the C-terminus domain leads to 
insufficient processing and massive intracellular retention of kAE1 protein (Quilty et al., 2002). 
On the contrary, the addition of a peptide tag at the N-terminal domain or the third exofacial 
loop of kAE1 protein does not influence its trafficking and functionality (Beckmann et al., 
2002; Cordat et al., 2006). To eliminate some potential negative effects of the initially tested 
C-terminally tagged constructs, ykAE1 variants with either an HA-epitope-tag or a yeGFP 
integrated to other intramolecular positions were used. Therefore, ykAE1 with an integrated 
HA tag within the third exofacial loop between Asn556 and Val557 (ykAE1HA) and ykAE1 with 
an N-terminal fusion to yeGFP (yeGFP-ykAE1) were constructed. A schema of the new full-
length kAE1 variants is shown in Figure 3.7. 
 
Figure 3.7: Schematic diagram of two different ykAE1 variants. 
Schemas are showing yeast-codon optimized full-length kAE1 constructs containing either a 
HA tag or a yeGFP. Positions of the HA tag, yeGFP and GGGGS-linker are indicated. ykAE1HA 
is carrying a HA tag within the third extracellular loop between Asn556 and Val557, and yeGFP-
kAE1 contains a yeGFP fused to the N-terminus of the ykAE1HA sequence with a flexible linker. 
Calculated length of the variants is shown (bp). Restriction sites: XhoI (5') and BamHI (3'). 
 
yeGFP-kAE1 was constructed via in vivo recombination in yeast (section 2.10.2.2), and 
ykAE1HA was synthetically generated by a company (GeneArt). These constructs were cloned 
into the expression vector pYES2.1 and transformed into BY4742 yeast cells. The expression 
of ykAE1HA and yeGFP-kAE1 variants were detected by Western blot analysis using anti-HA 




Figure 3.8: Expression of exofacial loop-3 HA-tagged or N-terminus yeGFP tagged kAE1 
variants. 
Wild-type BY4742 cells expressing different kAE1 variants were incubated with 3% galactose 
for 24 h before lysis. Representative images of the Western blot analysis of BY4742 cells 
expressing (A) exofacial loop-3 ykAE1(ykAE1HA) and (B) N-terminal yeGFP fused to kAE1 
(yeGFP-ykAE1). HA-tagged ykAE1 was identified by anti-HA antibody followed by anti-rat 
antibody conjugated with HRP. yeGFP fused ykAE1 was detected with anti-GFP antibody 
subsequently incubating with anti-mouse antibody coupled with HRP. Molecular weight 
marker is displayed (M). Pgk1p served as loading control (published in Sarder et al., 2020). 
 
Figure 3.8 shows a robust expression of both the ykAE1 variants (ykAE1HA and yeGFP-ykAE1) 
after 24 h expression in wild-type yeast cells. However, there is a double band visible in the 
N-terminus yeGFP fusion construct. Since there was no other band pattern visible on the 
immunoblot, this double band is unlikely to be a degradation product of the fusion protein. A 
previous study reported that overexpression of GFP-tagged membrane protein could lead to 
misfolded proteins that exhibit different running behaviors during the SDS-PAGE (Geertsma 
et al., 2008). Therefore, a portion of the expressed yeGFP-ykAE1 variant is in a misfolded state. 
Based on the molecular size of the bands, the upper band would correspond to a misfolded 
GFP-ykAE1 fused protein, whereas the lower band represents the properly folded chimeric 
protein. Wild-type BY4742 cells expressing empty vector (pYES2.1) were used as a negative 
control on the immunoblot.  
3.3.2 Colocalization analysis  
The subcellular localization of target proteins in a particular host organism is often determined 
by using a marker protein. To precisely verify the PM-localization of ykAE1, the PM-marker 
Pma1p-mRFP was expressed in S. cerevisiae. Pma1p works as a proton pump and is abundantly 
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present at the yeast cell surface (Ferreira et al., 2001). To facilitate the visualization in living 
cells, a monomeric red fluorescence protein (mRFP) was fused to the C-terminus of PMA1 gene 
to generate a PMA1-mRFP fusion construct (Malínská et al., 2003). A schema of the 
PMA1-mRFP construct is shown in Figure 3.9. 
 
Figure 3.9: Schematic outline of PMA1-mRFP construct for integration into the yeast 
genome.  
Schema is showing an illustration of the yeast PM marker Pma1p-mRFP variant. mRFP is fused 
to the C-terminus of Pma1p. The restriction site BglII in the construct is shown and is used for 
integration into the yeast chromosome. Position of the linker and the size of the construct (bp) 
are indicated. 
 
PMA1-mRFP construct was cloned into the integrative shuttle vector pYIplac128, which 
carries an AmpR and LEU2 markers for E. coli and S. cerevisiae, respectively. Wild-type 
BY4742 cells and its isogenic mutant Δend3 cells were transformed with the linearized 
recombinant plasmid pYIplac128-PMA1-mRFP digested with BglII. The purpose of using 
Δend3 mutant was to examine whether a defective endocytosis mechanism could trap more 
PM-localized kAE1. Stable strains of BY4742-PMA1-mRFP and Δend3-PMA1-mRFP were 
generated through the homologous recombination of PMA1-mRFP construct and positive 
transformants were selected in leucine d/o glucose medium. The chimeric Pma1p-mRFP 
protein was constitutively expressed under the control of the native PPMA1 promoter. Figure 3.10 
shows the expression of the fusion protein in BY4742 and Δend3 cells. A clear ring-like 
structure at the periphery was observed via fluorescence microscopy resembling the plasma 
membrane of the cell. In addition, the internalization of Pma1p-mRFP leads to vacuolar 
transport permitting vacuolar staining. Wild-type yeast cells mostly displayed a single 
circle-like vacuolar structure. In contrast, the Δend3 mutant showed punctured multi-vacuolar 
like structures. This might be due to the defect of its endocytosis process. 
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Figure 3.10: Fluorescence microscopy of stably transformed wild-type BY4742 and Δend3 
yeast cells expressing the Pma1p-mRFP fusion protein. 
BY4742 and its isogenic Δend3 mutant were transformed with linearized YIp128-PMA1-mRFP 
plasmid and stable cells constitutively expressing Pma1p-mRFP were generated via 
homologous recombination. Red signals correspond to Pma1p-mRFP. Pma1p signals located 
at the PM and vacuole were observed in living cells by fluorescence microscopy (Keyence). 
Objective: PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X TexasRed (560 nm 
excitation, 630 nm emission); Scale bar: 10 µm. 
 
After verifying the PM-localization of the Pma1p fusion protein, the transport of ykAE1 was 
further analyzed by a colocalization study. Therefore, a similar indirect immunofluorescence 
setup was used, but in order to enhance the image resolution, spinning-disk confocal 
microscopy was chosen. In this context, pYES2.1-ykAE1HA was transformed into the BY4742-
PMA1-mRFP strain, and the expression of ykAE1HA was induced with 3% galactose for 24 h 
followed by immunostaining for ykAE1HA with primary anti-HA antibody and secondary anti-
rat antibody conjugated with FITC. The samples were then analyzed carefully by spinning-disk 
confocal microscopy (Figure 3.11). 
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Figure 3.11: Colocalization study of ykAE1HA with Pma1p-mRFP in S. cerevisiae. 
Indirect immunofluorescence images of ykAE1HA (green) and yeast PM-marker Pma1p-mRFP 
(red) in BY4742 cells. (A) To induce kAE1 expression, yeast cells were incubated in 3% 
galactose for 24 h. Then, cells were spheroplasted, fixed and permeabilized. Subcellular 
localization of kAE1 was detected by probing the cells with anti-HA antibody followed by 
FITC-coupled anti-rat antibody. The cells were analyzed using a confocal spinning disk 
microscope (Ti-Eclipse, Nikon). Green and red overlay signals are indicated by white arrows. 
Objective: 100x Oil Plan Apo TIRF objective (Nikon); Laser: CSU488 and CSU 561; Scale 
bar: 5 µm (published in Sarder et al., 2020). (B) Pixel intensities along the arrow in the image 
of merged channels displayed in A. Green intensities were obtained for kAE1 and red intensities 
were captured for Pma1p. C) Average Pearson’s correlation coefficient values for 






Figure 3.11 shows the subcellular localization of ykAE1HA expressed in the 
BY4742-PMA1-mRFP strain. Here, the green fluorescence signals correspond to kAE1, while 
red fluorescence signals represent Pma1p-mRFP. Notably, a few green signals are overlapping 
with the red signals at the cell surface, whereas the majority of green signals are visible 
intracellularly and do not colocalize with the red signals. These data demonstrate that the cell 
surface transport of kAE1 in S. cerevisiae is very inefficient and most of the expressed protein 
is accumulated or aggregated in the cellular organelles. Nonetheless, the evaluation of 
colocalization of kAE1 with Pma1p yielded a Pearson’s coefficient of 0.5474 ± 0.051 (SEM, 
n = 6 cells), indicating that kAE1 and Pma1p colocalized to some extent (Figure 3.11 C). This 
evidence supported that a very limited amount of kAE1 protein is targeted to the yeast cell 
surface and the result was consistent with the previous observation of the untagged ykAE1 
protein in this study. 
In sum, indirect immunofluorescence data of HA-tagged kAE1 strengthen the evidence that a 
minor pool of kAE1 could reach the PM through the anterograde transport pathway. 
Nevertheless, these analyses are not sufficient to distinguish between the cortical-ER and the 
PM of yeast cells, as both are very tightly associated (West et al., 2011). Therefore, it was not 
excluded that the observed kAE1 signal might be cortical-ER localized protein and further 
experiments were necessary to confirm the PM localization of kAE1. 
 Approaches for improving the kAE1 plasma membrane localization 
Strong promoters are usually used to express foreign protein for high-yield production. 
However, this can lead to aggregation of the misfolded protein. Liu and colleagues reported 
that utilization of a strong promoter for synthesis of the insulin precursor protein or the 
α-amylase in S. cerevisiae leads to misfolded-proteins aggregating in the ER, and resulting in 
inadequate secretion (Liu et al., 2012). In this study, kAE1 expression was controlled by a 
strong and inducible PGAL1 promoter to facilitate robust protein synthesis. However, a strong 
overexpression, especially of larger transmembrane proteins, could induce cellular stress 
responses leading to reduced production and mistargeting of the desired protein. In order to 
boost plasma membrane localization, several approaches were taken into account. A reduction 
of the galactose concentration in the culture medium as well as the expression of ykAE1 in the 
endocytosis defective mutant Δend3 was conducted. Furthermore, the cultivation temperature 
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was lowered in an attempt to enhance the amount of PM-targeted kAE1 by increasing the 
cellular protein folding capacity. Lastly, the potential of a targeted induction of the cellular UPR 
by co-expression of Hac1p with ykAE1 to improve the localization of the transporter was 
analyzed. 
First, live-cell imaging using fluorescence microscopy was performed with BY4742-PMA1-
mRFP cells expressing yeGFP-ykAE1, where the expression of the kAE1 variant was induced 
by adding two different concentrations of galactose 1% and 3%, respectively, for 24 h at 30 °C 
(Figure 3.12). 
















    
 
Figure 3.12: yeGFP-ykAE1 expression under different galactose concentrations in 
BY4742-PMA1-mRFP strain. 
BY4742-PMA1-mRFP cells expressing yeGFP-ykAE1 variant in an inducible manner were 
incubated with either 1% or 3% galactose for 24 h. Intracellular localization of kAE1 protein 
(green) and Pma1p (red) was visualized in living cells by fluorescence microscopy (Keyence). 
Objective: PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X GFP (470 nm 
excitation, 535 nm emission) and BZ-X TexasRed (560 nm excitation, 630 nm emission); Scale 
bar: 10 µm. 
 
As shown in Figure 3.12, a high amount of yeGFP-ykAE1 protein was produced in 
BY4742-PMA1-mRFP cells under both galactose concentrations where the majority of the 
protein localized in subcellular structures. A very intense yeGFP-ykAE1 signal was observed 
after the supplementation of 3% galactose compared to 1% galactose. These data suggest that 
a massive transcription of yeGFP-ykAE1 occurred under galactose induction and resulted in a 
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significant amount of protein synthesis. This overproduction of heterologous protein could be 
problematic for the yeast cells to process and subsequently induce cellular stress. In fact, the 
massive kAE1 production did not contribute to a higher PM targeting of kAE1 in yeast. 
Since plasma membrane proteins are recycled back into the cells via endocytosis, the amount 
of PM-localized kAE1 protein could be increased by interfering with the endocytosis process 
and trapping kAE1 at the PM. In this background, a yeast strain lacking End3p (one of the key 
proteins responsible for endocytosis) was used to trap PM-located kAE1 (Raths et al., 1993). 
The yeGFP-kAE1 variant was transformed into the Δend3-PMA1-mRFP strain, and subsequent 
protein expression was induced by adding either 1% or 3% galactose. The subcellular 
localization of yeGFP-kAE1 in Δend3-PMA1-mRFP cells was analyzed via fluorescence 
microscopy, and the obtained images are shown in Figure 3.13. 
















    
 
Figure 3.13: yeGFP-ykAE1 expression under different galactose concentrations in Δend3 
mutated cells. 
Δend3-PMA1-mRFP cells expressing the yeGFP-ykAE1 variant in an inducible manner were 
incubated with either 1% or 3% galactose for 24 h. Intracellular localization of kAE1 protein 
(green) and Pma1p (red) was visualized in living cells by fluorescence microscopy (Keyence). 
Objective: PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X GFP (470 nm 
excitation, 535 nm emission) and BZ-X TexasRed (560 nm excitation, 630 nm emission); Scale 
bar: 10 µm. 
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As shown in Figure 3.13, the PM localization of yeGFP-ykAE1 could not be dramatically 
improved using mutants with defects in endocytosis. However, a slightly increased kAE1 signal 
was observed under both galactose concentrations that overlapped with the marker protein 
signal, suggesting kAE1 is likely recycled via endocytosis processes in yeast. Therefore, the 
mutation of other genes coding for endocytic proteins could result in an improvement of kAE1 
cell surface abundance. 
A further attempt for optimizing kAE1 protein synthesis in S. cerevisiae was made by reducing 
the growth temperature. Cell growth rates at low temperatures not only slowed down but the 
protein synthesis rate is also reduced enhancing the protein-folding accuracy (Shi et al., 2003; 
Vera et al., 2007). In addition, low temperature reduces protein aggregation in E. coli by 
limiting the temperature-dependent hydrophobic interaction (Baldwin, 1986; Robertson & 
Murphy, 1997). To investigate a potentially similar effect of temperature on kAE1 synthesis in 
yeast, BY4742-PMA1-mRFP and Δend3-PMA1-mRFP cells expressing yeGFP-ykAE1 were 
grown at 20 °C. In this experiment, kAE1 expression was induced using 0.5% galactose 
supplementation for a minimal level of protein synthesis to avoid the cellular burden due to 
heterologous protein overproduction. Yeast cells were analyzed via fluorescence microscopy. 
Respective images of the obtained results are shown in Figure 3.14. 
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Figure 3.14: yeGFP-ykAE1 expression at low temperature in wild-type and Δend3 
mutated cells. 
BY4742-PMA1-mRFP and Δend3-PMA1-mRFP cells expressing yeGFP-ykAE1 fusion 
protein in an inducible manner were incubated with 0.5% galactose for 24 h at 20 °C. 
Intracellular localization of kAE1 protein (green) and Pma1p (red) was visualized in living cells 
by fluorescence microscopy (Keyence). Objective: PlanApo VC 100x-1.4 Oil; Magnification: 
50x; Filter: BZ-X GFP (470 nm excitation, 535 nm emission) and BZ-X TexasRed (560 nm 
excitation, 630 nm emission); Scale bar: 10 µm. 
 
A partial colocalization of yeGFP-ykAE1 (green) and Pma1p (red) was observed in 
endocytosis-defective Δend3 cells in a reduced temperature environment, whereas nearly no 
overlapped signal was observed in wild-type BY4742 cells. This result suggests that the amount 
of PM-localized kAE1 protein was slightly increased in Δend3 mutated cells at low 
temperature. However, the expression rate seemed to be relatively low compared to expression 
levels after supplementation with higher galactose concentrations. 
As previously reported, recombinant proteins expressed in S. cerevisiae display a tendency to 
be retained in the ER, and usually, only a minor amount of the target protein reaches farther 
destinies of the secretory pathway. It is frequently observed that overexpression of heterologous 
proteins results in accumulation of improperly folded proteins leading to ER-overload 
(Mattanovich et al., 2004). Such a phenomenon activates the unfolded protein response (UPR) 
in host cells, a stress response pathway. It was previously reported that Hac1p (a UPR regulator) 
is synthesized in response to UPR and ultimately regulates UPR genes such as ER-located 
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chaperones, foldase and proteases for ER-associated degradation (Mattanovich et al., 2004). 
Finally, a potential improvement of kAE1 folding or a reduced intracellular accumulation of 
the anion transporter by the UPR activation was analyzed via Hac1p overexpression. It was 
previously reported that co-expression of Hac1p results in an increased intracellular protein and 
secretion level of the kringle fragment of human apolipoprotein-A in S. cerevisiae (Lee et al., 
2012). To achieve a continuous UPR activation, Hac1p was expressed under the control of a 
constitutive promoter PPGK1 on a single-copy yeast centromere vector pMS109 (Valkonen et 
al., 2003). Hac1p was then co-expressed with yeGFP-kAE1 in order to analyze intracellular 
trafficking of kAE1 in yeast under UPR activation. Wild-type BY4742 and its isogenic 
endocytosis defective mutant Δend3 cells were co-transformed with pMS109-HAC1 and 
pYES2.1-yeGFP-kAE1. Expression of yeGFP-kAE1 was initiated by culturing cells in 
uracil/leucin d/o galactose medium and the intracellular distribution of kAE1 was determined 
by fluorescence microscopy (Figure 3.15). 














   
 
Figure 3.15: Expression of yeGFP-ykAE1 during continuous activation of the UPR. 
BY4742 and Δend3 cells constitutively overexpressed Hac1p under control of PPGK1 promoter. 
Both cells were co-transformed with pYES2.1-yeGFP-ykAE1 plasmid. Expression was induced 
by culturing cells in 3% galactose-containing medium for 24 h at 30 °C. Intracellular 
localization of yeGFP-ykAE1 (green) was visualized in living cells by fluorescence microscopy 
(Keyence). Objective: PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X GFP (470 
nm excitation, 535 nm emission); Scale bar: 10 µm. 
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As shown in Figure 3.15, Hac1p co-expression had no profound influence on the ER-retained 
yeGFP-ykAE1 protein in wild-type and Δend3 cells. Green signals of yeGFP-ykAE1 were 
mostly visible in subcellular structures, corresponding to the previously observed ER-like 
localization of kAE1 variants. These data indicate that the majority of recombinant kAE1 
protein could not escape the ER membrane during activation of the UPR. Therefore, Hac1p 
overexpression in both wild-type and Δend3 cells does not improve yeGFP-ykAE1 trafficking 
to the cell surface. 
In short, all the aforementioned approaches taken in this study could not substantially improve 
the level of cell surface localization of the kAE1 variant in S. cerevisiae. 
 Biochemical detection of plasma membrane located kAE1 
To biochemically validate the observed PM-localization of kAE1, cell surface biotinylation was 
performed in wild-type yeast cells expressing untagged ykAE1 variant. It was previously 
reported that biotinylation of yeast plasma membrane protein is extensively prevented by the 
cell wall barrier and, therefore, generally limited to the cell wall proteins (Becker et al., 2016; 
Masuoka et al., 2002; Mrsǎ et al., 1997). However, a minor amount of kAE1 could be detected 
in the biotinylated cell surface fraction of wild-type yeast cells (Figure 3.16). This result was 
consistent with the aforementioned microscopic observation performed in this study 
(Figure 3.11). In contrast, there was no kAE1 signal observed in both of the fractions containing 
cells under non-induced conditions and cells expressing an empty vector (pYES2.1). The 
cytosolic marker Pgk1p was used to confirm cellular integration during the biotinylation 
process. As expected, the Pgk1p signal was detected from the whole cell lysate but not from 
the membrane fraction. 
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Figure 3.16: Cell surface biotinylation of wild-type yeast cells expressing ykAE1. 
BY4742 cells expressing ykAE1 were biotinylated with Sulfo-NHS-biotin under induced 
(+, galactose) or non-induced (-) conditions and a subsequent pull-down with avidin beads. 
Whole yeast cell lysates (input) are represented as control to determine the total amount of 
kAE1. Membrane fraction (membrane) represents the pool of kAE1 located at the cell surface. 
kAE1 was detected by probing with anti-kAE1Nter antibody followed by an anti-rabbit antibody 
coupled with HRP. Molecular weight marker is displayed (M). Pgk1p serves as a cytosolic 
marker protein used to validate cellular integrity during biotinylation (published in Sarder et 
al., 2020). 
 
 Glycosylation analysis of ykAE1 variants with glycosidase enzymes 
Human membrane proteins exhibit inadequate processing when expressed in yeast compared 
to the respective fungi or plant homologs (Tate, 2001). It was reported that truncated versions 
of AE1 or kAE1 protein expressed in yeast were not glycosylated (Groves et al., 1999). kAE1 
is N-glycosylated at a single site (Asn642) in mammalian cells. To verify whether yeast is able 
to perform N-glycosylation in kAE1, different full-length ykAE1 variants such as ykAE1, 
ykAE1HA and yeGFP-ykAE1 were incubated with endoglycosidase enzymes. For this purpose, 
wild-type BY4742 and mutated Δend3 cells expressing above-mentioned ykAE1 variants were 
grown in selective medium under inducing conditions (uracil d/o galactose) for 24 h at 30 °C, 
and lysed. The extracted ykAE1 variants were then treated with either Endo Hf or PNGase F. 
Endo HF is a recombinant glycosidase enzyme cloned from Streptomyces plicatus that cleaves 
the chitobiose core of high mannose glycans (Trimble et al., 1978). Alternatively, PNGase F, 
an amidase derived from Flavobacterium meningosepticum, hydrolyses the innermost core of 
any N-glycans (Plummer et al., 1984). The glycosylation analysis of ykAE1 variants is shown 
in Figure 3.17. 
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Figure 3.17: Enzymatic deglycosylation study of yeast expressed ykAE1 variants. 
Wild-type BY4742 or Δend3 mutant cells expressing different ykAE1 variants were lysed and 
protein extracts were incubated either in the presence or absence of Endo HF or PNGase F for 
1 h at 37 °C and analyzed via Western blot. Expression of ykAE1 variants was induced by 
culturing cells in medium containing 3% of galactose. (A) Lysate of BY4742 cells expressing 
untagged ykAE1 treated with Endo HF or PNGase F. (B) Lysate of BY4742 cells expressing 
HA-tagged ykAE1 (ykAE1HA) treated with Endo HF. (C) Lysate of BY4742 cells or Δend3 
mutant expressing yeGFP fussed ykAE1 variant (yeGFP-ykAE1) treated with Endo HF or 
PNGase F. (D) A glycosylated protein RNase B was treated with Endo HF or PNGase F served 
as a positive control and detected through SDS-PAGE with subsequent silver staining. Pgk1p 
was served as loading control and cells expressing empty vector (pYES2.1) used as a negative 
control for kAE1 detection. 
 
There was no difference found between the band signals of treated and untreated samples of 
ykAE1, ykAE1HA and yeGFP-ykAE1 variants with both Endo Hf and PNGase F on immunoblot 
(Figure 3.17). Interestingly in each sample of kAE1 variants, a top band and a bottom band was 
observed, whereas the top band corresponds to the estimated molecular weight of the respective 
kAE1 variant. Since the bottom band found across all samples (treated and untreated), it should 
not be considered as a deglycosylated protein. To perform glycosylation analysis, kAE1 was 
incubated at room temperature for a certain period of time (section 2.14.8) and then run on 
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SDS-PAGE under reducing condition. These bottom bands likely correspond to the degraded 
products of kAE1. In addition, a positive control experiment with a glycoprotein ribonuclease 
B (RNase B) was performed under identical conditions (Figure 3.17 D). A clear downshifted 
band of RNase B was observed for the protein treated with one of the glycosidase enzymes 
compared to the non-treated condition. This result verified that both enzymes were active. 
 Functional analysis of full-length ykAE1 variants in yeast 
3.7.1 Analyzing functional homology between kAE1 and Bor1p  
It has been reported that Bor1p in yeast is the structural homolog protein of human AE1 
(Jennings et al., 2007; Thurtle-Schmidt & Stroud, 2016). Bor1p is an integral membrane protein 
located at the plasma membrane of S. cerevisiae that actively transports boron against a 
concentration gradient (Takano et al., 2007). Therefore, to examine whether kAE1 could 
compensate for Bor1p functionality in S. cerevisiae, boric acid tolerance assays were 
performed. Wild-type BY4742 and Δbor1 mutated yeast cells transformed with either empty 
vector (pYES2.1) or pYES2.1-ykAE1V5 were spotted on solid selective medium containing 
different concentration of boric acid. Expression of kAE1 was induced by 3% galactose (uracil 
d/o galactose agar plate) and cell growth was monitored for three days. The corresponding 




Figure 3.18: Boric acid tolerance assay for wild-type and mutated yeast cells expressing 
ykAE1V5 in solid medium. 
BY4742 and Δbor1 cells expressing ykAE1V5 or empty vector were grown to stationary phase. 
The cell density was adjusted to OD600 = 0.7 and serially diluted. 5 µl of cell suspension from 
the diluted cultures (OD600 = 0.7 x 10−5 – 0.7 x 10−1) was spotted on uracil d/o galactose plates 
containing the indicated amount of boric acid. The plates were then incubated for 3 d at 30 ºC 
and photographed. 
 
The expression of ykAE1V5 did not improve the growth of BY4742 cells in the presence of a 
high concentration of boric acid in the medium. Additionally, kAE1 expression was also not 
able to rescue the growth defect of the Δbor1 mutant (Figure 3.18). Moreover, empty vector 
expressing Δbor1 cells displayed a less sensitive phenotype to boric acid (in the presence of 
20 mM and 40 mM boric acid) compared to wild-type cells. For further investigation, boric acid 





Figure 3.19: Boric acid tolerance assay for wild-type and Δbor1 yeast cells expressing 
ykAE1V5 in liquid medium. 
Wild-type BY4742 and Δbor1 mutated cells containing pYES2.1 (empty vector) or 
pYES2.1-ykAE1V5 plasmid were first grown into uracil d/o glucose medium for overnight. 
Cultures were then diluted to OD600 = 0.2 and placed into uracil d/o galactose medium 
containing the indicated amount of boric acid. Afterward, 200 µl of the individual cell 
suspension was transferred into a 96-well plate. Finally, plates were incubated for 15 h at 30 °C 
and cell growth was recorded by a multi-mode plate reader at 600 nm. Data are shown as 
mean ± SEM of n = 3 experiments. 
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In liquid medium, both wild-type BY4742 and Δbor1 cells expressing the ykAE1V5 variant 
displayed a strong reduction in cell growth in the presence of boric acid and the growth rate of 
these cells did not differ significantly from the empty vector expressing cells (Figure 3.19). 
Therefore, kAE1 expression did not improve the growth defect of yeast cells under high boric 
acid conditions, suggesting that kAE1 does not compensate for the function of Bor1p. However, 
in this experiment Δbor1 cells showed more sensitivity to boric acid in comparison to wild-type 
cells validating the experimental condition.  
In brief, Δbor1 mutant expressing ykAE1V5 did not show an improved growth rate compared 
to empty vector containing cells in the presence of boric acid. Thus, kAE1 did not compensate 
for the function of Bor1p in Δbor1 mutated cells. 
3.7.2 Correlation of intracellular pH and kAE1 expression 
kAE1-mediated Cl−/HCO3− exchange activity can alter cytosolic pH in mammalian cells. 
Rawad and colleagues recently found that expression of wild-type kAE1 in mIMCD3 cells 
resulted in a drastic reduction of cytosolic pH level compared to non-expressing cells (Lashhab 
et al., 2019). To verify whether the expressed full-length kAE1 is active in yeast, the cytosolic 
pH of ykAE1 variant expressing cells was determined. BCECF-AM dye is commonly used to 
determine the cytosolic pH of mammalian cells (Chu et al., 2010; Shnitsar et al., 2013). On the 
contrary, yeast cells tend to transport BCECF-AM into the vacuole and this dye was previously 
used to measure the vacuolar pH of S. cerevisiae (Diakov et al., 2013). Therefore, to measure 
the cytosolic pH of S. cerevisiae an alternative dye named SNARF-5F AM (a derivative of 
SNARF AM) was used in this study. SNARF AM is a naphthofluorecin derivative conjugated 
with acetoxymethyl ester, which was already utilized to determine cytosolic pH of S. cerevisiae 
(Valli et al., 2005). Yeast cells loaded with SNARF-5F AM were analyzed under a fluorescence 
microscope to observe the intracellular distribution of the pH probe (Figure 3.20). 
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Figure 3.20: Wild-type BY4742 cells treated with SNARF-
5F AM. 
BY4742 cells were incubated with 10.0 µg/ml SNARF-5F AM 
for 1 h at 30 °C. Red signals resemble the cytosolic presence of 
the dye in yeast cells. Live-cells were analyzed by fluorescence 
microscopy (Keyence). Objective: PlanApo VC 100x-1.4 Oil; 
Magnification: 50x; Filter: BZ-X TexasRed (560 nm excitation, 
630 nm emission); Scale bar: 10 µm. 
 
As shown in Figure 3.20, a diffused intracellular red fluorescence signal was detected 
corresponding to the cytoplasmic distribution of SNARF-5F in yeast cells. In contrast, nearly 
no fluorescence signal was observed from the core of the cells, which resembles the nucleus of 
the cells. This result indicated that SNARF-5F AM was suitable to measure the cytosolic pH of 
yeast cells. 
To avoid any effect due to alternating of carbon sources on the cytosolic pH analysis, the vector 
pPGK was utilized to express untagged ykAE1 in S. cerevisiae. The constitutive expression of 
ykAE1 was verified via Western blot analysis (data not shown). BY4742 cells expressing either 
wild-type kAE1 (pPGK-ykAE1) or empty vector (pPGK) were incubated with SNARF-5F AM 
for 1 h at 30 °C. The fluorescence signal was detected using a fluorometer and cytosolic pH 
was calculated by plotting a standard curve. Cytosolic pH measurement data of yeast cells 






Figure 3.21: Cytosolic pH measurement of S. cerevisiae during kAE1 expression. 
BY4742 cells expressing empty vector (pPGK) or wild-type ykAE1 were grown in 2% glucose 
for 24 h. Cells were treated with SNARF-5F AM and intracellular pH was measured. 
Intracellular pH values are displayed. Measurements were performed from n = 4 independent 
experiments and represent as mean ± SEM; *, p < 0.05; **, p < 0.01 using unpaired t-test 
(published in Sarder et al., 2020). 
 
The mean cytosolic pH value of cells expressing an empty vector was 6.81 ± 0.02 (SEM) 
(Figure 3.21), which is in agreement with the previously reported cytosolic pH value of the 
wild-type yeast cells (Valkonen et al., 2013). Surprisingly, a significant drop of cytosolic pH to 
6.54 ± 0.04 (SEM) occurred under ykAE1 expression (p < 0.01). 
3.7.3 Dose-dependent correlation of cytosolic pH and kAE1 expression 
To further verify the link between the cytosolic pH drop and kAE1 activity in yeast, a 
dose-dependent expression of ykAE1 using β-estradiol was performed in BY4742-GEV cells. 
Gal4dbd.ER.VP16 (GEV) is a chimeric transcriptional activator composed of a Gal4p DNA 
binding domain, a hormone-binding domain of the human estrogen receptor as well as an 
eukaryotic transcriptional activator domain of herpes simplex virus VP16 (McIsaac et al., 
2011). The BY4742-GEV strain contains an integrated copy of GEV driven by a constitutive 
promoter PACT1. In absence of β-estradiol, GEV is inactive and located in the cytosol coupled 
with the heat sensor protein HSP-90 complex. When β-estradiol is added to the growth medium, 
it diffuses through the cell membrane and binds to the estrogen binding site of GEV, which 
results in a dissociation of HSP-90 complex and relocation of GEV from the cytosol to the 
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nucleus. In the nucleus, GEV attaches to the UASGAL consensus sequence and initiates the 
transcription of the target protein by its VP16 domain. kAE1 induction in BY4742-GEV cells 
in a dose-dependent manner by β-estradiol is shown in Figure 3.22. 
 
Figure 3.22: Dose-dependent induction of ykAE1 expression in BY4742-GEV cells. 
BY4742-GEV cells were incubated with different concentrations of β-estradiol to induce 
expression of untagged ykAE1. After cell lysis, Western blot analysis was performed to verify 
the levels of kAE1 expression in the presence of β-estradiol. Blots were probed with primary 
anti-kAE1Nter antibody and secondary anti-rabbit antibody coupled with HRP (published in 
Sarder et al., 2020). 
 
BY4742-GEV cells were transformed with the pYES2.1-ykAE1 plasmid and the positive 
transformants were selected by culturing cells in selective medium (uracil d/o glucose). ykAE1 
expression was stimulated by adding β-estradiol for 18 h at 30 °C. The expression level of 
ykAE1 was directly proportional to the amount of β-estradiol in the medium (Figure 3.22). No 
kAE1 expression was detected on the immunoblot in cells without β-estradiol, which served as 
negative control. This result showed that kAE1 expression levels in the BY4742-GEV strain 
could be manipulated by simply providing a certain amount of β-estradiol to the respective 
growth medium. In order to determine whether the decrease in cytosolic pH had a direct 
connection to the level of kAE1 expression in yeast cells, cytosolic pH measurement of ykAE1 
expressing BY4742-GEV cells was performed by using SNARF-5F AM. ykAE1 expression 
was induced by adding defined amounts of β-estradiol ranging from 0.01 µM to 10.0 µM, and 
cells were incubated for 18 h at 30 °C. The cells were then treated with SNARF-5F AM for 1 h, 




Figure 3.23: Correlation between intracellular pH and kAE1 expression level in wild-type 
yeast cells. 
(A) Intracellular pH measurement of BY4742-GEV cells expressing ykAE1 induced by the 
indicated concentration of β-estradiol. Intracellular pH values are displayed. Measurements 
were performed from n = 4 independent experiments and represented as mean ± SEM; 
*, p < 0.05 using One-Way ANOVA. (B) Densitometry analysis of the ykAE1 expression in 
BY4742-GEV cells corresponding to the indicated amount of β-estradiol. Each signal for kAE1 
was normalized to the respective signals of Pgk1p and relative kAE1 signals were calculated. 
Data are shown as mean ± SEM of n = 2 separate experiments (published in Sarder et al., 2020). 
 
Figure 3.23 shows graphs of the cytosolic pH measurement of BY4742-GEV cells expressing 
ykAE1 (A) and the densitometry analysis of kAE1 expression level with the corresponding cells 
(B). A cytosolic pH value of 6.36 ± 0.02 (SEM) was detected from negative control cells 
(without β-estradiol), whereas cytosolic pH values of 6.34 ± 0.02, 6.26 ± 0.07, 6.25 ± 0.01 and 
6.16 ± 0.02 (SEM) were measured from cells incubated with 0.01 µM, 0.1 µM, 1.0 µM and 
10 µM β-estradiol, respectively. Interestingly, an elegant correlation was found between 
cytosolic pH and the kAE1 expression level in yeast cells (Figure 3.23). Cells expressing a high 
amount of kAE1 (1.0 µM and 10 µM of β-estradiol) displayed a significant drop of cytosolic 
pH (p < 0.05). In contrast, cells expressing a low level of kAE1 (0.1 µM and 0.01 µM of 
β-estradiol) showed no significant difference in cytosolic pH versus the negative control cells 
(cells without β-estradiol). The highest kAE1 expressing cells displayed the lowest cytosolic 
pH and vice-versa. Therefore, these results indicate that the drop of cytosolic pH is associated 
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with the level of kAE1 expression in wild-type yeast cells and are, therefore, in line with the 
previously observed data from mammalian cells. 
3.7.4 Determination of intracellular chloride transport in dependency of kAE1 expression 
The basic function of kAE1 is the exchange of Cl−/HCO3− in the kidney, hence the Cl− transport 
rate by kAE1 expressing yeast cells was determined for analyzing the biological activity of the 
protein. kAE1-mediated Cl− influx was measured via anion exchange chromatography in 




Figure 3.24: Cl− influx rate measurement of wild-type yeast cells expressing pPGK or 
ykAE1. 
(A) Cl− influx rate of BY4742 cells expressing pPGK or ykAE1 in the presence or absence of 
200 µM DIDS. Data is showing the Cl− influx rate per hour per cell as nanomolar per hour 
(nM/h) for n = 6 measurements and mean ± SEM; *, p < 0.05; **, p < 0.01; ***, p < 0.001 
using One-Way ANOVA. The Cl− influx rate was normalized to the total cell number 
(OD600 = 1, equivalent to 1 x 107 cells). (B) Relative intracellular Cl− concentration ([Cl−]in) of 
BY4742 cells expressing pPGK or ykAE1 indicated in nanomolar (nM). Each measurement 
was normalized to corresponding total cell numbers. Data represent the mean ± SEM of n = 3 
separate experiments and; *, p < 0.05; **, p < 0.01; using One-Way ANOVA (published in 
Sarder et al., 2020). 
 
Under hyperosmotic conditions (150 mM NaCl), a reduced Cl− influx rate together with a 
decreased intracellular Cl− concentration was detected in cells expressing ykAE1. In contrast, 
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the empty vector expressing cells exhibited an elevated level of Cl− influx, leading to a higher 
intracellular Cl− concentration (Figure 3.24). Surprisingly, the diminished Cl− influx rate 
observed in kAE1 expressing cells was opposite to a previous 36Cl− uptake study performed in 
yeast cells expressing the truncated AE1361–911 variant (Groves et al., 1996). However, 
restriction of kAE1 activity with the kAE1 inhibitor DIDS expectedly led to a high level of Cl− 
influx, resulting in the prevention of kAE1-mediated Cl− efflux compared to kAE1 expressing 
cells. Although increased Cl− influx by the kAE1 expressing cells was anticipated, the 
significant differences between the empty vector and kAE1 expressing cells strongly indicate a 
kAE1-mediated Cl− transport in yeast cells.  
Altogether, the occurrence of cytosolic pH drop along with the increased rate of Cl− efflux in 
kAE1 expressing cells is pointing towards the biological activity of the heterologously 
expressed anion exchanger in yeast. 
 Expression and localization analysis of kAE1 mutants in S. cerevisiae 
In order to validate yeast as a model organism to dissect pathophysiologic characteristics of 
kAE1, mutants of kAE1 were generated, such as E681Q and G701D, and their expression level 
and subsequent localization were investigated. kAE1 E681Q showed an impaired chloride-
bicarbonate exchange but was localized at the cells surface of HEK293 cells (Shnitsar et al., 
2013). Alternatively, kAE1 G701D displayed a complete retention in the ER of MDCK cells 
(Cordat et al., 2006). An untagged E681Q mutant was generated using pYES2.1-ykAE1 as 
template by PCR amplification (section 2.6). Similarly, the G701DFlag was created from 
pYES2.1-ykAE1Flag plasmid in the same way. A Flag tag was placed at the third exofacial loop 
between Asn556 and Val557 of G701DFlag mutant to facilitate the detection process. 
Unfortunately, the construction of a Flag-tagged kAE1 E681Q was not successful. 
Wild-type BY4742-GEV cells were transformed with pYES2.1-E681Q or pYES2.1-G701DFlag 
recombinant plasmid, and expression of the mutants was induced by adding 10 µM of 
β-estradiol hormone into the selective medium. Protein levels of kAE1 E681Q and G701DFlag 
mutants were analyzed via immunoblotting by probing with anti-kAE1Nter antibody and anti-
Flag antibody, respectively (Figure 3.25). A robust signal at ~94 kDa was detected for both 
untagged kAE1 E681Q and Flag-tagged kAE1 G701DFlag mutants on the immunoblot which is 
the expected molecular weight of the mutants. Expression level of the kAE1 E681Q mutant was 
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similar to the expression level of wild-type protein. Besides, the protein level of kAE1 
G701DFlag was also comparable to wild-type protein (data not shown). This result demonstrated 
that heterologous expression of kAE1 mutants at a high level is possible in S. cerevisiae.  
 
 
Figure 3.25: Expression analysis of kAE1 E681Q and G701DFlag mutant in yeast.  
BY4742-GEV cells expressing kAE1 E681Q and G701DFlag in an inducible manner were 
incubated with 10 µl of β-estradiol for 24 h prior to lysis. (A) Representative immunoblot of 
kAE1 E681Q probed with anti-kAE1Nter antibody followed by an anti-rabbit antibody coupled 
with HRP. Empty vector (pYES2.1) expressing cells represent as negative control and untagged 
kAE1 (ykAE1) expressing cells represent as positive control. (B) Representative immunoblot 
of kAE1 G701DFlag probed with primary anti-flag antibody and secondary anti-mouse antibody 
coupled with HRP. Pgk1p serves as a loading control.  
 
Investigation of kAE1 mutants’ trafficking in yeast cells was crucial for elucidating the role of 
mutants in pathological condition. Hence, indirect immunostaining was performed in order to 
detect subcellular localization of both kAE1 E681Q and G701D mutant. BY4742-GEV cells 
expressing E681Q or G701DFlag were incubated with 10 µΜ β-estradiol for 24 h at 30 °C and 
indirect immunostaining was performed. To determine intracellular localization of the mutants, 
cells expressing kAE1 E681Q or kAE1 G701DFlag were probed with the appropriate primary 
and secondary antibodies. By performing fluorescence microscopy, a peripheral ring-like 
structure (green) was observed in cells expressing kAE1 E681Q mutant (Figure 3.26), 
indicating a possible PM localization. In addition, fluorescence signals detected from 
intracellular structures resemble the localization at the intracellular membranes. Since kAE1 
E681Q was previously detected at the PM of mammalian cells (Shnitsar et al., 2013), this 
outcome from yeast cells was expected. However, it could not be clarified that the detected 
peripheral signal of the kAE1 E681Q mutant was not from the cortical-ER localized protein. In 
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contrast, the cells expressing kAE1 G701DFlag displayed a prominent diffused intracellular 
signal, which most likely arose from the protein located at the ER-like structure. 
 












   
 
Figure 3.26: Intracellular localization of kAE1 E681Q and G701DFlag in yeast.  
Indirect immunofluorescence images of kAE1 E681Q and G701DFlag in BY4742-GEV cells. 
Yeast cells were induced by 10 µM β-estradiol for 24 h. Intracellular localization of E681Q 
mutant was detected by using anti-kAE1Nter followed by anti-rabbit antibody coupled with 
FITC. G701DFlag was visualized by probing with a primary anti-flag antibody and a secondary 
anti-mouse antibody coupled with FITC. Cells were analyzed using fluorescence microscopy 
(Keyence). Objective: PlanApo VC 100x-1.4 Oil; Magnification: 50x; Filter: BZ-X GFP (470 
nm excitation, 535 nm emission); Scale bar: 10 µm. The pictures were taken during the bachelor 
thesis of Elisa Bertin (2017).  
 
In sum, these data demonstrate a robust expression of the two kAE1 mutants in S. cerevisiae. 
kAE1 E681Q mutant was found at the cell periphery, whereas kAE1 G701DFlag mutant was 
localized intracellularly. In fact, the localization of kAE1 E681Q mutant can be compared to 
the localization of wild-type kAE1 in BY7472 cells. However, further experiments are needed 
with marker protein for addressing the detailed subcellular localization of the mutants in yeast. 
 Characterization of novel dRTA mutants in mammalian cells 
In the second part of this project, three newly found dRTA mutants were characterized in mouse 
inner medullary collecting duct cells (mIMCD3): a recessive dRTA mutant kAE1 R295H and 
two dominant dRTA mutants kAE1 Y413H and S525F. It was previously reported that the 
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majority of dRTA mutants show mistrafficking rather than altered function in MDCK cells 
(Almomani et al., 2011). On the contrary, evidence from dominant dRTA patients (kAE1 
G609R) and a mouse model with the dominant dRTA mutation kAE1 R607H revealed that the 
mutated protein locates at the basolateral membrane of α-intercalated cells, but in a reduced 
amount. In addition, a secondary mistrafficking of V-H+-ATPase was detected with an overall 
depletion of α-intercalated cells in the kidney. The expression of kAE1 R589H mutant in 
polarized mIMCD3 cells resulted in the functional localization of the mutant at the basolateral 
membrane (Mumtaz et al., 2017). This preliminary finding suggests that in mIMCD3 cells, 
kAE1 mutant behaves similarly as the wild-type protein in terms of localization and 
functionality. Therefore, to characterize the novel dRTA mutants, mIMCD3 cells were used in 
this study which likely imitated the in vivo situation. 
3.9.1 Half-life of the three novel kAE1 mutants 
To express wild-type and mutated kAE1 variants, stable mIMCD3 cell lines were generated. 
Therefore, mIMCD3 cells were transduced with lentiviruses carrying the wild-type or a mutated 
kAE1 cDNA using the Clontech Lenti-X inducible expression system. Notably, after passages 
of the infected cells, the expression of kAE1 was not affected and the expression level was 
found to be identical. This strategy provides the opportunity to bypass the continuous loss of 
kAE1 when constitutively expressed (Chu et al., 2010). Wild-type kAE1 and its mutants were 
carrying an HA tag at the third extracellular loop between Val557 and Leu558. To assess the 
stability of the kAE1 mutants, protein expression was induced in presence of 1.0 µg/ml of 
doxycycline for 24 h. After removal of doxycycline, the relative amount of protein was 
measured at four time points such as 0, 8, 24, and 48 h by performing Western blot analysis and 




Figure 3.27: Degradation profile of wild-type and mutated kAE1 in mIMCD3 cells. 
Stably transduced mIMCD3 cells expressing wild-type and mutated kAE1 in an inducible 
manner were incubated with 1.0 µg/ml of doxycycline. After 24 h of induction, doxycycline 
was removed at the indicated time points and replaced with fresh medium. Cells were lysed and 
then analyzed by immunoblot. kAE1 variants were detected by using an anti-HA antibody 
succeeded by an anti-rat antibody coupled with HRP (upper panel). Representative immunoblot 
for (A) wild-type kAE1, (B) kAE1 R295H, (C) kAE1 Y413H, and (D) kAE1 S525F are shown. 
β-actin serves as a loading control (lower panel). White circle (top) corresponds to kAE1 
carrying a complex oligosaccharide and black circle (bottom) represents kAE1 carrying a high-
mannose oligosaccharide. 
 
On the immunoblot, two distinct bands of kAE1 (closely spaced) were detected where the top 
band corresponds to the protein carrying a complex oligosaccharide and the bottom band 
resembles the protein carrying a high-mannose oligosaccharide (Figure 3.27). Wild-type kAE1 
displayed an overall higher expression level compared to the three mutants. Therefore, the 
expression level of kAE1 and the mutants was normalized to the endogenous expression level 
of β-actin for each condition. After 8 h, there was no noticeable difference observed in protein 
levels between wild-type kAE1 and the three mutants. In contrast, after 24 h and 48 h removal 
of doxycycline from the medium, a significant reduction of protein level was observed for all 
the three mutants compared to wild-type kAE1. This result showed that all the novel dRTA 
mutants are degraded in a faster manner than the wild-type protein. In addition, the mutants 
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kAE1 Y413H and S525F displayed an increased amount of high-mannose carrying protein 
(bottom) compared to wild-type kAE1. These data indicate that the processing of these two 
mutants is affected in mIMCD3 cells. The dominant mutants were able to escape from the ER 
to the median Golgi, but not as efficiently as wild-type kAE1. In contrast, the complex- and 
high-mannose carrying protein band for the recessive kAE1 R295H was similar to that of the 
wild-type protein. This result suggests similar processing of the mutant occurred compared to 
wild-type kAE1 in the secretory pathway. In addition, the half-life of the mutants was 
calculated, and the results are shown in Figure 3.28. 
 
 
Figure 3.28: Half-life of kAE1 mutants compared to wild-type kAE1. 
(A) Densitometry analysis of the immunoblots to determine the relative amount of kAE1 
variants expressed in mIMCD3 cells. The relative amount of kAE1 was primarily determined 
by dividing the kAE1 band intensity with the corresponding β-actin band intensity. The initial 
time point was then set as 100% and used for normalization of the following time points. Data 
are shown as mean ± SEM of n = 3 independent experiments and are fitted by exponential 
regression. (B) Half-life of wild-type and mutated kAE1 was generated by using the equation 
obtained from the graph represented in A. Data represent the mean ± SEM of n = 3 separate 
experiments and; *, p < 0.05; **, p < 0.01 using One-Way ANOVA. 
 
Figure 3.28 shows a graphical representation of the half-life of three novel dRTA mutants. The 
detected half-life for kAE1 R295H, Y413H and S52F5 was 28.01 ± 0.91, 34.13 ± 8.73 and 
27.94 ± 0.91 h (SEM), respectively. In contrast, half-life for wild-type kAE1 was 
71.94 ± 10.76 h (SEM). As expected, the half-life of all three dRTA mutants was significantly 
lower than the wild-type protein (p < 0.05). These data indicated that dRTA-causing mutants 
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are likely recognized as misfolded proteins and are prematurely degraded aligning with the 
previously obtained result of dRTA mutants characterized in kidney cell lines (Chu et al., 
2014a; Kittanakom et al., 2004). 
3.9.2 Impact on p62 level in mIMCD3 cells 
The amount of α-intercalated cells was found to be remarkably depleted in dominant dRTA 
kAE1 R607H knock-in mice (Mumtaz et al., 2017). Moreover, kidney tissue immunostaining 
of these mice revealed that p62, a classical marker for autophagy, was highly accumulated in 
cells, suggesting an impairment in the autophagy process. To determine the effect of the 
expression of kAE1 mutants on p62 in mIMCD3 cells, the relative p62 level was examined by 
Western blot analysis. Wild-type and mutated kAE1 expression was initiated by incubating the 
stably transduced mIMCD3 cells with 1.0 µg/ml of doxycycline for 24 h. The p62 protein level 
upon mutant expression was detected by probing the blot with anti-HA, anti-β-actin and 





Figure 3.29: Investigation of p62 level in mIMCD3 cells expressing wild-type kAE1 and 
dRTA mutants. 
mIMCD3 cells expressing wild-type or mutated kAE1 were incubated either in the absence or 
presence of doxycycline (1.0 µg/ml) for 24 h. Cells were lysed and protein abundance was 
determined by performing Western blot. (A) Representative immunoblots for wild-type kAE1, 
kAE1 R295H, kAE1 Y413H and kAE1 S525F. The blot was probed with mouse anti-HA to 
detect kAE1 (upper panel), followed by mouse anti-p62 antibody for p62 (middle panel) or 
mouse-β-actin for β-actin (lower panel) detection. (B) Densitometry analysis of relative amount 
of p62 level (%) in mIMCD3 cells after expressing wild-type kAE1 and mutants. Each 
measurement of p62 was normalized to the corresponding signal of β-actin, and the relative p62 
signal was calculated. The p62 signal of cells expressing wild-type kAE1 was set to 100 %. 
Data represented as mean ± SEM of n = 5 different experiments and; *, p < 0.05; **, p < 0.01 
using One-Way ANOVA. The column graph and four replicates among five were kindly 
generated by Lalie Vergnaud (2019). 
 
Figure 3.29 shows the immunoblot and densitometry analysis of the relative p62 level in 
mIMCD3 cells expressing wild-type kAE1 and the mutants. The overall p62 level was higher 
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in mIMCD3 cells expressing the dRTA mutants. However, the p62 level was found to be 
significantly higher only for the dominant Y413H mutant compared to the wild-type protein 
(p < 0.01). Since the p62 level in mIMCD3 cells was not significantly higher when expressing 
R295H and S525F mutants (n = 5), this could be due to technical error while performing 
Western blot analysis. This issue might be solved by increasing sample numbers. 
3.9.3 Effect on mIMCD3 cells viability 
In dRTA patients or knock-in mice, a dramatic decline is seen in the viability of α-intercalated 
cells (Mumtaz et al., 2017; Vichot et al., 2017). Now an interesting point would be to know if 
the viability of mIMCD3 cells is also affected by expressing dRTA mutants. Therefore, an 
MTS-based assay was used to analyze the viability of mIMCD3 cells under the expression of 
the recessive kAE1 R295H or the dominant kAE1 S525F mutant in combination with different 
osmotic conditions. kAE1 is highly expressed in α-intercalated cells of the distal nephrons 
where the tubular fluid osmolality is very high reaching up to 1200 mOsmol/kg H2O 
(Gottschalk, 1960). On the contrary, mIMCD3 cells are typically in vitro cultivated under a 
relatively low osmotic pressure as the osmolality of the growth medium is roughly 
~300 mOsmol/kg H2O. To reduce this osmotic discrepancy, 100 mM NaCl or 200 mM 
Mannitol were added to growth media to reach a final osmolarity of ~500 mOsmol/kg H2O, 
representing hyperosmotic conditions. Stably transduced mIMCD3 cells were initially induced 
with 1.0 µg/ml of doxycycline (+Dox) to express wild-type kAE1, kAE1 R295H and kAE1 
S525F mutant for 24 h. Later on, the kAE1 expressing mIMCD3 cells along with non-induced 
(−Dox) mIMCD3 cells were grown under three different conditions: 1) standard growth 
medium, 2) 100 mM NaCl in growth medium, and 3) 200 mM Mannitol in the growth medium. 
The viability of mIMCD3 cells was measured using MTS reagent at 0, 48, and 72 h after placing 
cells under the indicated culture condition and the results are shown in Figure 3.30. 
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A)                                        Standard growth medium 
  
 
B)                                   100 mM NaCl in growth medium 
  
 





Figure 3.30: mIMCD3 cell proliferation analysis by MTS assay in non-induced (−Dox) 
and induced (+Dox) situation. 
Stably transduced mIMCD3 cells were incubated into growth medium with or without 
1.0 µg/ml of doxycycline for 24 h at 37 °C in 5% CO2 supplied incubator. In presence of 
doxycycline, cells were expressing wild-type kAE1, recessive kAE1 R295H, and dominant 
kAE1 S525F mutant. Afterward, cells were placed into three different osmotic mediums, and 
cell viability was measured after 0, 48, and 72 h. Cells were incubated in (A) standard growth 
medium, (B) 100 mM NaCl containing growth medium and (C) 200 mM Mannitol containing 
growth medium. The MTS absorbance of cells at 0 h was set to 100% and used for 
normalization of the following time points. Data are shown as mean ± SEM of n = 3 
independent experiments.  
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The viability of mIMCD3 cells expressing the kAE1 R295H and S525F mutants was not 
significantly different compared to cells expressing wild-type kAE1 in standard growth medium 
(Figure 3.30 A). In addition, a similar phenomenon was observed when cells were incubated 
into the hyperosmotic medium. The viability of mIMCD3 cells expressing kAE1 R295H and 
S525F mutant was found to be similar in comparison to the wild-type kAE1 expressing 
mIMCD3 cells under both hyperosmotic media (Figure 3.30 B, C). Simultaneously, the 
viability of non-induced mIMCD3 cells was found to be comparable to the induced mIMCD3 
cells under identical conditions. Thus, data from MTS-based cell proliferation assay showed no 
significant difference in proliferation of mIMCD3 cells expressing wild-type kAE1 and the 
mutants. The statistical analysis between −Dox and +Dox group in each condition were carried 









4. Discussion  
Ion homeostasis is one of the fundamental processes in cell physiology for regulating numerous 
cellular mechanisms, ranging from cell division to cell death. In order to pass impermeable ions 
through the cell boundary, membrane transporters are used and their expression varies between 
different cell types (Dubyak, 2004; Gautier & Hinner, 2015). Such transporters consist of a 
diverse group of proteins where Cl−/HCO3− exchangers play a decisive role in the acid-base 
homeostasis in the human body. The anion exchanger 1 protein controls Cl−/HCO3− exchange 
in a sodium-independent manner and is considered the founding member of the solute carrier 
SLC4 superfamily (Alper, 2006; Cordat & Casey, 2009). In the distal nephron, the kidney 
isoform of AE1, kAE1, facilitates bicarbonate reabsorption into the interstitium across the 
basolateral membrane of α-intercalated cells. Thus, the anion transporter plays a crucial role in 
the urine acidification process. Interestingly, mutations in the kAE1 encoding gene SLC4A1 
result in faulty acidification of urine, which is known as distal renal tubular acidosis. dRTA 
patients usually suffer from various complications that eventually arose from defective urine 
acidification, such as metabolic acidosis, hyperchloremia, hyperkalemia, kidney stone 
formation and failure to thrive (Shayakul & Alper, 2000). So far, only the structure of the 
AE1/kAE1 membrane domain (381–887 aa, except three exofacial loops region) has been 
revealed (Arakawa et al., 2015). In addition to the lack of a structural model of the full-length 
variant, there is also relatively little known about its cellular trafficking pathway. Heterologous 
expression of disease-causing kAE1 mutants in MDCK cells demonstrated that the mutant 
proteins were either mistargeted or intracellularly retained in ER-Golgi structures, thereby 
displaying improper function (Cordat et al., 2006; Devonald et al., 2003). For example, kAE1 
R589H mutant expressed in MDCK cells exhibited a complete intracellular retention in the ER 
compartment (Toye et al., 2004). In contrast, Mumtaz and colleagues reported that in α-
intercalated cells from kAE1 R607H knock-in mice (corresponding to human kAE1 R589H 
variant), the mutant protein was targeted to the basolateral membrane and was found to be 
functional, albeit a secondary mistrafficking of apically located V-H+-ATPase was observed. 
These observations from kAE1 R607H knock-in mice are consistent with the biopsy report of 
patients with dominant dRTA kAE1 G607R mutation, where trafficking of the mutant was 
unaffected and found at the basolateral membrane of α-intercalated cells (Vichot et al., 2017). 
However, the level of kAE1 expression was strongly reduced along with a severe depletion of 
α-intercalated cells in the patient’s kidneys. All these findings are pointing towards the fact that 
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the cellular model systems formally used for investigating kAE1 mutants were inadequate to 
dissect precise molecular mechanisms of the disease. Therefore, the use of a new model 
organism for addressing kAE1-related research questions in a fast and economical manner 
becomes inevitable. 
In the present study, analysis of intracellular transport and functionality of kAE1 and its mutant 
variants was performed in yeast and mammalian cells. The first part of the study highlights the 
capability of yeast as a model system for addressing kAE1 physiology-related questions. 
Saccharomyces cerevisiae is widely recognized as a model organism for analyzing various renal 
proteins such as epithelium sodium channel (ENaC), cystic fibrosis transmembrane 
conductance regulator (CFTR) and Na+-K+-ATPase (Buck et al., 2010; Kolb et al., 2011). 
Moreover, S. cerevisiae was previously used for the heterologous expression of kAE1, whereas 
only truncated kAE1 variants could be successfully expressed (Groves et al., 1996). The 
attempts to express full-length kAE1 in yeast were either unsuccessful or resulted in the 
accumulation of inactive protein in organelle membranes (Groves et al., 1999). In this study, 
several full-length kAE1 derivatives were constructed and expressed in S. cerevisiae. In 
addition, the potential plasma membrane localization of the variants was determined by various 
microscopic and biochemical techniques such as fluorescence microscopy, CLSM and a cell 
surface biotinylation assay. Furthermore, the functionality of selected full-length kAE1 
derivatives was analyzed by the measurement of cytosolic pH as well as the Cl− influx rate. 
Besides, the kAE1 mutants E681Q and G701D were expressed in yeast, and their cellular 
localization was determined by fluorescence microscopy. The second part of the study focused 
on the characterization of three novel dRTA mutants (recessive kAE1 R295H, dominant kAE1 
Y413H, and kAE1 S525F mutant) in mouse inner medullary collecting duct cells (mIMCD3). 
The stability of these mutants in mIMCD3 cells was investigated via Western blot analysis, and 
the effect of their expression on mIMCD3 cell viability was analyzed by MTS assay. 
Expression of full-length kAE1 in yeast 
In the present study, two different strategies were used to express full-length kAE1 in yeast. 
Firstly, a signal peptide of Kar2p (Kar2SS) was introduced at the N-terminal position of the 
human kAE1 sequence (hkAE1) to improve ER import of the newly synthesized protein. 
Secondly, the human cDNA sequence of kAE1 was optimized for the synonymous yeast codon 
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(ykAE1). So far, a few truncated versions of AE1/kAE1, such as AE1361–911 (361–911 aa), 
AE1183–911 and AE1388–911, were expressed in baker’s yeast. However, only AE1361–911 was able 
to exchange anions and could partially reach the cell surface, whereas other short versions 
AE1183–911 and AE1388–911 were retained into intracellular compartments (Bonar & Casey, 2010; 
Groves et al., 1996; Sekler et al., 1995). The idea behind introducing a Kar2SS was the 
attachment of a yeast signal peptide to the human protein, which has already been shown to 
facilitated ER translocation. For example, a fusion of Kar2SS to TorsinA, a human 
AAA+ ATPase, increased its ER translocation and stability in S. cerevisiae (Chalfant et al., 
2019). Besides, the generation of mRNA transcripts is one of the critical factors for an effective 
translation rate. Each organism uses a specific set of preferred codons during translation (64 
different codon triplet combinations are generally possible). It was proposed that the codon 
usage variability is determined by either the codon decoding rate or the codon reading ability 
of a particular organism (Chu & Haar, 2012; Routledge et al., 2016). 
Immunoblot results of the full-length kAE1 variants showed that the human cDNA sequence 
of kAE1 failed to be expressed in S. cerevisiae. This finding is in line with previous studies 
suggesting a failure to express the human sequence of kAE1 in yeast (Groves et al., 1999). 
Interestingly, it could be shown that the yeast codon-optimization of the human kAE1 sequence 
led to robust expression of the full-length kAE1, whereas addition of Kar2SS at the N-terminus 
of kAE1 only had a weak impact on the protein synthesis (Figure 3.2). Thus, the 
Kar2SS-hkAE1V5 variant was not considered for further experiments. Notably, the yeast codon-
optimized sequence of kAE1 seems to be expressed efficiently by yeast cells. It means that 
codon optimization has significantly improved the translation accuracy as well as the translation 
rate of the kAE1 mRNA in yeast. The human codon usage was found to be the restriction factor 
for the synthesis of full-length kAE1 in yeast cells. Therefore, it proposes that the codon 
optimization technique provides a valid possibility to express a variety of tagged and untagged 
full-length versions of kAE1 in S. cerevisiae. 
Plasma membrane localization of full-length kAE1 in yeast 
To study ykAE1 protein trafficking, the C-terminal end of kAE1 was tagged either with a 
V5 tag or yeGFP. Indirect immunofluorescence results of wild-type yeast cells expressing 
ykAE1V5 showed a complete intracellular localization of the protein (Figure 3.5). Similarly, 
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confocal microscopy images of BY4742 cells expressing ykAE1-yeGFP resulted in 
intracellular retention of the fusion protein at a comparable level to the ykAE1V5 variant 
(Figure 3.6). It has been reported that any alteration at the C-terminus of kAE1 may affect its 
functional targeting to the basolateral membrane (Cordat et al., 2003). The untagged ykAE1 
was generated to investigate the trafficking of the wild-type protein in yeast. Unlike the 
C-terminally tagged kAE1, indirect immunofluorescence data of untagged ykAE1 displayed 
few peripheral fluorescence signals (Figure 3.4). Although a substantial amount of the anion 
transporter was in the membrane of subcellular structures, this data showed a first hint of the 
plasma membrane localization of full-length kAE1. Several features on the C-terminal end of 
kAE1 are important for trafficking to the cell surface, and thus, tags could somehow interfere 
with proper recognition of kAE1 by transport machinery of the secretory pathway. The kAE1 
C-terminus contains a tyrosine-based sorting motif Y904DEV907 and a class-II PDZ-binding 
domain A908MPV911. It has been reported that the tyrosine-based sorting motif (YxxΦ; Y 
represents tyrosine, x represents for any amino acid and Φ represents a hydrophobic amino acid) 
is crucial for the basolateral membrane targeting of kAE1. AP-1 -mu1A directly interacts with 
the tyrosine-based motif at the trans-Golgi network and mediates the basolateral sorting process 
of kAE1 (Almomani et al., 2012; Junking et al., 2014). In addition, the last four amino acids of 
the kAE1 polypeptide chain (A908MPV911) act as a class-II PDZ-binding domain (xΦxΦ-
COOH; x represents any amino acid and Φ represents any hydrophobic amino acid). As 
reported previously, the class-II PDZ-binding domain also plays a role in the basolateral 
targeting of the kAE1 protein. The dominant kAE1 M909T mutant displayed both correct 
basolateral targeting and abnormal apical membrane targeting in polarized MDCK cells (Fry et 
al., 2012). Therefore, any alteration in the kAE1 C-terminal region could potentially interfere 
with the plasma membrane targeting of the transporter. 
On the contrary, insertion of an epitope tag at the third extracellular loop or modification of the 
N-terminus neither affects kAE1 function nor its localization to the plasma membrane in 
mammalian cells (Beckmann et al., 2002; Parker & Tanner, 2004). Therefore, a third 
extracellular loop HA-tagged ykAE1 (ykAE1HA) and an N-terminal yeGFP fusion of kAE1 
(yeGFP-ykAE1) were constructed. The colocalization study of ykAE1HA and yeGFP-ykAE1 
variants with a plasma membrane marker Pma1p-mRFP further strengthened the hypothesis of 
plasma membrane targeting of kAE1 in yeast (Figure 3.11 and 3.12). Colocalization images 
suggested that a small pool of kAE1 is overlapping with Pma1p. These data align with a recently 
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published electron microscopy (EM) study, where a precise plasma membrane localization of 
full-length kAE1 is confirmed (Sarder et al., 2020). In that study, two full-length kAE1 variants 
(HA-tagged ykAE1HA and untagged ykAE1) were expressed in Δend3 mutant cells (defective 
in endocytosis) or Δpep4 mutant cells (defective in vacuolar degradation) and found at the cell 
surface to a small extent. A positive control, the truncated version of yeast codon-optimized 
kAE1 (ykAE1B3mem, equivalent to AE1361–911), was also detected at the plasma membrane of 
yeast cells to comparable quantities to the full-length kAE1. Besides, cell surface biotinylation 
of wild-type yeast cells (BY4742) expressing the untagged ykAE1 variant further indicates that 
a small fraction of full-length kAE1 is localized at the yeast plasma membrane (Figure 3.16). 
Altogether, these data indicate—for the first time—that the full-length kAE1 variants are able 
to reach the plasma membrane of S. cerevisiae. Nevertheless, the plasma membrane localization 
of kAE1 is limited to a small fraction. The full-length versions of kAE1 are trafficked to the 
cell surface in a comparable amount to the previously reported AE1361–911 variant. Notably, the 
kAE1 C-terminus interactions with carrier molecules in yeast are vital for the cell surface 
localization. Therefore, an unmodified C-terminus of kAE1 is the most critical factor for the 
plasma membrane targeting of kAE1 in S. cerevisiae. 
Intracellular accumulation of kAE1 in S. cerevisiae 
Former studies in yeast reported that kAE1 is highly prone to be trapped in different subcellular 
membrane structures (Bonar & Casey, 2010). The observation of spinning disk microscopy data 
suggested that a majority of the expressed kAE1 was intracellularly accumulated in protein-rich 
membrane-like structure (Figure 3.11). This finding was in agreement with the EM study of 
three different ykAE1 variants (ykAE1HA, ykAE1 and ykAE1B3mem) expressed in yeast cells. 
Furthermore, the EM results revealed that kAE1 was additionally found in multivesicular 
bodies (MVBs), indicating a partial targeting of kAE1 to the vacuole for subsequent degradation 
(Sarder et al., 2020). MVBs usually form at late endosomes and are involved in the degradation 
of membrane proteins by fusing to the vacuole/lysosome. In yeast, proteins from the PM or 
trans-Golgi network are being sorted in MVBs and transported to the vacuole for degradation 
through endosomal sorting complexes for transport (ESCRT) pathways (Henne et al., 2011; 
Piper & Katzmann, 2010). The presence of an increased amount of kAE1 protein in the vacuole 
compared to the plasma membrane in Δend3 cells suggests that the protein is more likely 
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transported from the Golgi network to the vacuole via the ESCRT-mediated pathway than the 
alternative route from the plasma membrane to the vacuole known as the endocytic pathway. 
An increased amount of kAE1 protein in the vacuole of vacuolar protease deficient Δpep4 cells 
further supports this hypothesis (Feyder et al., 2015; Sarder et al., 2020).  
Since full-length kAE1 was severely aggregated in intracellular membranes, various parameters 
affecting protein synthesis and processing were tested for increasing the cell surface localization 
of the anion exchanger, such as inducer concentration, temperature, and UPR-activation. In this 
study, kAE1 was inducibly expressed by using a PGAL1 promoter, which is a strong metabolic 
promoter. The reason for selecting a strong promoter was that transcription should not be the 
limiting factor of kAE1 synthesis. Therefore, it was tested whether robust expression of kAE1 
is overwhelming for the cellular machinery of the host and leads to misfolded protein. It was 
found that the presence of 3% galactose in the selective medium (uracil d/o galactose) indeed 
produces a substantial amount of protein, which seems to be a burden for the protein processing 
machinery of S. cerevisiae resulting in aggregated protein (Figure 3.12). The reduction of the 
galactose amount from 3.0% to 1.0% showed less intracellular accumulation of yeGFP-kAE1 
in wild-type BY4742. It is to be noted that the low amount of galactose overall decreases the 
kAE1 expression, but does not increase the plasma membrane localization of the protein. In 
addition, these results correspond with a previous work reporting that the production of bovine 
rhodopsin (an integral membrane protein) using a PGAL1 promoter upon 2% galactose induction 
causes inactive partial/non-glycosylated protein due to overload on the secretory pathway 
(Mollaaghababa et al., 1996). Nevertheless, a slight increase in peripheral kAE1 protein was 
detected in Δend3 mutant cells, which correspond to the impaired endocytosis processes in 
these cells (Figure 3.13). Therefore, it is conceivable that one of the reasons for the 
accumulation of kAE1 in the ER or ER-derived vesicles is due to the extreme rate of mRNA 
synthesis, which subsequently produces an abundant amount of kAE1 protein. The high amount 
of newly synthesized kAE1 protein is translocated into the ER and trapped there. However, first 
attemps for a singly copy integration of the kAE1 gene into the yeast genome to reduce potential 
cellular burdens were not successful (Xiaobing Li, unpublished data). 
The next strategy considered to decrease the intracellular accumulation of kAE1 was a 
reduction of the culture temperature. During the heterologous protein expression, the 
sustainability of an expression vector imposes a significant metabolic burden on cells. 
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Reduction of culture temperature is often applied to decrease this burden. It has been previously 
reported that low culture temperature helps to improve protein folding by reducing the rate of 
protein synthesis followed by slowing down the cell growth rate (Vera et al., 2007). To 
determine the effect of growth temperature on kAE1 synthesis, wild-type BY4742 and 
Δend3 cells co-expressing yeGFP-kAE1 and Pma1p-mRPF were cultivated at 20 ºC. However, 
decreasing growth temperature from 30 ºC to 20 ºC did not reduce the intracellular 
accumulation of kAE1 in yeast. Fluorescence microscopy results showed that kAE1 was 
intracellularly accumulated in both wild-type and Δend3 yeast cells incubated at 20 ºC 
(Figure 3.14). These results suggest that there is no significant influence of reduced culture 
temperature on kAE1 processing in wild-type BY4742 cells and Δend3 cells. Since low culture 
temperature also induces stress that influences major cellular processes including transcription, 
translation, protein folding rates and membrane composition (Barria et al., 2013), a temperature 
lower than 20 ºC was not considered for incubating cells. 
Another way of improving proper protein folding is to alter the functional mechanism of the 
secretory pathway, in particular, the controlling of unfolded protein response (UPR). UPR is an 
adaptive cellular pathway that checks the folding state of a newly synthesized protein in the 
ER-lumen. During the membrane protein processing for subsequent migration in the secretory 
pathway, it regulates the level of luminal foldase and chaperones as required (Kaufman et al., 
2002; Spear & Ng, 2001). In this study, UPR was activated by additional overexpression of 
Hac1p, one of the main regulators of the UPR, in kAE1 expressing cells to determine whether 
activation of the UPR could enhance kAE1 processing in the secretory pathway as well as the 
subsequent targeting to the plasma membrane. The fluorescence microscopy images indicate 
that there was no significant reduction of intracellular accumulation of yeGFP-kAE1 as well as 
no noticeable increment of the cell surface localization (Figure 3.15). Previously, it was shown 
in many studies that manipulation of the stress response has a positive impact on membrane 
protein synthesis; however, the amplitude of the effect is only protein-specific (Breinig et al., 
2006; Griffith et al., 2003; Lee et al., 2012). These results indicate that merely overexpression 
of Hac1p could not significantly reduce intracellular retention and subsequent plasma 
membrane targeting of kAE1 in yeast. 
In addition, an important element of membrane protein functionality is the adequate post-
transitional modification such as glycosylation. Improper glycosylation of membrane proteins 
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causes misfolding or aggregation that ultimately leads to dysfunctional proteins. For instance, 
glycosylation is critical for plasma membrane localization of nephrin, a transmembrane 
glycoprotein expressed in glomerular podocytes, and impairment of glycosylation results in a 
complete ER retention of the protein in HEK293 cells (Yan et al., 2002). However, it has been 
reported that mammalian plasma membrane proteins typically display less maturation when 
expressed in yeast compared to their plant or fungi homologs (Groves et al., 1999). Since full-
length kAE1 lacks Asn642 glycosylation (Figure 3.17), it is conceivable that the overexpression 
of this variant in S. cerevisiae causes folding defects which prevent its efficient trafficking 
through the secretory pathway. Nevertheless, unglycosylated full-length versions of kAE1 were 
able to reach the yeast plasma membrane, which is in agreement with mammalian studies 
reporting that the N-linked glycosylation is not essential for the kAE1 function and plasma 
membrane localization (Casey et al., 1992; Groves & Tanner, 1994). 
Taken together, optimization of the parameters including induction system, temperature and 
UPR regulation is necessary for maximizing the functional expression of multiple 
transmembrane proteins in yeast. However, the current undertaken approaches were not 
efficient enough to achieve an optimal plasma membrane expression of kAE1 protein in 
S. cerevisiae. Additionally, data represented in this study have not adequately addressed the 
basis of this massive accumulation of kAE1 in yeast. In the future, it would be interesting to 
examine the effects of overexpression of different proteins such as HSP10, PHB2 and/or 
ERV29 which are involved in the correct folding, secretion, or trafficking of synthesized 
proteins in the secretory pathway. In addition, previous yeast studies showed that co-expression 
of AE1361–911 with glycophorin A substantially increased plasma membrane located functional 
protein (Groves et al., 1999). As the electron microscopy images also demonstrate inefficient 
plasma membrane targeting of ykAE1B3mem, it can be assumed that a distinct interacting partner 
of kAE1 is absent in yeast, essential for the adequate trafficking of the protein to the plasma 
membrane. Thereby, it would also be interesting to verify the effect of other known interacting 
partners of kAE1 such as AP-1 mu1A, TMEM139, ILK (integral linked kinase) or 
glycophorin A on plasma membrane targeting by co-expressing them in yeast (Groves & 
Tanner, 1992; Keskanokwong et al., 2007). Further experiments are needed to achieve an ideal 
condition for the cell surface localization of kAE1 in yeast. 
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Biological activity of full-length kAE1 in yeast 
Once the expression of the full-length kAE1 was verified in yeast, the biological activity of the 
anion exchanger was determined. Initially, the activity was checked by performing a functional 
complementation assay of Bor1p and full-length kAE1. Bor1p is a borate transporter in yeast 
and shares structural homology with AE1/kAE1 (Thurtle-Schmidt & Stroud, 2016). 
Overexpression of ykAE1V5 variant could not compensate and rescue the growth of Δbor1 cells 
when challenged with boric acid (Figure 3.18 and 3.19). This result correlates with previous 
studies reported that the anion exchanger does not mediate borate transport (Jennings, 1976; 
Jennings & Adame, 1996), and likewise, could not recover cells from borate toxicity. Thus, this 
study did not support the hypothesis of the functional homology between kAE1 and Bor1p. 
Notably, both BY4742 and Δbor1 cells expressing ykAE1V5 exhibited an overall reduction of 
growth rate in the absence of boric acid, indicating that kAE1 expression likely induces cellular 
stress. It is known that heterologous expression of foreign proteins leads to cell growth defect 
which is often coupled with ER-stress (Kauffman et al., 2002; Kintaka et al., 2016). Since this 
finding was not within the scope of this study, no further experiments in that direction were 
carried out. However, it would be interesting to address kAE1 related growth defects in the 
future. 
Next, the functionality of kAE1 was determined by intracellular pH measurements using the 
pH-sensitive dye SNARF-5F AM, and the results confirm the biological activity of the protein. 
Constitutive expression of untagged ykAE1 using a PPGK promoter led to a significant drop in 
cytosolic pH compared to empty vector expression in wild-type BY4742 cells (Figure 3.21). 
To show that the decrease in cytosolic pH was mainly caused by kAE1, cytosolic pH of 
BY4742-GEV cells was further determined in which kAE1 expression was induced in a dose-
dependent manner via β-estradiol addition. In BY4742-GEV cells, a clear correlation between 
kAE1 expression and the decline of cytosolic pH was observed (Figure 3.23). These data are 
consistent with previous research by Lashhab and colleagues, showing that the expression of 
wild-type kAE1 in mIMCD3 cells decreases the steady-state cytosolic pH level (Lashhab, et 
al., 2019). Furthermore, it has been reported that AE1/kAE1 can perform non-bicarbonate 
transport such as transport of SO42− ions instead of HCO3− ions in exchange for Cl− ions 
(Jennings & Smith, 1992). This non-bicarbonate transport through kAE1 occurs when a proton 
(H+) is transported with SO42− ions in return for Cl− ions as an electroneutral exchange. The 
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absence of HCO3− ions in the experimental setup likewise indicates the transportation of H+ 
coupled with SO42− ions than HCO3− ions in exchange with Cl− ions via the yeast expressed 
kAE1. Figure 4.1 shows a hypothetical model of possible substrate exchange in a yeast model. 
 
 
Figure 4.1: Hypothetical model for the observed cytosolic pH drop of S. cerevisiae 
expressing kAE1. 
A small pool of kAE1 protein can reach the plasma membrane after being expressed in yeast 
cells and shows a biological activity of the protein. kAE1 is likely transporting intracellular Cl− 
ions in exchange for H+ + SO42− ions (alternative of HCO3− ions) due to the presence of 40 mM 
SO42− in the growth medium and absence of HCO3− ions in the experimental setup. A previous 
study already mentioned that kAE1 could regulate the influx or efflux of SO42− ions coupled 
with protons in yeast cells. The influx of excess H+ ions then leads to the cytosolic pH drop in 
yeast cells. Figure is modified from Sarder et al., 2020. 
 
As illustrated in the aforementioned model, the presence of extracellular excess SO42− ions in 
the culture medium (40 mM) would result in the influx of H+ coupled with SO42− and efflux of 
Cl− ions in presence of kAE1. Therefore, this phenomenon led to an increased influx of H+ 
inflow into the yeast cytosol that ultimately causes a reduction of cytosolic pH. In agreement 
with this theory, the gradual increment of kAE1 protein level resulted in a stepwise reduction 
of cytosolic pH, which was presumably caused by the increasing amount of functional kAE1 at 
the plasma membrane under higher expression level condition. 
The biological activity of kAE1 in yeast was further demonstrated by measuring the Cl− influx 
rate and intracellular Cl− concentration of kAE1 expressing cells. Under hyperosmotic 
conditions (150 mM NaCl), there were neither SO42− ions nor HCO3− ions present in the 
extracellular buffer solution. The results of anion-exchange chromatography showed a 
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significant difference between the influx rate of Cl− and intracellular Cl− concentration in cells 
expressing kAE1 than the empty vector expressing cells. Yeast cells expressing kAE1 exhibited 
a significant reduction of Cl− ions influx rate compared to empty vector expressing cells 
(Figure 3.24). Nevertheless, it is still puzzling to explain why the kAE1 expression results in 
the efflux of Cl− ions. In yeast, passive diffusion of Cl− ions takes place under hyperosmotic 
conditions (Jennings & Cui, 2008). Based on the findings of this study, it could be possible that 
Cl− ions, transgressing the yeast plasma membrane via passive diffusion, would constantly be 
exported from the cytosol by the activity of correctly localized and active kAE1. In contrast, 
cells expressing the empty vector could not conduct such outflow of Cl− ions in a similar 
manner. The kAE1-mediated Cl− efflux was additionally characterized by incubation of kAE1 
expressing yeast cells with the supplementation of DIDS, a kAE1-specific inhibitor. As 
predicted, inactivation of kAE1 with DIDS leads to an impairment of kAE1-mediated Cl− efflux 
causing a higher Cl− influx rate than kAE1 expressing cells. This result indicates kAE1 function 
is necessary for the excessive efflux of Cl− ions from the cytosol of yeast cells. However, these 
observations are opposite to a former study reporting an influx of Cl− ions in yeast cells 
expressing truncated AE1361–911 (Groves et al., 1996). Notably, the results may not be suitable 
to be directly correlated to the results gained after the expression of a truncated AE1361–911 
version due to the entirely different experimental setups used in both studies. Moreover, a little 
is known about the Cl− and cytosolic pH regulation of yeast cells impeding an extensive 
interpretation of the data obtained in this study. Figure 4.2 shows a hypothetical model of Cl− 
efflux as a result of kAE1 expression in yeast cells. 
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Figure 4.2: Hypothetical model for kAE1-mediated Cl− efflux under hyperosmotic 
condition. 
Under hyperosmotic conditions (150 mM NaCl), Cl− passively diffuses into the cytosol of 
S. cerevisiae (dashed arrow). (A) Empty vector cells have less outflow of cytosolic Cl− (solid 
arrow), which results in a rise of intracellular Cl− ([Cl−]in) and ultimately leading to a drop of 
extracellular Cl− ([Cl−]ex). (B). In case of kAE1 expressing yeast cells, it seems that the excess 
amount of cytosolic Cl− is ejected by the activity of kAE1 which leads to the decrease of [Cl−]in. 
Notably, it is still not clear which anion is exchanged for Cl− (indicated as a question mark). 
Since SO42− is absent in the extracellular buffer, it is most unlikely that the observed Cl− efflux 
is achieved in exchange with SO42− as previously observed in the pH measurement. (C) DIDS 
treatment of kAE1 expressing cells, which selectively blocks the activity of kAE1, again 
displays a rise of [Cl−]in leading to a decrease of [Cl−]ex comparable to empty vector expressing 
cells like phenotype. The model is modified from Sarder et al., 2020. 
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In addition, wild-type BY4742 cells treated with DIDS displayed a little reduction of 
extracellular Cl− concentration (data not shown). It might be possible that DIDS unspecifically 
binds/blocks some of the endogenous Cl− transporters. In yeast, Gef1p is known as a 
voltage-gated Cl− channel located in the Golgi membrane, endosomal compartments and 
plasma membrane. It plays a crucial role in ion homeostasis in yeast cells (Flis et al., 2002; 
López-Rodríguez et al., 2007). Additionally, Yh1008cp is another protein reported to be 
involved in the uptake of Cl− (Jennings & Cui, 2008). Thus, Δgef1 or Δyh1008c cells could be 
suitable candidates for a better understanding of the kAE1-mediated Cl− efflux. Moreover, an 
increment of the NaCl concentration would be another approach to clarify the kAE1-mediated 
Cl− transport. It was previously reported that high salt concentrations (≥ 0.6 M NaCl) have a 
negative impact on the growth of S. cerevisiae (André et al., 1991; Prista et al., 1997). Thus, it 
would be interesting to examine if the expression of kAE1 could improve/rescue the growth 
defects of S. cerevisiae in high salinity conditions. Indeed, further experiments are required for 
understanding the appropriate mechanism of kAE1 in yeast. 
Expression and localization of kAE1 mutants in yeast 
After the successful expression of different wild-typic kAE1 variants, attempts were taken to 
express kAE1 mutants in S. cerevisiae for further understanding of the kAE1 trafficking 
process. Interestingly, two kAE1 mutants were able to be expressed in S. cerevisiae in this 
study: the Cl−/HCO3− exchange impaired mutant kAE1 E681Q and the recessive mutant kAE1 
G701D. The mutant proteins were expressed in BY4742-GEV cells upon 10 µM β-estradiol 
induction. The immunoblot results indicated that both kAE1 E681Q and G701DFlag mutant 
protein levels are comparable to the wild-type kAE1 protein level (Figure 3.25). Hence, this 
data suggests that the expression of different kAE1 mutants is now possible in yeast at a high 
quantity. Furthermore, the indirect immunofluorescence results of the untagged E681Q showed 
a peripheral localization of the mutant protein (Figure 3.26), which is consistent with similar 
studies in mammalian cells. It was reported that E681Q mutant was predominantly localized at 
the plasma membrane of polarized and non-polarized mIMCD3 cells (Lashhab et al., 2019) In 
contrast, the G701DFlag mutant was retained in the ER in yeast cells that was similar to the 
results observed in MDCK cells (Cordat et al., 2006). Altogether, localization of both E681Q 
and G701D in yeast was comparable to the results obtained in mammalian studies. These results 
suggest as a piece of first body evidence that it is possible to use S. cerevisiae for 
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characterization of kAE1 mutants to find their degradation pathway or interacting partners for 
the plasma membrane targeting. Thus, this study further highlights the potential of yeast as a 
model organism. Nevertheless, it was only the initial investigation of kAE1 mutant localization 
in yeast, and further analysis is needed by high-resolution microscopy or transmission electron 
microscopy to have a precise understanding of the intracellular localization of the kAE1 
mutants. 
Characterization of the novel dRTA mutants in mIMCD3 cells 
In the second part of this study, three novel dRTA mutants, a recessive kAE1 R295H and two 
dominant kAE1 Y413H and S525F mutants, were characterized in a mouse inner medullary 
cell line (mIMCD3). It was mentioned in previous studies that the specific trafficking 
phenotypes of dRTA mutants could be influenced by the genetic background of the used host 
cells or organisms; however, it is also important to identify a suitable mammalian model system 
for analyzing the characteristics of dRTA mutants in vitro. Preliminary evidence in mIMCD3 
cells supports that the kAE1 R589H mutant behaves similarly to the wild-type protein, which 
corresponds with the study in kAE1 R607H knock-in mice as well as biopsy data of dRTA 
patients (Mumtaz et al., 2017; Vichot et al., 2017). This observation highlights that mIMCD3 
cells are an excellent mammalian cell model to mimic the in vivo dRTA situation. Therefore, 
the three new mutants were characterized in mIMCD3 cells by generating a stable cell line 
using the pLVX-TRE3G inducible expression system in which mutant proteins were expressed 
upon doxycycline induction. On the immunoblot, two distinct bands for wild-type protein and 
all the three mutants were seen, where the top band refers to protein carrying a complex-
oligosaccharide and the bottom band refers to protein carrying a high-mannose oligosaccharide 
(Figure 3.27). The matured kAE1 protein resided at the plasma membrane naturally carries an 
N-linked complex-oligosaccharide (Drickamer, 1978). It is known that nascent membrane 
proteins are initially processed into the ER with the assist of an array of complex quality-control 
mechanisms for proper folding and subsequently sorting for targeting to the Golgi, trans-Golgi 
network (TGN) and plasma membrane (Chu et al., 2013). Similarly, newly produced kAE1 
protein is translocated into the ER where it co-translationally gains a high-mannose 
oligosaccharide at the position of Asn642 (Li et al., 2000; Quilty et al., 2002). Furthermore, when 
kAE1 reaches the median Golgi compartment, its high-mannose glycosylation is modified to 
complex-oligosaccharide and sorted for its final destination from the TGN to the plasma 
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membrane (Toye et al., 2004). Therefore, the location of kAE1 in the cell can be identified by 
its type of oligosaccharide processing. A careful observation of the immunoblot results points 
out that the two dominant kAE1 Y413H and S525F mutants produced a higher amount of high-
mannose oligosaccharide protein compared to wild-type kAE1. This high-mannose protein 
indicates that a large amount of the protein resides in the ER and may have difficulties to move 
to the Golgi compartment. In contrast, the recessive mutant kAE1 R295H showed a comparable 
band pattern to wild-type kAE1 protein, suggesting that this mutant could escape from the ER 
and Golgi, and could be transported to the plasma membrane. In addition, all three mutants 
showed a significant reduction of half-life compared to the wild-type protein (Figure 3.28) 
which is due to the premature degradation of mutant proteins in mIMCD3 cells. It was also 
reported that ER accumulation of the misfolded proteins initiates the endoplasmic 
reticulum-associated degradation (ERAD) system for protein degradation (Bravo et al., 2013). 
Therefore, it can be postulated that the mutant variants are recognized as misfolded proteins. In 
MDCK cells, dominant mutants kAE1 R589H and S613F were retained in the ER by 
chaperones and destined for the ERAD system (Toye et al., 2004). However, plasma 
membrane-located misfolded proteins can be recognized by the peripheral quality control 
machinery, known as endosomal sorting complexes required for transport (ESCRT) system, 
and prematurely targeted for lysosomal degradation (Apaja et al., 2010). For example, an 
investigation of the recessive mutant kAE1 G701D in MDCK cells showed that the mutant 
protein reached the plasma membrane but was prematurely endocytosed before it was targeted 
for lysosomal degradation using the ESCRT machinery (Chu et al., 2014). 
Previously, studies in kAE1 R607H knock-in mice revealed that there was a defect in the 
autophagy process, which was identified by the accumulations of p62 protein in α-intercalated 
cells (Mumtaz et al., 2017). p62 is known as a regulator of autophagy and is usually found to 
be aggregated after defects in the autophagy process (Komatsu et al., 2007). In this study, the 
overall level of p62 was found to be elevated in mIMCD3 cells expressing dRTA mutants 
compared to the cells expressing wild-type kAE1 (Figure 3.29). However, among the three 
dRTA mutants, only the dominant kAE1 Y413H mutant displayed a significant rise of p62 
level. In addition, this mutant showed a more intense band of protein carrying high-mannose 
oligosaccharides compared to the other two dRTA mutants on the immunoblot. This result 
suggests that during the maturation process in mIMCD3, a large amount of kAE1 Y413H 
mutant is only connected to high-mannose oligosaccharides and consequently recognized as a 
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misfolded protein. Therefore, the accumulation of the misfolded mutant proteins in ER likely 
triggers the ERAD system followed by ubiquitination. The ubiquitinated protein aggregates are 
then recognized by p62 and destined for autophagy processes (Cohen-Kaplan et al., 2016; 
Ichimura et al., 2008). Previous studies reported that autophagy is activated when the 
proteasome can not adequately sequester the polyubiquitinylated target protein (Liu et al., 
2016). Unfortunately, the data obtained in this study have not sufficiently addressed the reason 
for the increased level of p62 in mIMCD3 cells. Therefore, the elevated p62 level in mIMCD3 
cells could be a result of either a high amount of protein marked for clearance via the autophagy 
process or an impairment in the proteasomal degradation pathway. Therefore, further 
experiments are needed for a detailed understanding of the effect on the autophagy process by 
the dRTA mutants in mIMCD3 cells. One possibility would be monitoring the degradation of 
p62 or analyzing the level of LC3-II (an autophagosome marker) in dRTA mutant expressing 
cells. 
In addition, the effect of dRTA-causing mutants on the viability of mIMCD3 cells was 
investigated by a colorimetric assay (MTS assay). The basis of this analysis was that the number 
of α-intercalated cells found severely depleted in dRTA patients as well as in dominant dRTA 
knock-in mice (Mumtaz et al., 2017; Vichot et al., 2017). The dRTA mutants were expressed 
until 72 h to check their effect on cell viability. Expression of kAE1 R295H, Y413H and S525F 
mutants in mIMCD3 cells showed no adverse effect on mIMCD3 cell proliferation under 
normal or hyperosmotic conditions (Figure 3.30). This result suggests that these dRTA mutants 
are not toxic to mIMCD3 cells under the experimental conditions. It is conceivable that the 
cellular environment is different between mIMCD3 and α-intercalated cells. It was reported 
that wild-type kAE1 expression leads to the acidification of cytosolic pH in mIMCD3 cells due 
to the transport of bicarbonate into the growth medium (Lashhab et al., 2019). Moreover, the 
in vivo study of kAE1 R607H knock-in mice proposed that the depletion of α-intercalated cells 
is based on the dysfunction of V-H+-ATPase coupled with defective autophagy processes 
(Mumtaz et al., 2017). V-H+-ATPase was mistargeted in α-intercalated cells under dRTA 
condition, which likely results in impaired cellular pH homeostasis. Unfortunately, this is not 
possible in mIMCD3 cells due to the lack of expression of V-H+-ATPase (Madsen et al., 1988). 
Therefore, it can be postulated that the expression of the kAE1 mutant may not alkalinize the 
cytosolic pH in mIMCD3 as observed in vivo dRTA conditions. Another possible reason might 
be the reduced osmotic pressure of in vitro culture condition of mIMCD3 cells. In distal 
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nephrons, α-intercalated cells are exposed to a hyperosmotic condition (up to 1200 mOsmol/kg 
H2O) in vivo under normal physiological state (Gottschalk, 1960). The hyperosmotic medium 
used in this study (~500 mOsmol/kg H2O) does not appear to be adequate to cause osmotic 
stress on mIMCD3 cells as the cells can adapt to osmotic pressure even higher 
(up to 910 mOsmol/kg H2O). Therefore, a higher osmolarity of the culture medium would be 
interesting to analyze the effect of the mutant on mIMCD3 cells. 
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5. Outlook 
The primary objective of this project was to establish S. cerevisiae as a cellular model system 
for a comprehensive analysis of kAE1 physiology and identifying the specific features of its 
disease-causing mutants. So far, the data presented in this study show the first insight of full-
length kAE1 expression, localization, and functionality in yeast. However, only a minor amount 
of expressed protein was able to reach the yeast cell surface, which could hinder the 
understanding kAE1 activity and its trafficking mechanism(s) in yeast. To achieve a larger 
quantity of kAE1 at the cell surface, it is essential to identify the crucial interacting partners 
involved in the cell surface targeting of the anion exchanger in yeast. For this purpose, a 
single-gene overexpression screening, especially for the genes involved in protein transport, 
would permit for more understanding of the responsible genes in kAE1 trafficking. Moreover, 
a massive accumulation of the anion transporter was observed in intracellular membrane-like 
structures. The origin of the kAE1-aggregates would be possible to detect by using specific 
marker proteins for different intracellular organelles. A further knock-out screen of proteins 
responsible for the misfolded protein degradation in those particular compartments would be 
useful for attaining a more in-depth insight into kAE1 transport to the cell periphery. In 
addition, the data generated from those studies could then be translated to the situation of human 
cells for finding homologous genes. This would help to understand the premature degradation 
of the dRTA-causing mutants. However, baker’s yeast also possesses few limitations likewise 
any other system for studying kAE1. Since it is a single cell organism and is not polarized, the 
cell-to-cell interaction study typically occurring in a complex organ like the kidney is not 
possible. Therefore, it might exclude the possibility to study more complex dRTA-causing 
conditions. Furthermore, investigation of the three novel dRTA mutants (kAE1 R295H, 
Y413H, and S525F) in mIMCD3 cells provided new information about the premature 
degradation of those mutants. Nevertheless, expression of the mutants did not affect the 
viability of mIMCD3 cells as it has been observed in the in vivo dRTA condition. In dRTA 
patients as well as in a dRTA knock-in mouse model, the trafficking defects of the 
V-H+-ATPase were found that likely result in cytotoxicity due to cellular acid-base imbalance. 
Since the in vivo dRTA condition is very complicated, the generation of a stable cell line of 
α-intercalated cells or three-dimensional cell culture of mIMCD3 cells mimicking the in vivo 
situation more closely would be interesting and could provide a better understanding of the 
molecular mechanism of dRTA in future.  
 131 
6. Summary 
Under physiological conditions, kAE1 plays a significant role in renal acid-base regulation. 
Mutations in the kAE1 encoding gene lead to a disease called dRTA. Until now, the underlying 
mechanism for disease progression is unknown. The detailed knowledge of kAE1 biogenesis, 
structural-functionality, and its interplay with other proteins is one of the fundamental ways to 
elucidate the complex process of dRTA progression. In this context, the present study 
highlighted the potential of S. cerevisiae as a “prototype” for investigating physiological 
aspects of kAE1 in a fast and affordable manner. To achieve that goal, several kAE1 variants 
were constructed. The data of this study confirm that different untagged and tagged full-length 
kAE1 variants can be expressed in yeast. Moreover, only the yeast codon-optimized kAE1 
constructs were found to be expressed at a high level in S. cerevisiae. The subcellular 
localization of the protein was then determined by fluorescence-based and confocal 
microscopy. Tagging at the C-terminus of yeast codon-optimized kAE1 constructs inhibited the 
cell surface targeting of the anion exchanger in yeast. Additionally, the untagged full-length 
kAE1 variant was found at the plasma membrane of yeast—for the first time—though to a 
minor extent. The third exofacial loop HA tag did not alter plasma membrane targeting of kAE1 
in yeast and was found at a comparable level on the cell surface to the untagged kAE1 variant. 
Notably, the results of cytosolic pH measurement and anion exchange chromatography 
represent a piece of primary evidence for the biological activity of kAE1 in yeast, although the 
complex molecular mechanistic of its activity remain unclear. Furthermore, three new dRTA 
mutants (kAE1 R295H, Y413H and S525F) were analyzed in mIMCD3 cells, and it was found 
that the mutants are degraded at a faster rate than the wild-type protein. However, expression 
of these mutants did not have any influence on the proliferation rate of mIMCD3 cells. 
Overall, this work provided a first stepping stone to analyze the full-length functional 
kAE1 rapidly and inexpensively by utilizing yeast. Thus, the study facilitates a quick screening 
of the complete kAE1 sequence for mutants affecting transport activity. This will open the 
opportunity to map the global interactions of kAE1 with other proteins, which will further assist 
in identifying the crucial interacting partners and enlightening the complex dRTA mechanism 
in the future. Moreover, the investigations in mIMCD3 cells enable resolving the phenotype of 
dRTA mutants in an in vivo dRTA situation. 
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DNA sequences (5´–3´ direction) purchased to generate various kAE1 expression plasmid for 
yeast are shown below. Restriction sites are displayed in lower-case letters, signal sequences 
are in red color, epitope-tag sequences are in bold and linker sequences are underlined. (A) V5-
tagged human kAE1 sequence, (B) V5-tagged human kAE1 sequence with an additional Kar2p 
signal sequence at the N-terminus, (C) V5-tagged yeast codon-optimized kAE1 sequence, (D) 
yeast codon-optimized kAE1 sequence fused to a yeGFP sequence at the C-terminus, (E) yeast 
codon-optimized kAE1 sequence with an integrated HA tag in the third extracellular loop 
between amino acid 557 and 578 (according to AE1 sequence) and (F) the sequence of a N-
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